Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - SYMBION INC/TN | exh312symbion.htm |
| EX-32.1 - EXHIBIT 32.1 - SYMBION INC/TN | exh321symbion.htm |
| EX-31.1 - EXHIBIT 31.1 - SYMBION INC/TN | exh311symbion.htm |
| EX-32.2 - EXHIBIT 32.2 - SYMBION INC/TN | exh322symbion.htm |
| EX-15 - 2010 INTEREST RATE SWAP AGREEMENT - SYMBION INC/TN | exh15swapagreement.htm |
| EX-21 - EXHIBIT 21 - SYMBION INC/TN | exh21symbion.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________________
Form 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 2010
Commission file number: 000-50574
Symbion, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 62-1625480 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
40 Burton Hills Boulevard, Suite 500
Nashville, Tennessee 37215
(Address of principal executive offices and zip code)
(615) 234-5900
(Registrant’s telephone number, including area code)
Securities Registered Pursuant to Section 12(b) of the Act: None
Securities Registered Pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes x No o
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes o No x
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer o | Accelerated filer o | |
Non-accelerated filer x | Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
None of the registrant’s common stock is held by non-affiliates.
As of March 25, 2011, 1,000 shares of the registrant’s common stock were outstanding.
Cautionary Note Regarding Forward-Looking Statements
This Annual Report on Form 10-K contains forward-looking statements based on our current expectations, estimates and assumptions about future events. All statements other than statements of current or historical fact contained in this report, including statements regarding our future financial position, business strategy, budgets, projected costs and plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “plan,” “will” and similar expressions are generally intended to identify forward-looking statements.
These forward-looking statements involve various risks and uncertainties, some of which are beyond our control. Any or all of our forward-looking statements in this report may turn out to be wrong. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. They can be affected by inaccurate assumptions we might make or by known or unknown risks, uncertainties and assumptions, including the risks, uncertainties and assumptions described in Item 1A. “Risk Factors.”
In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. When you consider these forward-looking statements, you should keep in mind these risk factors and other cautionary statements in this report.
Our forward-looking statements speak only as of the date made. Other than as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
PART I
Item 1. Business
Overview
We own and operate a national network of short stay surgical facilities in 27 states. Our surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics, pain management, gastroenterology and ophthalmology. Some of our hospitals also offer additional services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, physical therapy and wound care.
We own our surgical facilities in partnership with physicians and in some cases healthcare systems in the markets and communities we serve. We apply a market-based approach in structuring our partnerships with individual market dynamics driving the structure. We believe this approach aligns our interests with those of our partners.
As of December 31, 2010, we owned and operated 54 surgical facilities, including 49 ASCs, four surgical hospitals, and one general acute care hospital with a surgical and obstetrics focus. We also managed eight additional ASCs. We owned a majority interest in 29 of the 54 surgical facilities and consolidated 49 facilities for financial reporting purposes. In addition to our surgical facilities, we also manage one physician network in a market in which we operate an ASC.
We have benefited from both the growth in overall outpatient surgery cases as well as the migration of surgical procedures from the hospital to the surgical facility setting. Advancements in medical technology, such as lasers, arthroscopy and enhanced endoscopic techniques, have reduced the trauma of surgery and the amount of recovery time required by patients following a surgical procedure. Improvements in anesthesia also have shortened the recovery time for many patients and have reduced post-operative side effects such as pain, nausea and drowsiness. These medical advancements have enabled more patients to undergo surgery in a surgical facility setting.
On September 16, 2002, we reincorporated in Delaware after originally incorporating in Tennessee in January 1996. On August 23, 2007, we were acquired by Symbion Holdings Corporation (“Holdings”), which is owned by Crestview Partners, L.P. (“Crestview”) and certain affiliated funds managed by Crestview and co-investors, in a merger transaction (the “Merger”). As a result of the Merger, we no longer have publically traded equity securities.
Industry Overview
The outpatient ambulatory surgery market in the United States has grown to a $17.0 billion industry according to the Medicare Payment Advisory Commission. There are several factors leading to increased utilization of outpatient surgical facilities. We believe physicians often prefer to operate in surgical facilities, as compared to acute care hospitals, because of the efficiency and convenience surgical facilities afford. Procedures performed at surgical facilities are typically non-emergency, allowing physicians to schedule their time more efficiently and increase the number of procedures performed in a given period. Surgical facilities also provide physicians with more consistent nurse staffing and faster turnaround time between cases, as compared to acute care hospitals.
Many patients also prefer surgical facilities as a result of more convenient locations, shorter waiting times, and more convenient scheduling and registration than acute care hospitals. Additionally, Medicare beneficiaries generally experience lower coinsurance as a result of lower Medicare payment rates. As patients increasingly have more input into the delivery of their healthcare, we believe these factors will be drivers of growth in ASC utilization.
Surgeries performed in surgical facilities are generally less expensive than those performed in acute care hospitals because of lower
2
facility development costs, more efficient staffing and work flow processes. We believe payors are attracted to the lower costs available at surgical facilities, as compared to acute care hospitals. With increased attention on controlling healthcare costs in the United States, we feel our facilities will benefit from their position as a low-cost alternative for delivering surgical procedures.
Advancements in medical technology such as lasers, arthroscopy, fiber optics and enhanced endoscopic techniques have reduced the trauma of surgery and the amount of recovery time required by patients following a surgical procedure. Improvements in anesthesia also have shortened the recovery time for many patients and have reduced certain post-operative side effects. These medical advancements have enabled more patients to undergo surgery not requiring an overnight stay and reduced the need for hospitalization following surgery.
The number of surgical procedures performed in ASCs reimbursed by Medicare now exceeds 3,400. As the Centers for Medicare and Medicaid Services ("CMS") continues to add surgical procedures to Medicare's list of approved ASC procedures, we believe this will have the effect of further expanding the market opportunity. There currently are approximately 5,300 Medicare certified ASCs operating in the United States according to the CMS. As the industry remains very fragmented, we believe there continues to be significant opportunities for consolidation.
Our Strategy
Our intent is to enhance the performance of our existing facilities by increasing revenues, profitability and return on our invested capital at all of our surgical facilities through operational focus, including recruitment and retention of surgeons and other physicians. We also intend to expand our network of surgical facilities in attractive markets throughout the United States by selectively acquiring established facilities, developing new facilities, and expanding our presence in existing markets. When attractive opportunities arise, we may acquire or develop other types of facilities. The key components of our strategy are to:
▪ Enhance the performance of our existing facilities through operational focus, including recruitment and retention of leading surgeons and other physicians for our surgical facilities.
We have a dedicated operations team that is responsible for implementing best practices, cost controls and overall efficiencies at each of our surgical facilities. Our facilities benefit from our network of facilities by sharing best practices and participating in group purchasing agreements designed to reduce the cost of supplies and equipment. We also review our managed care contracts to ensure that we are operating under the most favorable terms available to us.
We believe that establishing and maintaining strong relationships with surgeons and other physicians is a key factor to our success in acquiring, developing and operating surgical facilities. We identify and partner with surgeons and other physicians that we believe have established reputations for clinical excellence in their communities. We believe that we have had success in recruiting and retaining physicians because of the ownership structure of our surgical facilities and our staffing, scheduling and clinical systems that are designed to increase physician productivity, promote physicians' professional success and enhance the quality of patient care. We also believe that forming relationships with health care systems and other healthcare providers can enhance our ability to recruit physicians. We currently have strategic relationships with five health care systems. We intend to continue to recruit additional physicians and expand the range of services offered at our surgical facilities to increase the number and types of surgeries performed in our facilities, including a focus on higher acuity cases. We are committed to enhancing programs and services for our physicians and patients by providing advanced technology, quality care, cost-effective service and convenience.
▪ Capitalize on our experienced management team to expand our network of surgical facilities in attractive markets throughout the United States by selectively acquiring established facilities, developing new facilities, and expanding our presence in existing markets.
We believe that the experience and capabilities of our senior management team provide a strategic advantage in improving the operations of our surgical facilities, attracting physicians and identifying new development and acquisition opportunities. Our senior management team has an average of over 30 years of experience in the healthcare industry having held senior management positions at public and private healthcare companies. Our management's broad industry experience has allowed us to establish strong relationships with participants throughout the healthcare industry. These relationships are helpful in forming leads for acquisitions and in making decisions about expanding into new markets and services. The experience and capabilities of our management team also enable us to pursue multiple growth strategies in the surgical facility market, including acquisitions of established surgical facilities, de novo developments in attractive markets, strategic relationships with prominent healthcare systems and other healthcare providers and turnaround opportunities in connection with underperforming facilities. We have successfully executed each of these growth strategies, and intend to pursue each of them in the future.
3
Operations
Surgical Facility Operations
As of December 31, 2010, we owned (with physician investors or healthcare systems) and operated 54 surgical facilities and managed eight additional surgical facilities. Five of our surgical facilities are licensed as hospitals. Our typical ASC is a freestanding facility with about 14,000 square feet of space and four fully equipped operating rooms, two treatment rooms and ancillary areas for preparation, recovery, reception and administration.
Our typical surgical hospital is larger than a typical ASC and includes inpatient hospital rooms and, in some cases, an emergency department. Our surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics, gynecology, general surgery, ear, nose and throat, pain management, gastroenterology, plastic surgery and ophthalmology. Our hospitals may also provide additional services such as diagnostic imaging, pharmacy, laboratory, obstetrics, physical therapy and wound care. In certain markets where we believe it is appropriate, we operate surgical facilities that focus on a single specialty.
Our surgical facilities are generally located in close proximity to physicians’ offices. Each surgical facility typically employs a staff of about 30, depending on its size, the number of cases and the type of services provided. Our staff at each surgical facility generally includes a facility administrator, a business manager, a medical director, registered nurses, operating room technicians and clerical workers. At each of our surgical facilities, we have arrangements with anesthesiologists to provide anesthesiology services. We also provide each of our surgical facilities with a full range of financial, marketing and operating services. For example, our regional managed care directors assist the local management team at each of our surgical facilities in developing relationships with managed care providers and negotiating managed care contracts.
All of our surgical facilities are Medicare certified. To ensure that a high level of care is provided, we implement quality assurance procedures at each of our surgical facilities. In addition, a majority of our surgical facilities are also independently accredited by either the Joint Commission or the Accreditation Association for Ambulatory Health Care. Each of our surgical facilities is available for use only by licensed physicians who have met professional credentialing requirements established by the facility’s medical advisory committee. In addition, each surgical facility’s medical director supervises and is responsible for the quality of medical care provided at the surgical facility.
Surgical Facility Ownership Structure
We own and operate our surgical facilities through partnerships or limited liability companies. Local physicians or physician groups also own interests in most of our surgical facilities. In some cases, a hospital system may own an interest in our surgical facility. One of our wholly owned subsidiaries typically serves as the general partner or managing member of our surgical facilities. We seek to own a majority interest in our surgical facilities, or otherwise have sufficient control over the facilities to be able to consolidate the financial results of operations of the facilities with ours. In some instances, we will acquire ownership in a surgical facility with the prior owners retaining ownership, and, in some cases, we offer new ownership to other physicians or hospital partners. We hold majority ownership in 29 of the 54 surgical facilities in which we own an interest. We typically guarantee all of the debts of these partnerships and limited liability companies, even though we do not own all of the interests in the surgical facilities. We also provide intercompany debt, which often is secured by a pledge of assets of the partnership or limited liability company. We also have a management agreement with each of the surgical facilities, under which we provide day-to-day management services for a management fee, which is typically equal to a percentage of the revenues of the facility.
Each of the partnerships and limited liability companies through which we own and operate our surgical facilities is governed by a partnership or operating agreement. These partnership and operating agreements typically provide, among other things, for voting rights and limited transfer of ownership. The partnership and operating agreements also provide for the distribution of available cash to the owners. In addition, the agreements typically restrict the physician owners from owning an interest in a competing surgical facility during the period in which the physician owns an interest in our surgical facility and for one year after that period. The partnership and operating agreements for our surgical facilities typically provide that the facilities will purchase all of the physicians’ ownership if certain adverse regulatory events occur, such as it becoming illegal for the physicians to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The purchase price that we would be required to pay for the ownership is based on pre-determined formulas, typically either a multiple of the surgical facility’s EBITDA, as defined in our partnership and operating agreements, or the fair market value of the ownership as determined by an independent third-party appraisal. Some of these agreements require us to make a good faith effort to restructure our relationships with the physician investors in a manner that preserves the economic terms of the relationship prior to purchasing these interests. In certain circumstances, we have the right to purchase a physician’s ownership, including upon a physician’s breach of the restriction on ownership provisions of a partnership or operating agreement. In some cases, we have the right to require the physician owners to purchase our ownership in the event our management agreement with a surgical facility is terminated. In certain surgical facilities, the physician owners have the right to purchase our ownership upon a change in our control.
4
Surgical Facilities
The following table sets forth information regarding each of our surgical facilities as of December 31, 2010:
Surgical Facility | City | Number of Operating Rooms | Number of Treatment Rooms | Symbion Percentage Ownership | ||||||
Alabama | ||||||||||
Birmingham Surgery Center | Birmingham | 6 | 2 | 59 | % | (1) | ||||
California | ||||||||||
Specialty Surgical Center of Beverly Hills / Brighton Way | Beverly Hills | 3 | 1 | 41 | % | (1) | ||||
Specialty Surgical Center of Beverly Hills / Wilshire Boulevard | Beverly Hills | 4 | 2 | 42 | % | (1) | ||||
Specialty Surgical Center of Encino | Encino | 4 | 2 | 61 | % | (1) | ||||
Specialty Surgical Center of Irvine | Irvine | 5 | 1 | 51 | % | (1) | ||||
Specialty Surgical Center of Westlake Village | Westlake Village | 4 | 2 | 19 | % | |||||
Colorado | ||||||||||
Minimally Invasive Spine Institute | Boulder | 2 | 1 | 41 | % | (1) | ||||
Animas Surgical Hospital | Durango | 4 | 1 | 65 | % | (1)(2) | ||||
12 hospital rooms | ||||||||||
Florida | ||||||||||
West Bay Surgery Center | Largo | 4 | 4 | 51 | % | (1) | ||||
Jacksonville Beach Surgery Center | Jacksonville | 4 | 1 | 82 | % | (1) | ||||
Cape Coral Ambulatory Surgery Center | Cape Coral | 5 | 6 | 65 | % | (1) | ||||
Lee Island Coast Surgery Center | Fort Myers | 5 | 3 | 50 | % | (1) | ||||
Tampa Bay Regional Surgery Center | Largo | 0 | 3 | 51 | % | (1) | ||||
The Surgery Center of Ocala | Ocala | 4 | 2 | 51 | % | (1) | ||||
Blue Springs Surgery Center | Orange City | 3 | 2 | 34 | % | (1) | ||||
Georgia | ||||||||||
Premier Surgery Center | Brunswick | 3 | 0 | 58 | % | (1) | ||||
The Surgery Center | Columbus | 4 | 2 | 63 | % | (1) | ||||
Hawaii | ||||||||||
Honolulu Spine Center | Honolulu | 2 | 0 | 50 | % | (1) | ||||
Idaho | ||||||||||
Mountain View Hospital | Idaho Falls | 10 | 3 | 49 | % | (1)(2) | ||||
43 hospital rooms | ||||||||||
Illinois | ||||||||||
Valley Ambulatory Surgery Center | St. Charles | 6 | 1 | 40 | % | (1) | ||||
Indiana | ||||||||||
New Albany Outpatient Surgery | New Albany | 3 | 1 | 79 | % | (1) | ||||
Kansas | ||||||||||
Cypress Surgery Center | Wichita | 6 | 5 | 54 | % | (1) | ||||
Kentucky | ||||||||||
DuPont Surgery Center | Louisville | 5 | 0 | 61 | % | (1) | ||||
Louisiana | ||||||||||
Greater New Orleans Surgery Center | Metairie | 2 | 0 | 30 | % | (1) | ||||
Physicians Medical Center | Houma | 5 | 3 | 53 | % | (1)(2) | ||||
30 hospital rooms | ||||||||||
Massachusetts | ||||||||||
Worcester Surgery Center | Worcester | 4 | 1 | 56 | % | (1) | ||||
Michigan | ||||||||||
Novi Surgery Center | Novi | 4 | 3 | 13 | % | |||||
Missouri | ||||||||||
5
Surgical Facility | City | Number of Operating Rooms | Number of Treatment Rooms | Symbion Percentage Ownership | ||||||
Central Missouri Medical Park Surgical Center | Jefferson City | 4 | 2 | 40 | % | (1) | ||||
Timberlake Surgery Center | Chesterfield | 4 | 1 | 56 | % | (1) | ||||
St. Louis Spine and Orthopedic | Chesterfield | 3 | 1 | 50 | % | (1) | ||||
Mississippi | ||||||||||
DeSoto Surgery Center | DeSoto | 2 | 1 | — | % | (3) | ||||
Physicians Outpatient Center | Oxford | 4 | 2 | — | % | (3) | ||||
New York | ||||||||||
South Shore Ambulatory Surgery Center | Lynbrook | 4 | 1 | 40 | % | (4)(1) | ||||
North Carolina | ||||||||||
Orthopaedic Surgery Center of Asheville | Asheville | 3 | 0 | 59 | % | (1) | ||||
Wilmington SurgCare | Wilmington | 7 | 3 | 75 | % | (1) | ||||
Ohio | ||||||||||
Physicians Ambulatory Surgery Center | Circleville | 2 | 0 | 56 | % | (1) | ||||
Valley Surgical Center | Steubenville | 3 | 1 | 58 | % | (1) | ||||
Oklahoma | ||||||||||
Lakeside Women’s Hospital | Oklahoma City | 3 | 3 | 42 | % | (2) | ||||
23 hospital rooms | ||||||||||
Oregon | ||||||||||
Gresham Station Surgery Center | Gresham | 5 | 1 | 38 | % | |||||
Pennsylvania | ||||||||||
Village SurgiCenter | Erie | 5 | 1 | 72 | % | (1) | ||||
Surgery Center of Pennsylvania | Havertown | 5 | 1 | 49 | % | (1) | ||||
Rhode Island | ||||||||||
Bayside Endoscopy Center | Providence | 0 | 6 | 75 | % | (1) | ||||
East Greenwich Endoscopy Center | East Greenwich | 0 | 4 | 45 | % | (1) | ||||
East Bay Endoscopy Center | Portsmouth | 0 | 1 | 75 | % | (1) | ||||
South Carolina | ||||||||||
The Center for Specialty Surgery | Greenville | 2 | 0 | 78 | % | (1) | ||||
Tennessee | ||||||||||
Baptist Germantown Surgery Center | Memphis | 6 | 1 | — | % | (3) | ||||
Cool Springs Surgery Center | Franklin | 5 | 1 | 36 | % | |||||
East Memphis Surgery Center | Memphis | 6 | 2 | — | % | (3) | ||||
Midtown Surgery Center | Memphis | 4 | 0 | — | % | (3) | ||||
Southwind GI | Memphis | 2 | 0 | 100 | % | (1) | ||||
Union City Surgery Center | Union City | 3 | 1 | — | % | (3) | ||||
UroCenter | Memphis | 3 | 0 | — | % | (3) | ||||
Premier Orthopaedic Surgery Center | Nashville | 2 | 0 | 20 | % | |||||
Renaissance Surgery Center | Bristol | 2 | 1 | 37 | % | (1) | ||||
Texas | ||||||||||
Surgical Hospital of Austin | Austin | 6 | 1 | 42 | % | (1)(2) | ||||
26 hospital rooms | ||||||||||
Central Park Surgery Center | Austin | 5 | 1 | 45 | % | (1) | ||||
Clear Fork Surgery Center | Fort Worth | 4 | 1 | 34 | % | (1) | ||||
Village Specialty Surgical Center | San Antonio | 4 | 4 | 58 | % | (1) | ||||
NorthStar Surgical Center | Lubbock | 6 | 3 | 45 | % | (1) | ||||
Texarkana Surgery Center | Texarkana | 4 | 3 | 58 | % | (1) | ||||
Washington | (1) | |||||||||
Bellingham Surgery Center | Bellingham | 4 | 0 | 84 | % | (1) | ||||
Microsurgical Spine Center | Puyallup | 1 | 1 | 50 | % | (1) | ||||
(1) | We consolidate this surgical facility for financial reporting purposes. |
6
(2) | This surgical facility is licensed as a hospital. |
(3) | We manage this surgical facility, but do not have ownership in the facility. |
(4) | Due to regulatory restrictions in the State of New York, we cannot directly hold ownership in the surgical facility. We hold 40% ownership in the limited liability company (the “Operating Company”) which provides administrative services to this surgical facility and consolidate the facility for financial reporting purposes. Additionally, we manage this facility. Subject to satisfaction of certain conditions, we will be required to sell, and a group of physician owners of the Operating Company will be required to purchase, our remaining 40% ownership in the Operating Company. If certain conditions are not satisfied, we will have the right to acquire the approximately 25% ownership interest of such physician owners in the Operating Company. We are currently arbitrating various matters in dispute relative to our arrangements with this group of physician owners of the Operating Company. |
Strategic Relationships
When attractive opportunities arise, we may develop, acquire or operate surgical facilities through strategic relationships with healthcare systems and other healthcare providers. We believe that forming a relationship with a healthcare system can enhance our ability to attract physicians and access managed care contracts for our surgical facilities in that market. We currently have strategic relationships with:
▪ | Vanderbilt Health Services, Inc., with which we own and operate a surgical facility in Franklin, Tennessee; |
▪ | Vanguard Health Systems, Inc., with which we own and operate a surgical facility in San Antonio, Texas; |
▪ | Baptist Memorial Health Services, Inc. (“Baptist Memorial”), for which we manage seven surgical facilities in Memphis, Tennessee and surrounding areas; |
▪ | Harris Methodist Ft. Worth, with which we own and operate a surgical facility in Fort Worth, Texas; and |
▪ | Adventist Health System, with which we own and operate a surgical facility in Orange City, Florida. |
The strategic relationships through which we own and operate surgical facilities are governed by partnership and operating agreements that are generally comparable to the partnership and operating agreements of the other surgical facilities in which we own an interest. The primary difference between the structure of these strategic relationships and the other surgical facilities in which we hold ownership is that, in these strategic relationships, a healthcare system holds ownership in the surgical facility, in addition to physician investors. For a general description of the terms of our partnership and operating agreements, see “—Operations—Surgical Facility Ownership Structure.” In each of these strategic relationships, we also have entered into a management agreement under which we provide day-to-day management services for a management fee equal to a percentage of the revenues of the surgical facility. The terms of those management agreements are comparable to the terms of our management agreements with other surgical facilities in which we own an interest.
We manage seven surgical facilities owned by Baptist Memorial under management agreements with Baptist Memorial in exchange for a management fee based on a percentage of the revenues of these surgical facilities. The management agreements terminate in 2014 and may be terminated earlier by either party for material breach after notice and an opportunity to cure.
Acquisition and Development of Surgical Facilities
During 2010, our significant acquisitions were as follows:
▪ | Acquired an incremental, controlling ownership interest in one of our Chesterfield, Missouri facilities which we began consolidating for financial reporting purposes in the third quarter of 2010. |
▪ | Acquired ownership in a general acute care hospital with a surgical and obstetrics focus in Idaho Falls, Idaho which we consolidate for financial reporting purposes. |
We continuously evaluate opportunities to expand our presence in the surgical facility market by making strategic acquisitions of existing surgical facilities and by developing new surgical facilities in cooperation with local physician partners and, when appropriate, with hospital systems and other strategic partners. We have the flexibility to structure our partnerships as two-way arrangements where either we are a majority owner partnered with physicians or we are a minority owner with buy-up rights. These buy-up rights give us the option to own a controlling interest at some point in the future. Alternatively, we may choose to pursue a three-way arrangement with physicians and a healthcare system partner.
Acquisition Program
We employ a dedicated acquisition team with experience in healthcare services. Our team seeks to acquire surgical facilities that meet our criteria, including prominence and quality of physician partners, specialty mix, opportunities for growth, level of competition in the local market, level of managed care penetration and our ability to access managed care organization contracts. Our team utilizes its extensive industry contacts, as well as referrals from current physician partners and other sources, to identify, contact and develop potential acquisition candidates.
We believe there are numerous acquisition opportunities that would pass our general screening criteria. We carefully evaluate each of our acquisition opportunities through an extensive due diligence process to determine which facilities have the greatest potential for growth and profitability improvements under our operating structure. In many cases, the acquisition team identifies specific opportunities to enhance a facility’s productivity post-acquisition. For example, we may renovate or construct additional operating or treatment rooms in existing facilities to meet anticipated demand for procedures based on an analysis of local market characteristics. Our team may also identify opportunities to attract additional physicians to increase the acquired facility’s revenues and profitability. We have acquired 52 surgical
7
facilities since January 1999.
Development Program
We develop surgical facilities in markets in which we identify substantial interest by physicians and payors. We have experience in developing both single and multi-specialty surgical facilities. When we develop a new surgical facility, we generally provide all of the services necessary to complete the project. We offer in-house capabilities for structuring partnerships and financing facilities and work with architects and construction firms in the design and development of surgical facilities. Before and during the development phase of a new surgical facility, we analyze the competitive environment in the local market, review market data to identify appropriate services to provide, prepare and analyze financial forecasts, evaluate regulatory and licensing issues and assist in designing the surgical facility and identifying appropriate equipment to purchase or lease. After the surgical facility is developed, we generally provide startup operational support, including information systems, equipment procurement and financing. We have developed 24 surgical facilities since January 1999.
Development of a typical ambulatory surgery center generally occurs over a 12 to 18 month period, depending on whether the facility is being constructed or available space improved. Total development costs typically amount to $4.0 to $6.0 million. Development costs include estimated costs of $1.5 million to $2.0 million typically for improving existing space and equipment plus other furnishing costs of $1.5 million to $2.5 million and working capital of approximately $1.0 million to $1.5 million that is generally required to sustain operations for the initial six to 12 months of operations. We typically fund about 80% of the development costs of a new surgical facility with a combination of corporate borrowings and cash from operations, and the remainder with equity contributed by us and the other owners of the facility. For our consolidated surgical facilities, the indebtedness typically consists of intercompany loans that we provide, and for our non-consolidated surgical facilities, the indebtedness typically consists of third-party debt for which we provide a guarantee for only our pro rata share.
Other Services
Although our business is primarily focused on owning and operating surgical facilities, we also manage a physician practice in Memphis, Tennessee. This physician practice has entered into an agreement with us, which provides, among other things, that we will provide billing, financial services and other business management services in exchange for a management fee.
Information Systems and Controls
Each of our surgical facilities uses a financial reporting system that provides information to our corporate office to track financial performance on a timely basis. In addition, each of our surgical facilities uses an operating system to manage its business that provides critical support in areas such as scheduling, billing and collection, accounts receivable management, purchasing and other essential operational functions. We have implemented systems to support all of our surgical facilities and to enable us to more easily access information about our surgical facilities on a timely basis.
We calculate net revenues through a combination of manual and system-generated processes. Our operating systems include insurance modules that allow us to establish profiles of insurance plans and their respective payment rates. The systems then match the charges with the insurance plan rates and compute a contractual adjustment estimate for each patient account. We then manually review the reasonableness of the systems’ contractual adjustment estimate using the insurance profiles. This estimate is adjusted, if needed, when the insurance payment is received and posted to the account. Net revenues are computed and reported by the systems as a result of this activity.
It is our policy to collect co-payments and deductibles prior to providing services. It is also our policy to verify a patient’s insurance 72 hours prior to the patient’s procedure. Because our services are primarily non-emergency, our surgical facilities have the ability to control these processes. We do not track exceptions to these policies, but we believe that they occur infrequently and involve insignificant amounts. When exceptions do occur, we require patients whose insurance coverage is not verified to assume full responsibility for the fees prior to services being rendered, and we seek prompt payment of co-payments and deductibles and verification of insurance following the procedure.
We manually input each patient’s account record and the associated billing codes. Our operating systems then calculate the amount of fees for that patient and the amount of the contractual adjustments. Claims are submitted electronically if the payor accepts electronic claims. We use clearinghouses for electronic claims, which then forward the claims to the respective payors. Payments are manually input to the respective patient accounts.
We have developed proprietary measurement tools to track key operating statistics at each of our surgical facilities by integrating data from our local operating systems and our financial reporting systems. Management uses these tools to measure operating results against target thresholds and to identify, monitor and adjust areas such as specialty mix, staffing, operating costs, employee expenses and accounts receivable management. Our corporate and facility-level management teams are compensated in part using performance-based incentives focused on revenue growth and improving operating income.
Marketing
We primarily direct our sales and marketing efforts at physicians who would use our surgical facilities. Marketing activities directed at physicians and other healthcare providers are coordinated locally by the individual surgical facility and are supplemented by dedicated corporate personnel. These activities generally emphasize the benefits offered by our surgical facilities compared to other facilities in the market, such as the proximity of our surgical facilities to physicians’ offices, the ability to schedule consecutive cases without
8
preemption by inpatient or emergency procedures, the efficient turnaround time between cases, our advanced surgical equipment and our simplified administrative procedures. Although the facility administrator is the primary point of contact, physicians who utilize our surgical facilities are important sources of recommendations to other physicians regarding the benefits of using our surgical facilities. Each facility administrator develops a target list of physicians, and we continually review these marketing lists and the facility administrator’s progress in contacting and successfully attracting additional local physicians.
We also market our surgical facilities directly to payors, such as health maintenance organizations, or HMOs, preferred provider organizations, or PPOs, and other managed care organizations and employers. Payor marketing activities conducted by our corporate office management and facility administrators emphasize the high quality of care, cost advantages and convenience of our surgical facilities, and are focused on making each surgical facility an approved provider under local managed care plans.
Competition
In each market in which we operate a surgical facility, we compete with hospitals and operators of other surgical facilities to attract physicians and patients. We believe that the competitive factors that affect our surgical facilities’ ability to compete for physicians are convenience of location of the surgical facilities, access to capital and participation in managed care programs. In addition, we believe the national prominence, scale and reputation of our company are instrumental in attracting physicians. We believe that our surgical facilities attract patients based upon our quality of care, the specialties and reputations of the physicians who operate in our surgical facilities, participation in managed care programs, ease of access and convenient scheduling and registration procedures.
In developing or acquiring existing surgical facilities, we compete with other public and private surgical facility and hospital companies. Several large national companies own and/or manage surgical facilities, including HCA Inc., Surgical Care Affiliates, Inc., AmSurg Corp. and United Surgical Partners International, Inc. We also face competition from local hospitals, physician groups and other providers who may compete with us in the ownership and operation of surgical facilities, as well as the trend of physicians choosing to perform procedures in an office-based setting rather than in a surgical facility.
Employees
At December 31, 2010, we had approximately 3,300 employees, of which about 1,900 were full-time employees. None of our employees are represented by a collective bargaining agreement. We believe that we have a good relationship with our employees.
Environmental
We are subject to various federal, state and local laws and regulations relating to the protection of the environment and human health and safety, including those governing the management and disposal of hazardous substances and wastes, the cleanup of contaminated sites and the maintenance of a safe workplace. Our operations include the use, generation and disposal of hazardous materials. We may, in the future, incur liability under environmental statutes and regulations with respect to contamination of sites we own or operate (including contamination caused by prior owners or operators of such sites, adjoining properties or other persons) and the off-site disposal of hazardous substances. We believe that we have been and are in substantial compliance with the terms of all applicable environmental laws and regulations and that we have no liabilities under environmental requirements that we would expect to have a material adverse effect on our business, results of operations or financial condition.
Insurance
We maintain liability insurance in amounts that we believe are appropriate for our operations. Currently, we maintain professional and general liability insurance that provides coverage on a claims-made basis of $1.0 million per occurrence with a retention of $50,000 per occurrence and $3.0 million in annual aggregate coverage per surgical facility, including the facility and employed staff. We also maintain business interruption insurance and property damage insurance, as well as an additional umbrella liability insurance policy in the aggregate amount of $20.0 million. Coverage under certain of these policies is contingent upon the policy being in effect when a claim is made regardless of when the events which caused the claim occurred. The cost and availability of such coverage has varied widely in recent years. In addition, physicians who provide professional services in our surgical facilities are required to maintain separate malpractice coverage with similar minimum coverage limits. While we believe that our insurance policies are adequate in amount and coverage for our anticipated operations, we cannot assure you that the insurance coverage is sufficient to cover all future claims or will continue to be available in adequate amounts or at a reasonable cost.
Sources of Revenue
Approximately 97% of our revenues in 2010 were obtained from facility fees related to healthcare services performed in our surgical facilities. The fee charged varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, supplies, nursing staff and medications. Also, in a very limited number of surgical facilities, we charge for anesthesia services. Our fees do not include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. We recognize our facility fee on the date of service, net of estimated contractual adjustments and discounts for third-party payors, including Medicare and Medicaid. Any changes in estimated contractual adjustments and discounts are recorded in the period of change.
We are dependent upon private and government third-party sources of payment for the services we provide. The amounts that our surgical facilities and physician network receive in payment for their services may be adversely affected by market and cost factors as well as
9
other factors over which we have no control, including Medicare, Medicaid, and state regulations and the cost containment and utilization decisions and reduced reimbursement schedules of third-party payors. Approximately 25%, 24% and 22% of our revenues were from government sources, mostly Medicare, for the years ended December 31, 2010, 2009 and 2008, respectively. The following table sets forth by type of payor the percentage of our patient service revenues generated in the periods indicated:
Year Ended December 31, | ||||||||
2010 | 2009 | 2008 | ||||||
Private Insurance | 69 | % | 71 | % | 72 | % | ||
Government | 25 | 24 | 22 | |||||
Self-pay | 4 | 4 | 4 | |||||
Other | 2 | 1 | 2 | |||||
Total | 100 | % | 100 | % | 100 | % | ||
Medicare Reimbursement-Ambulatory Surgery Centers
Payments under the Medicare program to ASCs are made under a system whereby the Secretary of the Department of Health and Human Services (the “Secretary”) determines payment amounts prospectively for various categories of medical services performed in ambulatory surgery centers. Beginning in 2008, CMS transitioned Medicare payments to ASCs to a system based upon the hospital outpatient prospective payment system ("OPPS"). On November 2, 2010, CMS issued a final rule to update the Medicare program's payment policies and rates for ASCs for 2011. The final rule applies a 0.2% increase to the ASC payment rate. The final rule will also add six procedures to the list of procedures for which Medicare will reimburse when performed in an ASC. If the annual payment recalculations result in a decrease in ambulatory surgery center payment rates for procedures performed in our centers, our revenues and profitability could be materially adversely affected.
Medicare Reimbursement-Hospital Inpatient Services
Five of our surgical facilities are licensed as hospitals. Most inpatient services provided by hospitals are reimbursed by Medicare under the inpatient prospective payment system (“IPPS”). Under this prospective payment system, a hospital receives a fixed amount for inpatient hospital services based on each patient's final assigned diagnosis related group (“DRG”). Each DRG is assigned a payment rate that is prospectively set using national average resources used per case for treating a patient with a particular diagnosis. This DRG assignment also affects the prospectively determined capital rate paid with each DRG. DRG and capital payments are adjusted by a predetermined geographic adjustment factor assigned to the geographic area in which the hospital is located. The index used to adjust the DRG rates, known as the “hospital market basket index,” gives consideration to the inflation experienced by hospitals in purchasing goods and services.
On July 30, 2010, CMS issued the final IPPS rates for the federal fiscal year ("FFY") 2011. Per the final rule, the market basket update for FFY 2011 for hospitals under the IPPS was raised to 2.35 % for hospitals that submit quality data in accordance with the Reporting Hospital Quality Date for Annual Payment Update and 0.35% for hospitals that do not submit quality data. Future realignments in the DRG system could impact the margins we receive for certain services and additional adjustments will reduce IPPS payments to hospitals and could adversely impact our Medicare revenues.
Medicare Reimbursement-Hospital Outpatient Services
Most outpatient services provided by hospitals are reimbursed by Medicare under the OPPS whereby hospital outpatient services are classified into groups called ambulatory payment classifications (“APCs”). CMS establishes a payment rate for each APC by multiplying the scaled relative weight for the APC by a conversion factor. The payment rate is further adjusted to reflect geographic wage differences. APC classifications and payment rates are reviewed and adjusted on an annual basis. If CMS' annual payment recalculations result in a decrease in APC payment rates for procedures performed in our hospitals, our revenues and profitability could be materially adversely affected.
On November 2, 2010, CMS issued the final OPPS rates for calendar year ("CY") 2011. Per the final rule, the market basket update for CY 2011 for hospitals under the OPPS was raised to 2.35 % for hospitals that submit quality data in accordance with the Hospital Outpatient Quality Data Reporting Program and 0.35% for hospitals that do not submit quality data. In addition, OPPS rule would also waive the Medicare deductibles and copayments for certain preventative services reimbursed under OPPS.
Private Third-Party Payors
Most third-party payors pay pursuant to a written contract with our surgical facilities. These contracts generally require our hospitals and ASCs to offer discounts from their established charges. Some of our payments come from third-party payors with which our surgical facilities do not have written contracts. In those situations, commonly known as “out-of-network” services, we generally charge the patients the same co-payment or other patient responsibility amounts that we would have charged had our center had a contract with the third-party payor. We also submit a claim for the services to the third-party payor along with full disclosure that our surgical facility has charged the patient an in-network patient responsibility amount.
10
Annual Cost Reports
Hospitals participating in the Medicare and some Medicaid programs, whether paid on a reasonable cost basis or under a prospective payment system, are required to meet certain financial reporting requirements. Federal and, where applicable, state regulations require submission of annual cost reports identifying medical costs and expenses associated with the services provided by each hospital to Medicare beneficiaries and Medicaid recipients.
Annual cost reports required under the Medicare and some Medicaid programs are subject to routine governmental audits. These audits may result in adjustments to the amounts ultimately determined to be payable to us under these reimbursement programs. Finalization of these audits often takes several years. Providers may appeal any final determination made in connection with an audit.
Governmental Regulation
General
The healthcare industry is highly regulated, and we cannot provide any assurance that the regulatory environment in which we operate will not significantly change in the future or that we will be able to successfully address any such changes. In addition to extensive, existing government healthcare regulation, there continue to be numerous and potentially far-reaching initiatives on the federal and state levels affecting the payment for and availability of healthcare services. Some of the reform initiatives proposed, such as further reductions in Medicare and Medicaid payments and additional prohibitions on physician ownership of facilities to which they refer patients, could, if adopted, adversely affect us and our business.
Every state imposes licensing requirements on individual physicians and healthcare facilities. In addition, federal and state laws regulate HMOs and other managed care organizations. Many states require regulatory approval, including licensure, and in some cases certificates of need, before establishing certain types of healthcare facilities, including surgical hospitals and ASCs, offering certain services, including the services we offer, or making expenditures in excess of certain amounts for healthcare equipment, facilities or programs. Our ability to operate profitably will depend in part upon all of our surgical facilities obtaining and maintaining all necessary licenses, certificates of need and other approvals and operating in compliance with applicable healthcare regulations. Failure to do so could have a material adverse effect on our business.
The laws of many states prohibit physicians from splitting fees with non-physicians (i.e., sharing in a percentage of professional fees), prohibit non-physician entities (such as us) from practicing medicine and exercising control over or employing physicians and prohibit referrals to facilities in which physicians have a financial interest. We believe our activities do not violate these state laws. However, future interpretations of, or changes in, these laws might require structural and organizational modifications of our existing relationships with facilities and the physician network, and we cannot assure you that we would be able to appropriately modify such relationships. In addition, statutes in some states could restrict our expansion into those states.
Our surgical facilities are subject to federal, state and local laws dealing with issues such as occupational safety, employment, medical leave, insurance regulations, civil rights, discrimination, building codes and medical waste and other environmental issues. Federal, state and local governments are expanding the regulatory requirements on businesses. The imposition of these regulatory requirements may have the effect of increasing operating costs and reducing the profitability of our operations.
We believe that hospital, outpatient surgery and diagnostic services will continue to be subject to intense regulation at the federal and state levels. We are unable to predict what additional government regulations, if any, affecting our business may be enacted in the future or how existing or future laws and regulations might be interpreted. If we, or any of our surgical facilities, fail to comply with applicable laws, it might have a material adverse effect on our business.
Certificates of Need and Licensure
Capital expenditures for the construction of new healthcare facilities, the addition of beds or new healthcare services or the acquisition of existing healthcare facilities may be reviewable by state regulators under statutory schemes that are sometimes referred to as certificate of need laws. States with certificate of need laws place limits on the construction and acquisition of healthcare facilities and the expansion of existing facilities and services. In these states, approvals, generally known as certificates of need, are required for capital expenditures exceeding certain pre-set monetary thresholds for the development, acquisition and/or expansion of certain facilities or services, including surgical facilities. We have a concentration of surgical facilities in certificate of need states as we believe the regulations present a competitive advantage to existing operators.
Our healthcare facilities also are subject to state licensing requirements for medical providers. Our facilities have licenses to operate as ASCs in the states in which they operate, except for (i) one facility in Colorado, one facility in Louisiana, one facility in Oklahoma, one facility in Texas and one facility in Idaho, each of which is licensed as a hospital, and (ii) one surgical facility in the State of Washington where such state does not issue licenses for ASCs. Our surgical facilities that are licensed as ASCs must meet all applicable requirements for ASCs. In addition, even though our surgical facilities that are licensed as hospitals primarily provide surgical services, they must meet all applicable requirements for general hospital licensure. To assure continued compliance with these regulations, governmental and other authorities periodically inspect our surgical facilities. The failure to comply with these regulations could result in the suspension or revocation of a facility's license. In addition, based on the specific operations of our surgical facilities, some of these facilities maintain a pharmacy license, a controlled substance registration, a clinical laboratory certification waiver, and environmental protection permits for biohazards and/or radioactive materials, as required by applicable law.
11
Healthcare Reform
The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 were signed into law on March 23, 2010 and March 30, 2010, respectively, dramatically altering the U.S. healthcare system. The Affordable Care Act is intended to provide coverage and access to substantially all Americans, to increase the quality of care provided, and to reduce the rate of growth in healthcare expenditures. The changes include, among other things, reducing payments to Medicare Advantage plans, expanding the Medicare program's use of value-based purchasing programs, tying hospital payments to the satisfaction of certain quality criteria, bundling payments to hospitals and other providers, reducing Medicare and Medicaid payments, expanding Medicare and Medicaid eligibility, and expanding access to health insurance. As part of the effort to control or reduce healthcare spending, the Affordable Care Act also contains a number of measures intended to reduce fraud and abuse in the Medicare and Medicaid programs, such as requiring the use of recovery audit contractors in the Medicaid program and limitations on the federal physician self-referral law (“Stark Law”) exception that allows physicians to have ownership interests in hospitals (the “Whole Hospital Exception”). Among other things, the Affordable Care Act prohibits hospitals from increasing the percentages of the total value of the ownership interests held in the hospital by physicians after March 23, 2010, as well as place severe restrictions on the ability of a hospital subject to the Whole Hospital Exception to add operating rooms, procedure rooms and beds. The Affordable Care Act provides for additional enforcement tools, cooperation between agencies, and funding for enforcement. It is difficult to predict the impact the Affordable Care Act will have on the Company's operations given the delay in implementing regulation, pending court challenges, and possible amendment or repeal of elements of the Affordable Care Act. The Affordable Care Act mandates reductions in reimbursement, such as adjustments to the hospital inpatient and outpatient prospective payment system market basket updates and productivity adjustments to Medicare's annual inflation updates, which became effective in 2010 or will be effective in 2011 and 2012. Further, a majority of the measures contained in the Affordable Care Act do not take effect until 2013 or later. The Affordable Care Act could have a material adverse effect on our financial condition and results of operations.
Quality Improvement
Quality of care and value-based purchasing also have become significant trends and competitive factors in the healthcare industry. In 2005, CMS began making public performance data relating to ten quality measures that hospitals submit in connection with their Medicare reimbursement. Since that time, CMS has on several occasions increased the number of quality measures hospitals are required to report in order to receive the full IPPS and OPPS market basket updates. In addition, the Medicare program no longer reimburses hospitals for the cost of care relating to certain preventable adverse events, and many private healthcare payers have adopted similar policies. The Affordable Care Act also contains a number of provisions that are intended to improve the quality of care that is provided to Medicare and Medicaid beneficiaries. For example, beginning July 1, 2011, the Affordable Care Act prohibits Medicaid programs from using federal funds to reimburse providers for the costs of care needed to treat hospital acquired conditions (“HACs”). Beginning in FFY 2015, the Affordable Care Act mandates a 1% reduction in Medicare payments for hospitals that were in the highest quartile of national risk-adjusted HAC rates for the previous FFY. Beginning in FFY 2013, the Affordable Care Act requires CMS to implement a value-based purchasing program for Medicare hospitals that would reduce IPPS payments by 1% in FFY 2013 (gradually increasing to 2% in FFY 2017) and to use those funds to provide additional payments to hospitals that meet certain clinical and patient experience of care quality measures. If the public performance data becomes a primary factor in where patients choose to receive care, and if competing hospitals have better results than our hospitals on those measures, we would expect that our patient volumes could decline. In addition, if our hospitals have high HAC rates or are unable to meet the required quality measures, the implementation of the value-based purchasing programs potentially could have a negative effect on our revenues.
Accountable Care Organizations
The Affordable Care Act requires HHS to establish a Medicare Shared Savings Program that promotes accountability and coordination of care through the creation of Accountable Care Organizations (“ACOs”). Beginning no later than January 1, 2012, Medicare will allow providers (including hospitals), physicians and other designated professionals and suppliers to form ACOs and voluntarily work together to invest in infrastructure and redesign delivery processes to achieve high quality and efficient delivery of services. The program is intended to produce savings as a result of improved quality and operational efficiency. ACOs that achieve quality performance standards established by HHS will be eligible to share in a portion of the amounts saved by the Medicare program. HHS has significant discretion to determine key elements of the program, including what steps providers must take to be considered an ACO, how to decide if Medicare program savings have occurred, and what portion of such savings will be paid to ACOs. In addition, HHS will determine to what degree hospitals, physicians and other eligible participants will be able to form and operate an ACO without violating certain existing laws, including the Civil Monetary Penalty Law, the Anti-kickback Statute and the Stark Law. However, the Affordable Care Act does not authorize HHS to waive other laws that may impact the ability of hospitals and other eligible participants to participate in ACOs, such as antitrust laws. The implementation of ACOs could have a negative impact on our financial condition and results of operations if our facilities and physician network are unable to participate or if reimbursement is greatly reduced.
Medicare and Medicaid Participation
The majority of our revenues are expected to continue to be received through third-party reimbursement programs, including state and federal programs, such as Medicare and Medicaid, and private health insurance programs. To participate in the Medicare program and receive Medicare payment, our surgical facilities must comply with regulations promulgated by HHS. Among other things, these regulations, known as “conditions of coverage” or “conditions of participation,” impose numerous requirements on our facilities, their equipment, their personnel and their standards of medical care, as well as compliance with all applicable state and local laws and regulations. On April 26, 2007, CMS issued a policy memorandum that reaffirmed its prior interpretation of its conditions of participation that all hospitals (other than Critical Access Hospitals) participating in the Medicare program are required to provide basic emergency care interventions regardless of
12
whether or not the hospital maintains an emergency department. Our five facilities licensed as hospitals are required to meet this requirement to maintain their participating provider status in the Medicare program. One of our hospitals, which does not have an emergency room, maintains a protocol for the transfer of patients requiring emergency treatment, which protocol may be interpreted as inconsistent with a recent CMS policy memorandum. Our surgical facilities must also satisfy the conditions of participation to be eligible to participate in the various state Medicaid programs. The requirements for certification under Medicare and Medicaid are subject to change and, in order to remain qualified for these programs, we may have to make changes from time to time in our facilities, equipment, personnel or services. Although we intend to continue to participate in these reimbursement programs, we cannot assure you that our surgical facilities will continue to qualify for participation.
CMS requires hospitals to disclose physician ownership to patients. Changes in the Affordable Care Act provide for written disclosures of physician ownership interests to the hospital's patients and on the hospital's website and in any advertising, along with annual reports to the government detailing such interests as well as a requirement that any hospital that does not have 24/7 physician coverage inform patients of this fact and receive signed acknowledgment from the patients of the disclosure. A hospital's provider agreement may be terminated if it fails to provide the notice. A hospital that does not have a physician on site 24 hours per day and 7 days per week could have its provider agreement terminated if it fails to provide notice of this circumstance. In 2010 CMS also issued a “self-referral disclosure protocol” for hospitals and other providers that wish to self-disclose potential violations of the Stark Law to CMS and to attempt to resolve those potential violations and any related overpayment liabilities at levels below the maximum penalties and amounts set forth in the statute. The Disclosure of Financial Relationships Report ("DFRR"), the disclosure requirements set forth in the Affordable Care Act, and the self-referral disclosure protocol reflect a move towards increasing government scrutiny of the financial relationships between hospitals and referring physicians and increasing disclosure of potential violations of the Stark Law to the government by hospitals and other healthcare providers. We intend for all of our facilities to meet their disclosure obligations.
Survey and Accreditation
Hospitals are subject to periodic inspection by federal, state and local authorities to determine their compliance with applicable regulations and requirements necessary for licensing, certification and accreditation. Our hospitals currently are licensed under appropriate state laws and are qualified to participate in the Medicare and Medicaid programs.
Utilization Review
Federal law contains numerous provisions designed to ensure that services rendered by hospitals to Medicare and Medicaid patients meet professionally recognized standards and are medically necessary and that claims for reimbursement are properly filed. These provisions include a requirement that a sampling of admissions of Medicare and Medicaid patients must be reviewed by quality improvement organizations, which review the appropriateness of Medicare and Medicaid patient admissions and discharges, the quality of care provided, the validity of MS-DRG classifications and the appropriateness of cases of extraordinary length of stay or cost. Quality improvement organizations may deny payment for services provided or assess fines and also have the authority to recommend to HHS that a provider which is in substantial noncompliance with the standards of the quality improvement organization be excluded from participation in the Medicare program. Utilization review is also a requirement of most non-governmental managed care organizations.
Federal Anti-Kickback Statute and Medicare Fraud and Abuse Laws
The Social Security Act includes provisions addressing false statements, illegal remuneration and other instances of fraud and abuse in the Medicare program. These provisions are commonly referred to as the Medicare fraud and abuse laws, and include the statute commonly known as the federal anti-kickback statute (the “Anti-Kickback Statute”). The Anti-Kickback Statute prohibits providers and others from, among other things, soliciting, receiving, offering or paying, directly or indirectly, any remuneration in return for either making a referral for, or ordering or arranging for, or recommending the order of, any item or service covered by a federal healthcare program, including, but not limited to, the Medicare program. Violations of the Anti-Kickback Statute are criminal offenses punishable by imprisonment and fines of up to $25,000 for each violation. Civil violations are punishable by fines of up to $50,000 for each violation, as well as damages of up to three times the total amount of remuneration received from the government for healthcare claims.
In addition, the Medicare Patient and Program Protection Act of 1987, as amended by the Health Insurance Portability and Accountability Act of 1996, (“HIPAA”), and the Balanced Budget Act of 1997, impose civil monetary penalties and exclusion from state and federal healthcare programs on providers who commit violations of the Medicare fraud and abuse laws. Pursuant to the enactment of HIPAA, as of June 1, 1997, the Secretary may, and in some cases must, exclude individuals and entities that the Secretary determines have “committed an act” in violation of the Medicare fraud and abuse laws or improperly filed claims in violation of the Medicare fraud and abuse laws from participating in any federal healthcare program. HIPAA also expanded the Secretary's authority to exclude a person involved in fraudulent activity from participating in a program providing health benefits, whether directly or indirectly, in whole or in part, by the U.S. government. Additionally, under HIPAA, individuals who hold a direct or indirect ownership or controlling interest in an entity that is found to violate the Medicare fraud and abuse laws may also be excluded from Medicare and Medicaid and other federal and state healthcare programs if the individual knew or should have known, or acted with deliberate ignorance or reckless disregard of, the truth or falsity of the information of the activity leading to the conviction or exclusion of the entity, or where the individual is an officer or managing employee of such entity. This standard does not require that specific intent to defraud be proven by the Office of the Inspector General of the U.S. Department of Health and Human Services (the “OIG”). Under HIPAA it is also a crime to defraud any commercial healthcare benefit program.
Because physician-investors in our surgical facilities are in a position to generate referrals to the facilities, the distribution of available cash to those investors could come under scrutiny under the Anti-Kickback Statute. The U.S. Third Circuit Court of Appeals has
13
held that the Anti-Kickback Statute is violated if one purpose (as opposed to a primary or sole purpose) of a payment to a provider is to induce referrals. Other federal circuit courts have followed this decision. Because none of these cases involved a joint venture such as those owning and operating our surgical facilities, it is not clear how a court would apply these holdings to our activities. It is clear, however, that a physician's investment income from a surgical facility may not vary with the number of his or her referrals to the surgical facility, and we comply with this prohibition.
In a case involving a physician-owned joint venture, the U.S. Ninth Circuit Court of Appeals held that the Anti-Kickback Statute is violated when a person or entity (1) knows that the statute prohibits offering or paying remuneration to induce referrals and (2) engages in prohibited conduct with the specific intent to violate the law. In that case, the joint venture was determined to have violated the law because its agent solicited prospective limited partners by implying that eligibility to purchase shares in the limited partnership was dependent on an agreement to refer business to it, told prospective limited partners that the number of shares they would be permitted to purchase would depend on the volume of business they referred to the venture, and stated that partners who did not refer business would be pressured to leave the partnership. The court also determined that the joint venture was vicariously liable for the actions of its agents, notwithstanding that the agent's actions were contrary to the principal's stated policy.
Under regulations issued by the OIG, certain categories of activities are deemed not to violate the Anti-Kickback Statute (commonly referred to as the safe harbors). According to the preamble to these safe harbor regulations, the failure of a particular business arrangement to comply with the regulations does not determine whether the arrangement violates the Anti-Kickback Statute. The safe harbor regulations do not make conduct illegal, but instead outline standards that, if complied with, protect conduct that might otherwise be deemed in violation of the Anti-Kickback Statute. Failure to meet a safe harbor does not indicate that the arrangement violates the Anti-Kickback Statute.
We believe the ownership and operations of our surgery centers and hospitals will not fit wholly within safe harbors, but we attempt to incorporate elements of a safe harbor in all of our facilities. Our ASCs, for example, are structured to fit as closely as possible within the safe harbor designed to protect distributions to physician-investors in ambulatory surgery centers who directly refer patients to the ambulatory surgery center and personally perform the procedures at the center as an extension of their practice (the “ASC Safe Harbor”). The ASC Safe Harbor protects four categories of investors, including facilities owned by (1) general surgeons, (2) single-specialty physicians, (3) multi-specialty physicians and (4) hospital/physician ventures, provided that certain requirements are satisfied. These requirements include the following:
1. | The ASC must be an ASC certified to participate in the Medicare program, and its operating and recovery room space must be dedicated exclusively to the ambulatory surgery center and not a part of a hospital (although such space may be leased from a hospital if such lease meets the requirements of the safe harbor for space rental); |
2. Each investor must be either (a) a physician who derived at least one-third of his or her medical practice income for the previous fiscal year or 12-month period from performing procedures on the list of Medicare-covered procedures for ambulatory surgery centers, (b) a hospital, or (c) a person or entity not in a position to make or influence referrals to the center, nor to provide items or services to the ambulatory surgery center, nor employed by the ASC or any investor;
3. Unless all physician-investors are members of a single specialty, each physician-investor must perform at least one-third of his or her procedures at the ASC each year (this requirement is in addition to the requirement that the physician-investor has derived at least one-third of his or her medical practice income for the past year from performing procedures);
4. Physician-investors must have fully informed their referred patients of the physician's investment;
5. The terms on which an investment interest is offered to an investor are not related to the previous or expected volume of referrals, services furnished or the amount of business otherwise generated from that investor to the entity;
6. Neither the ASC nor any other investor nor any person acting on their behalf may loan funds to or guarantee a loan for an investor if the investor uses any part of such loan to obtain the investment interest;
7. The amount of payment to an investor in return for the investment interest is directly proportional to the amount of the capital investment (including the fair market value of any pre-operational services rendered) of that investor;
8. All physician-investors, any hospital-investor and the center agree to treat patients receiving benefits or assistance under a federal healthcare program in a non-discriminatory manner;
9. All ancillary services performed at the ASC for beneficiaries of federal healthcare programs must be directly and integrally related to primary procedures performed at the ASC and may not be billed separately;
10. No hospital-investor may include on its cost report or any claim for payment from a federal healthcare program any costs associated with the ASC;
11. The ASC may not use equipment owned by or services provided by a hospital-investor unless such equipment is leased in accordance with a lease that complies with the Anti-Kickback statute equipment rental safe harbor and such services are provided in accordance with a contract that complies with the Anti-Kickback Statute personal services and management contract safe harbor; and
14
12. No hospital-investor may be in a position to make or influence referrals directly or indirectly to any other investor or the ASC.
We believe that the ownership and operations of our surgical facilities will not satisfy this ASC Safe Harbor for investment interests in ASCs because, among other things, we or one of our subsidiaries will generally be an investor in and provide management services to each ambulatory surgery center. We cannot assure you that the OIG would view our activities favorably even though we strive to achieve compliance with the remaining elements of this safe harbor.
In addition, although we expect each physician-investor to utilize the ASC as an extension of his or her practice, we cannot assure you that all physician-investors will derive at least one-third of their medical practice income from performing Medicare-covered ASC procedures, perform one-third of their procedures at the ASC or inform their referred patients of their investment interests. Interests in our ASC joint ventures are purchased at fair market value. Investors who purchase at a later time generally pay more for a given percentage interest than founding investors. The result is that while all investors are paid distributions in accordance with their ownership interests, for ASCs where there are later purchases we cannot meet the safe harbor requirement that return on investment is directly proportional to the amount of capital investment. The OIG has on several occasions reviewed investments relating to ASCs, and in Advisory Opinion No. 07-05, raised concerns that (a) purchases of interests from physicians might yield gains on investment rather than capital infusion to the ASCs, (b) such purchases could be meant to reward or influence the selling physicians' referrals to the ASC or the hospital, and (c) such returns might not be directly proportional to the amount of capital invested. Nonetheless, we believe our fair market value purchase requirements and distribution policies comply with the Anti-Kickback Statute.
We hold ownership in one ambulatory surgery center in which a physician group that includes primary care physicians who do not use the ambulatory surgery center also holds ownership. In OIG Advisory Opinion No. 03-5 (February 6, 2003), the OIG declined to grant a favorable opinion to a proposed ambulatory surgery center structure that would have been jointly owned by a hospital and a multi-specialty group practice that was composed of a substantial number of primary care physicians who would not personally use the ambulatory surgery center. We believe that the ownership of our ambulatory surgery center complies with the Anti-Kickback Statute because we understand that the physician group that owns an interest in our ambulatory surgery center is structured to fit within the definition of a unified group practice under the federal law prohibiting physician self-referrals, commonly known as the Stark Law, and the income distributions of the group practice comply with the Stark Law's acceptable methods of income distribution. Although these provisions directly apply only to liability under the Stark Law, we believe that the same principles are relevant to an analysis under the Anti-Kickback Statute. We believe that no physician in the group practice receives an income distribution that is based directly on his or her referrals to the ASC, and we believe that the group's ownership of the ASC is no different than its ownership of other ancillary services common in physician practices. Nevertheless, there can be no assurance that the proposed arrangement will not be determined to be in violation of the law.
In OIG Advisory Opinion No. 09-09 (July 29, 2009), the OIG concluded that an arrangement involving an ASC joint venture between a hospital and physicians involving the combination of their two ASCs into a single, larger ASC presented minimal risk of fraud or abuse, despite the fact that it did not fit within any applicable anti-kickback safe harbors. Additionally, the OIG stated that fair market value should be determined based only on the tangible assets of each ASC since the physician investors are referral sources for the ASC. The OIG stated that a cash flow-based valuation of the business contributed by the physician investors potentially would include the value of the physician investors' referrals over the time that their ASC was in existence prior to the merger with the hospital's ASC. The OIG went on to note that a valuation involving intangible assets would not necessarily result in a violation of the Anti-Kickback Statute, but would require a review of all the facts and circumstances. It is not clear whether the OIG is concerned about using a cash flow-based valuation in most healthcare transactions involving referral sources, or just transactions, like this one, where the parties' contributions would be valued differently for contributing the same assets if only one party's contribution is valued as a going concern based on cash flow. Also, the OIG appears to be focused on historical cash flow rather than a projected, discounted cash flow, which is a commonly used valuation methodology. What is clear is that for the first time, the OIG addressed valuation methodologies, which could lead to increased scrutiny of all transactions involving physicians.
Our hospitals comply as closely as possible with the safe harbor for investments in small entities. Our hospital investments do not fit wholly within the safe harbor because more than 40% of the investment interests are held by investors who are either in a position to refer to the hospital or who provide services to the hospital and more than 40% of the hospital's gross revenues last year were derived from referrals generated by investors. However, we believe we comply with the remaining elements of the safe harbor.
In addition to the physician ownership in our surgical facilities, other financial relationships of ours with potential referral sources could potentially be scrutinized under the Anti-Kickback Statute. We have entered into management agreements to manage many of our surgical facilities, as well as our physician network. Most of these agreements call for our subsidiary to be paid a percentage-based management fee. Although there is a safe harbor for personal services and management contracts (the “Personal Services and Management Safe Harbor”), the Personal Services and Management Safe Harbor requires, among other things, that the amount of the aggregate compensation paid to the manager over the term of the agreement be set in advance. Because our management fees are generally based on a percentage of revenues, our management agreements do not typically meet this requirement. We do, however, believe that our management arrangements satisfy the other requirements of the Personal Services and Management Safe Harbor for personal services and management contracts. The OIG has taken the position in several advisory opinions that percentage-based management agreements are not protected by a safe harbor, and consequently, may violate the Anti-Kickback Statute. We have implemented formal compliance programs designed to safeguard against overbilling and believe that our management agreements comply with the requirements of the Anti-Kickback Statute. However, we cannot assure you that the OIG would find our compliance programs to be adequate or that our management agreements would be found to comply with the Anti-Kickback Statute.
We also typically guarantee a surgical facility's third-party debt financing and certain lease obligations as part of our obligations
15
under a management agreement. Physician investors are generally not required to enter into similar guarantees. The OIG might take the position that the failure of the physician investors to enter into similar guarantees represents a special benefit to the physician investors given to induce patient referrals and that such failure constitutes a violation of the Anti-Kickback Statute. We believe that the management fees (and in some cases guarantee fees) are adequate compensation to us for the credit risk associated with the guarantees and that the failure of the physician investors to enter into similar guarantees does not create a material risk of violating the Anti-Kickback Statute. However, the OIG has not issued any guidance in this regard.
The OIG is authorized to issue advisory opinions regarding the interpretation and applicability of the Anti-Kickback Statute, including whether an activity constitutes grounds for the imposition of civil or criminal sanctions. We have not, however, sought such an opinion regarding any of our arrangements. If it were determined that our activities, or those of our surgical facilities, violate the Anti-Kickback Statute, we, our subsidiaries, our officers, our directors and each surgical facility investor could be subject, individually, to substantial monetary liability, prison sentences and/or exclusion from participation in any healthcare program funded in whole or in part by the U.S. government, including Medicare, TRICARE or state healthcare programs.
Evolving interpretations of current, or the adoption of new, federal or state laws or regulations could affect many of our arrangements. Law enforcement authorities, including the OIG, the courts and Congress, are increasing their scrutiny of arrangements between healthcare providers and potential referral sources to ensure that the arrangements are not designed as a mechanism to exchange remuneration for patient care referrals or opportunities. Investigators have also demonstrated a willingness to look behind the formalities of a business transaction to determine the underlying purposes of payments between healthcare providers and potential referral sources.
Federal Physician Self-Referral Law
Congress has enacted the federal physician self-referral law, or Stark Law, that prohibits certain self-referrals for healthcare services. As currently enacted, the Stark Law prohibits a practitioner, including a physician, dentist or podiatrist, from referring patients to an entity with which the practitioner or a member of his or her immediate family has a “financial relationship” for the provision of certain “designated health services” that are paid for in whole or in part by Medicare or Medicaid unless an exception applies. The term “financial relationship” is broadly defined and includes most types of ownership and compensation relationships. The Stark Law also prohibits the entity from seeking payment from Medicare or Medicaid for services that are rendered through a prohibited referral. If an entity is paid for services provided through a prohibited referral, it may be required to refund the payments. Violations of the Stark Law may also result in the imposition of damages equal to three times the amount improperly claimed and civil monetary penalties of up to $15,000 per prohibited claim and $100,000 per prohibited circumvention scheme and exclusion from participation in the Medicare and Medicaid programs. For the purposes of the Stark Law, the term “designated health services” is defined to include:
▪ clinical laboratory services;
▪ physical therapy services;
▪ occupational therapy services;
▪ radiology services, including magnetic resonance imaging, computerized axial tomography scan and ultrasound services;
▪ radiation therapy services and supplies;
▪ durable medical equipment and supplies;
▪ parenteral and enteral nutrients, equipment and supplies;
▪ prosthetics, orthotics and prosthetic devices and supplies;
▪ home health services;
▪ outpatient prescription drugs; and
▪ inpatient and outpatient hospital services.
The list of designated health services does not, however, include surgical services that are provided in an ASC. Furthermore, in final Stark Law regulations published by HHS on January 4, 2001, the term “designated health services” was specifically defined to not include services that are reimbursed by Medicare as part of a composite rate, such as services that are provided in an ASC. However, if designated health services are provided by an ASC and separately billed, referrals to the ASC by a physician-investor would be prohibited by the Stark Law. Because our facilities that are licensed as ASCs do not have independent laboratories and do not provide designated health services apart from surgical services, we do not believe referrals to these facilities by physician-investors are prohibited. If legislation or regulations are implemented that prohibit physicians from referring patients to surgical facilities in which the physician has a beneficial interest, our business and financial results would be materially adversely affected.
Five of our facilities are licensed as hospitals. The Stark Law currently includes the Whole Hospital Exception, which applies to physician ownership of a hospital, provided such ownership is in the whole hospital and the physician is authorized to perform services at the hospital. Physician investment in our facilities licensed as hospitals meet this requirement. However, changes to the Whole Hospital Exception have been the subject of recent regulatory action and legislation. Changes in the Affordable Care Act include:
▪ a prohibition on hospitals from having any physician ownership unless the hospital already had physician ownership and a Medicare provider agreement in effect as of December 31, 2010;
▪ a limitation on the percentage of total physician ownership or investment interests in the hospital or entity whose assets include the hospital to the percentage of physician ownership or investment as of March 23, 2010;
▪ a prohibition from expanding the number of beds, operating rooms, and procedure rooms for which it is licensed after March 23, 2010, unless the hospital obtains an exception from the Secretary of the Department of Health and Human Services;
▪ a requirement that return on investment be proportionate to the investment by each investor;
16
▪ restrictions on preferential treatment of physician versus nonphysician investors;
▪ a requirement for written disclosures of physician ownership interests to the hospital's patients and on the hospital's website and in any advertising, along with annual reports to the government detailing such interests;
▪ a prohibition on the hospital or other investors from providing financing to physician investors;
▪ a requirement that any hospital that does not have 24/7 physician coverage inform patients of this fact and receive signed acknowledgement from the patients of the disclosure; and
▪ a prohibition on “grandfathered” status for any physician owned hospital that converted from an ambulatory surgery center to a hospital on or after March 23, 2010.
We cannot predict whether other proposed amendments to the Whole Hospital Exception will be included in any future legislation or if Congress will adopt any similar provisions that would prohibit or otherwise restrict physicians from holding ownership interests in hospitals. The Affordable Care Act could have an adverse effect on our financial condition and results of operations.
In addition to the physician ownership in our surgical facilities, we have other financial relationships with potential referral sources that potentially could be scrutinized under the Stark Law. We have entered into personal service agreements, such as medical director agreements, with physicians at our hospitals. We believe that our agreements with referral sources satisfy the requirements of the personal service arrangements exception to the Stark Law and have implemented formal compliance programs designed to safeguard against overbilling. However, we cannot assure you that the OIG would find our compliance programs to be adequate or that our agreements with referral sources would be found to comply with the Stark Law.
Additionally, the physician network we manage must comply with the “in-office ancillary services exception” of the Stark Law. We believe that this physician network operates in compliance with the applicable language of statutory exceptions to the Stark Law, including the exceptions for services provided by physicians within a group practice or in-office ancillary services. There have been extensive discussions and proposed changes to these exceptions. We cannot provide assurances that CMS may not propose and later adopt changes to the in-office ancillary services exception or whether if adopted any such changes would not adversely affect the physician practices that we manage, and thus that portion of our business. If future revisions modify the provisions of the Stark Law regulations that are applicable to our business, our revenues and profitability could be materially adversely affected and could require us to modify our relationships with our physician and healthcare system partners.
False and Other Improper Claims
The U.S. government is authorized to impose criminal, civil and administrative penalties on any person or entity that files a false claim for payment from the Medicare or Medicaid programs or other federal and state healthcare programs. Claims filed with private insurers can also lead to criminal and civil penalties, including, but not limited to, penalties relating to violations of federal mail and wire fraud statutes, as well as penalties under the anti-fraud provisions of HIPAA. While the criminal statutes are generally reserved for instances of fraudulent intent, the U.S. government is applying its criminal, civil and administrative penalty statutes in an ever-expanding range of circumstances. For example, the U.S. government has taken the position that a pattern of claiming reimbursement for unnecessary services violates these statutes if the claimant merely should have known the services were unnecessary, even if the government cannot demonstrate actual knowledge. The U.S. government has also taken the position that claiming payment for low-quality services is a violation of these statutes if the claimant should have known that the care being provided was substandard.
Over the past several years, the U.S. government has accused an increasing number of healthcare providers of violating the federal Act. The False Claims Act prohibits a person from knowingly presenting, or causing to be presented, a false or fraudulent claim to the U.S. government. The statute defines “knowingly” to include not only actual knowledge of a claim's falsity, but also reckless disregard for or intentional ignorance of the truth or falsity of a claim. The Fraud Enforcement and Recovery Act of 2009 further expanded the scope of the False Claims Act by, among other things, creating liability for knowingly and improperly avoiding or decreasing an obligation to pay money to the federal government. The Affordable Care Act also created federal False Claims Act liability for the knowing failure to report and return an overpayment within 60 days of the identification of the overpayment or the date by which a corresponding cost report is due, whichever is later. The Affordable Care Act also provides that claims submitted in connection with patient referrals that result from violations of the Anti-Kickback Statute constitute false claims for the purposes of the federal False Claims Act, and some courts have held that a violation of the Stark Law can result in False Claims Act liability, as well. Because our surgical facilities perform hundreds of similar procedures a year for which they are paid by Medicare, and there is a relatively long statute of limitations, a billing error or cost reporting error could result in significant civil or criminal penalties.
Under the qui tam, or whistleblower, provisions of the False Claims Act, private parties may bring actions on behalf of the U.S. government. These private parties, often referred to as relators, are entitled to share in any amounts recovered by the government through trial or settlement. Both whistleblower lawsuits and direct enforcement activity by the government have increased significantly in recent years and have increased the risk that a healthcare company, like us, will have to defend a false claims action, pay fines or be excluded from the Medicare and Medicaid programs and other federal and state healthcare programs as a result of an investigation resulting from a whistleblower case. Although we believe that our operations materially comply with both federal and state laws, they may nevertheless be the subject of a whistleblower lawsuit or may otherwise be challenged or scrutinized by governmental authorities. Providers found liable for False Claims Act violations are subject to damages of up to three times the actual damage sustained by the government plus mandatory civil monetary penalties between $5,500 and $11,000 for each separate false claim. A determination that we have violated these laws could have a material adverse effect on us.
17
Privacy and Security Requirements
We are subject to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and the Health Information Technology for Economic and Clinical Health Act (“HITECH Act”), which was enacted as part of the American Recovery and Reinvestment Act of 2009. The HITECH Act strengthened the requirements and significantly increased the penalties for violations of the HIPAA privacy and security regulations. The HITECH Act also requires us to notify patients of any unauthorized access, acquisition, or disclosure of their unsecured protected health information that poses significant risk of financial, reputational or other harm to a patient.
The HIPAA privacy standards apply to individually identifiable information held or disclosed by a covered entity in any form, whether communicated electronically, on paper or orally. These standards impose extensive administrative requirements on us. These standards require our compliance with rules governing the use and disclosure of this health information. They create rights for patients in their health information, such as the right to amend their health information, and they require us to impose these rules, by contract, on any business associate to whom we disclose such information in order to perform functions on our behalf.
The HIPAA security standards require us to establish and maintain reasonable and appropriate administrative, technical and physical safeguards to ensure the integrity, confidentiality and the availability of electronic health and related financial information. The security standards were designed to protect electronic information against reasonably anticipated threats or hazards to the security or integrity of the information and to protect the information against unauthorized use or disclosure. Although the security standards do not reference or advocate a specific technology, and covered healthcare providers, plans and clearinghouses have the flexibility to choose their own technical solutions, the security standards have required us to implement significant new systems, business procedures and training programs. We believe that we are in material compliance with the privacy and security requirements of HIPAA.
Violations of the HIPAA privacy and security regulations may result in civil and criminal penalties. The HITECH Act strengthened the requirements of the HIPAA privacy and security regulations and significantly increased the penalties for violations by introducing a tiered penalty system, with penalties of up to $50,000 per violation with a maximum civil penalty of $1.5 million in a calendar year for violations of the same requirement. Under the HITECH Act, HHS is required to conduct periodic compliance audits of covered entities and their business associates. The HITECH Act also extends the application of certain provisions of the security and privacy regulations to business associates and subjects business associates to civil and criminal penalties for violation of the regulations.
The HITECH Act authorizes State Attorneys General to bring civil actions seeking either an injunction or damages in response to violations of HIPAA privacy and security regulations or the new data breach law that affects the privacy of their state residents. We expect vigorous enforcement of the HITECH Act's requirements by HHS and State Attorneys General. Final rules relating to the HITECH Act, HIPAA enforcement and breach notification are expected to be published in 2011. We cannot predict whether our surgical facilities will be able to comply with the final rules and the financial impact to our surgical facilities in implementing the requirements under the final rules when they take effect.
Our facilities also remain subject to any state laws that relate to privacy or the reporting of data breaches that are more restrictive than the regulations issued under HIPAA and the requirements of the HITECH Act. For example, various state laws and regulations may require us to notify affected individuals in the event of a data breach involving certain personal information, such as social security numbers, dates of birth and credit card information.
Red Flags Rule
The Federal Trade Commission (“FTC”) issued a final rule, known as the Red Flags Rule, in October 2007 requiring financial institutions and businesses that maintain accounts that permit multiple payments for primarily individual purposes. The Red Flag Program Clarification Act of 2010, signed on December 18, 2010, appears to exclude healthcare providers from the Red Flags Rule, but permits the FTC or relevant agencies to designate additional creditors subject to the Red Flags Rule through future rulemaking if the agencies determine that the person in question maintains accounts subject to foreseeable risk of identity theft. Compliance with any such future rulemaking may require additional expenditures in the future.
Adoption of Electronic Health Records
The HITECH Act also includes provisions designed to increase the use of Electronic Health Records (“EHR”) by both physicians and hospitals. Beginning with FY 2011 and extending through FY 2016, eligible hospitals may receive reimbursement incentives based upon successfully demonstrating "meaningful use" of its certified EHR technology. Beginning in FY 2015, those hospitals that do not successfully demonstrate meaningful use of EHR technology are subject to reductions in reimbursements. On July 13, 2010, HHS released final meaningful use regulations. We are currently planning the implementation of EHR at some of our facilities and intend to comply with the EHR meaningful use requirements, but we may not comply in time to qualify for the maximum available incentive payments in FY 2011. Implementation of EHR and compliance with the HITECH Act will result in significant costs. While we do not currently know the cost that will be associated with implementation and the amount of reimbursement incentives we will receive, we estimate that at a minimum our costs of implementation and compliance will be recovered through improved reimbursement over the course of the initiative program.
HIPAA Administrative Simplification Requirements
The HIPAA transaction regulations were issued to encourage electronic commerce in the healthcare industry. These regulations include standards that healthcare providers must follow when electronically transmitting certain healthcare transactions, such as healthcare claims. We believe that we are in compliance with these regulations.
18
State Regulation
Many of the states in which our surgical facilities operate have adopted statutes and/or regulations that prohibit the payment of kickbacks or any type of remuneration in exchange for patient referrals and that prohibit healthcare providers from, in certain circumstances, referring a patient to a healthcare facility in which the provider has an ownership or investment interest. While these statutes generally mirror the federal Anti-Kickback Statute and Stark Law, they vary widely in their scope and application. Some are specifically limited to healthcare services that are paid for in whole or in part by the Medicaid program; others apply to all healthcare services regardless of payor; and others apply only to state-defined designated services, which may differ from the designated health services under the Stark Law. In addition, many states have adopted statutes that mirror the False Claims Act and that prohibit the filing of a false or fraudulent claim with a state governmental agency. We intend to comply with all applicable state healthcare laws, rules and regulations. However, these laws, rules and regulations have typically been the subject of limited judicial and regulatory interpretation. As a result, we cannot assure you that our surgical facilities will not be investigated or scrutinized by the governmental authorities empowered to do so or, if challenged, that their activities would be found to be lawful. A determination of non-compliance with the applicable state healthcare laws, rules, and regulations could subject our surgical facilities to civil and criminal penalties and could have a material adverse effect on our operations.
Many states in which our surgical facilities are located or may be located in the future, do not permit business corporations to practice medicine, exercise control over or employ physicians, or engage in various business practices, such as fee-splitting with physicians (i.e. the sharing in a percentage of professional fees). The existence, interpretation and enforcement of these laws vary significantly from state to state. A determination of non-compliance with these laws could result in fines and or require us to restructure some of our existing relationships with our physicians. We are also subject to various state insurance statutes and regulations that prohibit us from submitting inaccurate, incorrect or misleading claims. Many state insurance laws and regulations are broadly worded and could be implicated, for example, if our surgical facilities were to waive an out-of-network co-payment or other patient responsibility amounts without fully disclosing the waiver on the claim submitted to the payor. While some of our surgical facilities waive the out-of-network portion of patient co-payment amounts when providing services to patients whose health insurance is covered by a payor with which the surgical facilities are not contracted, our surgical facilities fully disclose waivers in the claims submitted to the payors. We believe that our surgical facilities are in compliance with all applicable state insurance laws and regulations regarding the submission of claims. We cannot assure you, however, that none of our surgical facilities' insurance claims will ever be challenged. If we were found to be in violation of a state's insurance laws or regulations, we could be forced to discontinue the violative practice, which could have an adverse effect on our financial position and results of operations, and we could be subject to fines and criminal penalties.
Recovery Audit Contractors and Medicaid Integrity Contractors
CMS has expanded the pilot recovery audit contractor (“RAC”) program to a permanent nationwide program. RACs are private contractors contracting with CMS to identify overpayment and underpayments for services through post-payment reviews of Medicare providers and suppliers. The Affordable Care Act expands the RAC program's scope to include managed Medicare and to include Medicaid claims by requiring all states to establish programs to contract with RACs by December 31, 2010. In addition, CMS employs Medicaid Integrity Contractors (“MICs”) to perform post-payment audits of Medicaid claims and identify overpayments. The Affordable Care Act increases federal funding for the MIC program for federal fiscal year 2011 and later years. In addition to RACs and MICs, the state Medicaid agencies and other contractors have increased their review activities. MICs are assigned to five geographic regions and have commenced audits in states assigned to those regions. We cannot quantify the financial impact of potential RAC or MIC audits, but could incur expenses associated with responding to and challenging any audit, as well as costs of repayment of alleged overpayments.
Regulations Affecting Our New York Operations
We own an interest in a limited liability company which provides administrative services to a surgery center located in New York. Laws in the State of New York require that corporations have natural persons as stockholders to be approved by the New York Department of Health as a licensed healthcare facility. Accordingly, we are not able to own interests in a limited partnership or limited liability company that owns an interest in a healthcare facility located in New York. Laws in the State of New York also prohibit the delegation of certain management functions by a licensed healthcare facility, including but not limited to the authority to appoint and discharge senior management, independently control the books and records of the facility, dispose of assets of the facility outside of day-to-day operations and adopt policies affecting the delivery of healthcare services. The law does permit a licensed facility to lease premises and obtain various services from non-licensed entities. However, it is not clear what types of delegation constitute a violation. Although we believe that our operations and relationships in New York are in compliance with these laws, if New York regulatory authorities or a third-party asserts a contrary position, we may be unable to continue or expand our operations in New York.
Emergency Medical Treatment and Active Labor Act
Our hospitals are subject to the Emergency Medical Treatment and Active Labor Act (“EMTALA”). This federal law requires any hospital that participates in the Medicare program to conduct an appropriate medical screening examination of every person who presents to the hospital's emergency department for treatment and, if the patient is suffering from an emergency medical condition, to either stabilize that condition or make an appropriate transfer of the patient to a facility that can handle the condition. The obligation to screen and stabilize emergency medical conditions or transfer exists regardless of a patient's ability to pay for treatment. Off-campus facilities such as surgery centers that lack emergency departments or otherwise do not treat emergency medical conditions generally are not subject to EMTALA. They must, however, have policies in place that explain how the location should proceed in an emergency situation, such as transferring the patient to the closest hospital with an emergency department. There are severe penalties under EMTALA if a hospital fails to screen or appropriately stabilize or transfer a patient or if the hospital delays appropriate treatment in order to first inquire about the patient's ability to pay, including civil monetary penalties and exclusion from participation in the Medicare program. In addition, an injured patient, the patient's
19
family or a medical facility that suffers a financial loss as a direct result of another hospital's violation of the law can bring a civil suit against that other hospital. CMS has actively enforced EMTALA and has indicated that it will continue to do so in the future. Although we believe that our hospitals comply with EMTALA, we cannot predict whether CMS will implement new requirements in the future and, if so, whether our hospitals will comply with any new requirements.
Regulatory Compliance Program
It is our policy to conduct our business with integrity and in compliance with the law. We have in place and continue to enhance a company-wide compliance program that focuses on all areas of regulatory compliance including billing, reimbursement, cost reporting practices and contractual arrangements with referral sources.
This regulatory compliance program is intended to help ensure that high standards of conduct are maintained in the operation of our business and that policies and procedures are implemented so that employees act in full compliance with all applicable laws, regulations and company policies. Under the regulatory compliance program, every employee and certain contractors involved in patient care, and coding and billing, receive initial and periodic legal compliance and ethics training. In addition, we regularly monitor our ongoing compliance efforts and develop and implement policies and procedures designed to foster compliance with the law. The program also includes a mechanism for employees to report, without fear of retaliation, any suspected legal or ethical violations to their supervisors, designated compliance officers in our facilities, our compliance hotline or directly to our corporate compliance office. We believe our compliance program is consistent with standard industry practices. However, we cannot provide any assurances that our compliance program will detect all violations of law or protect against qui tam suits or government enforcement actions.
Available Information
Our website is www.symbion.com. We make available free of charge on this website under “Investors — SEC Filings” links to our periodic and other reports and amendments to those reports filed with or furnished to the Securities and Exchange Commission (“SEC”) as soon as reasonably practicable after we electronically file or furnish such materials.
Item 1A. Risk Factors
The following are some of the risks and uncertainties that could cause our actual financial condition, results of operations, business and prospects to differ materially from those contemplated by the forward-looking statements contained in this report or our other filings with the SEC. If any of the following risks actually occurred, our business, financial condition and operating results could suffer.
Risks Related to Our Business and Industry
Our substantial leverage could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry and expose us to interest rate risk to the extent of our variable rate debt.
We incurred a significant amount of indebtedness in connection with the Merger. As of December 31, 2010, we had (a) total outstanding indebtedness of approximately $536.6 million and (b) approximately $44.0 million of revolving credit borrowings available under our senior secured credit facility, subject to customary conditions. In addition, subject to the restrictions in our senior secured credit facility and the indenture governing our 11.00%/11.75% Senior PIK toggle notes due 2015 (the “Toggle Notes”), we may incur significant additional indebtedness, which may be secured, from time to time. Further, we expect we will need to incur additional debt to fund development activities.
The level of our indebtedness could have important consequences, including:
· making it more difficult for us to make payments on the Toggle Notes;
· limiting cash flow available for general corporate purposes, including capital expenditures and acquisitions, because a substantial portion of our cash flow from operations must be dedicated to servicing our debt;
· limiting our ability to obtain additional debt financing in the future for working capital, capital expenditures or acquisitions;
· limiting our flexibility in reacting to competitive and other changes in our industry and economic conditions generally; and
· exposing us to risks inherent in interest rate fluctuations because some of our borrowings will be at variable rates of interest, which could result in higher interest expense in the event of increases in interest rates.
Restrictive covenants in our debt instruments may adversely affect us.
The indenture governing our Toggle Notes contains various covenants that limit, among other things, our ability and the ability of our subsidiaries to:
· incur additional indebtedness;
· make certain distributions, investments and other restricted payments;
· dispose of our assets;
· grant liens on our assets;
· engage in transactions with affiliates; and
· merge or consolidate or transfer substantially all of our assets.
20
In addition, our senior secured credit facility contains other and more restrictive covenants, including requiring us to maintain specified financial ratios when we have outstanding revolver balances and to satisfy other financial condition tests. These covenants and tests become more restrictive over time. Our ability to meet those financial ratios and tests can be affected by events beyond our control, and we cannot assure you that we will continue to meet those tests. A breach of any of these covenants could result in a default under our senior secured credit facility and/or the indenture governing our Toggle Notes. Upon the occurrence of an event of default under our senior secured credit facility, the lenders could elect to declare all amounts outstanding under our senior secured credit facility to be immediately due and payable and terminate all commitments to extend further credit. If we were unable to repay those amounts, the lenders could proceed against the collateral granted to them to secure that indebtedness. We have pledged substantially all of our assets, other than assets of our non-guarantor subsidiaries, as security under our senior secured credit facility. If the lenders under our senior secured credit facility accelerate the repayment of borrowings, we cannot assure you that we will have sufficient assets to repay our senior secured credit facility and our other indebtedness, including the Toggle Notes.
We may not be able to generate sufficient cash to meet our obligations under our debt instruments or refinance our indebtedness on satisfactory terms.
Our ability to pay or to refinance our indebtedness will depend upon our future operating performance, which will be affected by general economic, financial, competitive, legislative, regulatory, business and other factors beyond our control.
We cannot assure you that our business will generate sufficient cash flow from operations, that currently anticipated revenue growth and operating improvements will be realized or that future borrowings will be available to us under our senior secured credit facility in amounts sufficient to enable us to pay our indebtedness or to fund our other liquidity needs. In the absence of such operating results and resources, we could face substantial liquidity problems and might be required to dispose of material assets or operations to meet our debt service and other obligations. In 2008, 2009 and 2010, in order to preserve cash to fund potential buy-ups, developments and acquisitions, we elected to pay interest on the Toggle Notes in kind. The Toggle Notes mature on August 23, 2015, but the option to pay interest in kind expires with the interest payment due August 23, 2011, after which time interest on the Toggle Notes will be paid in cash. We may find it necessary or prudent to refinance our outstanding indebtedness, including the Toggle Notes, in order to satisfy future principal, premium, if any, and interest payments and to preserve available cash for purposes other than debt service obligations. If we are unable to meet our indebtedness obligations or fund our other liquidity needs, we could attempt to restructure our indebtedness or seek additional equity capital. We cannot assure you that we will be able to accomplish those actions on satisfactory terms, if at all.
The current state of the economy and future economic conditions may adversely impact our business.
The United States economy continues to experience difficult conditions. Burdened by economic constraints, patients have delayed or canceled non-emergency surgical procedures. It is difficult to predict the degree to which our business will continue to be impacted by such conditions or the course of the economy in the coming year.
We depend on payments from third-party payors, including government healthcare programs and managed care organizations. If these payments are reduced or eliminated, our revenues and profitability could be adversely affected.
We are dependent upon private and governmental third-party sources of payment for the services provided to patients in our surgical facilities and the physician networks we manage. The amounts that our surgical facilities and physician networks receive in payment for their services may be adversely affected by market and cost factors as well as other factors over which we have no control, including Medicare, Medicaid and state regulations and the cost containment and utilization decisions and reduced reimbursement schedules of third-party payors, Congressional changes and refinements to the Medicare ambulatory surgery center payment system and CMS refinements to Medicare’s reimbursement policies. See Item 1. “Business — Sources of Revenue”
If we are unable to negotiate contracts or maintain satisfactory relationships with private third-party payors, our revenues and operating income will decrease.
Payments from private third-party payors (including state workers’ compensation programs) represented about 76% and 75% of our patient service revenues for the years ended December 31, 2009 and 2010, respectively. Most of these payments came from third-party payors with which our facilities have contracts. Managed care companies such as HMOs and PPOs, which offer prepaid and discounted medical service packages, represent a growing segment of private third-party payors. If we fail to enter into favorable contracts and to maintain satisfactory relationships with managed care organizations, our revenues may decrease. Cost containment measures, such as fixed fee schedules, capitation payment arrangements, reductions in reimbursement schedules by third-party payors and closed provider networks, could also cause a reduction of our revenues in the future. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Overview—Operating Trends.”
Some of our payments from third-party payors in the past year came from third-party payors with which our surgical facilities did not have a contract. In those cases, commonly known as “out-of-network” services, we generally charge the patients the same co-payment or other patient responsibility amounts that we would have charged had our center had a contract with the payor. We also submit a claim for the services to the payor along with full disclosure that our surgical facility has charged the patient an in-network patient responsibility amount. Historically, those third-party payors who do not have contracts with our surgical facilities typically have paid our claims at higher than comparable contracted rates. However, there is a growing trend for third-party payors to adopt out-of-network fee schedules that are more comparable to our contracted rates or to take other steps to discourage their enrollees from seeking treatment at out-of-network surgical facilities. In these cases, we seek to enter into contracts with the payors. In certain situations, we have seen an increase in the volume of cases in those instances where we transition from out-of-network to in-network billing, although we may experience an overall decrease in
21
revenues to the surgical facility. We can provide no assurance that we will see a sufficient increase in volume of cases to compensate for the decrease in per case revenues where we transition from out-of-network to in-network billing.
Payments from workers’ compensation payors represented approximately 10% and 11% of our patient service revenues for the years ended December 31, 2009 and 2010, respectively. Several states have recently considered or implemented workers’ compensation provider fee schedules. In some cases, the fee schedule rates contain lower rates than the rates our surgical facilities have historically been paid for the same services. If the trend of states adopting lower workers’ compensation fee schedules continues, it could have a material adverse effect on our financial condition and results of operations.
Our growth strategy depends in part on our ability to acquire and develop additional surgical facilities on favorable terms. If we are unable to do so, our future growth could be limited and our operating results could be adversely affected.
Our strategy is to increase our revenues and earnings by continuing to focus on existing surgical facilities and continuing to acquire and develop additional surgical facilities. Between January 1999 and December 31, 2010, we acquired 52 surgical facilities and developed 24 surgical facilities, including 22 surgical facilities that we subsequently divested. We may be unable to identify suitable acquisition and development opportunities and to negotiate and complete acquisitions and new projects on favorable terms. In addition, our acquisition and development program requires substantial capital resources, and we may need to obtain additional capital or financing, from time to time, to fund these activities. As a result, we may take actions that could have a materially adverse effect on our financial condition and results of operations, including incurring substantial debt. Sufficient financing may not be available to us on satisfactory terms, if at all.
We may encounter numerous business risks in acquiring and developing additional surgical facilities, and may have difficulty operating and integrating those surgical facilities.
If we acquire or develop additional surgical facilities, we may be unable to successfully operate the surgical facilities, and we may experience difficulty in integrating their operations and personnel. For example, in some acquisitions, we have experienced delays in implementing standard operating procedures and systems and improving existing managed care agreements and the mix of specialties offered at the surgical facilities. Following the acquisition of a surgical facility, key physicians may cease to use the facility or we may be unable to retain key management personnel. If we acquire the assets of a surgical facility rather than ownership in the entity that owns the surgical facility, we may be unable to assume the surgical facility’s existing managed care contracts and may have to renegotiate, or risk losing, one or more of the surgical facility's managed care contracts. We may also be unable to collect the accounts receivable of an acquired surgical facility. We may also experience negative effects on our reported results of operations because of acquisition-related charges and potential impairment of goodwill and other intangibles.
In addition, we may acquire surgical facilities with unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations. Although we maintain professional and general liability insurance, we do not maintain insurance specifically covering any unknown or contingent liabilities that may have occurred prior to the acquisition of companies and surgical facilities. In some cases, our right to indemnification for these liabilities may be subject to negotiated limits.
In developing new surgical facilities, we may be unable to attract physicians to use our facilities or contract with third-party payors. In addition, our newly developed surgical facilities typically incur net losses during the initial periods of operation and, unless and until their case loads grow, they generally experience lower total revenues and operating margins than established surgical facilities. Integrating a new surgical facility could be expensive and time consuming and could disrupt our ongoing business and distract our management and other key personnel. If we are unable to timely and efficiently integrate an acquired or newly developed facility, our business could suffer.
Efforts to regulate the construction, acquisition or expansion of healthcare facilities could prevent us from acquiring additional surgical facilities, renovating our existing facilities or expanding the breadth of services we offer.
Some states require prior approval for the construction, acquisition or expansion of healthcare facilities or expansion of the services the facilities offer. In giving approval, these states consider the need for additional or expanded healthcare facilities or services, as well as the financial resources and operational experience of the potential new owners of existing healthcare facilities. In many of the states in which we currently operate, certificates of need must be obtained for capital expenditures exceeding a prescribed amount, changes in capacity or services offered and various other matters. The remaining states in which we now or may in the future operate may adopt similar legislation. Our costs of obtaining a certificate of need could be significant, and we cannot assure you that we will be able to obtain the certificates of need or other required approvals for additional or expanded surgical facilities or services in the future. In addition, at the time we acquire a surgical facility, we may agree to replace or expand the acquired facility. If we are unable to obtain required approvals, we may not be able to acquire additional surgical facilities, expand healthcare services we provide at these facilities or replace or expand acquired facilities.
If we fail to maintain good relationships with the physicians who use our surgical facilities, our revenues and profitability could be adversely affected.
Our business depends upon the efforts and success of the physicians who provide medical services at our surgical facilities and the strength of our relationships with these physicians. These physicians are not employees of our surgical facilities and are not contractually required to use our facilities. We generally do not enter into contracts with physicians who use our surgical facilities, other than partnership and operating agreements with physicians who own interests in our surgical facilities, provider agreements with anesthesiology groups that provide anesthesiology services in our surgical facilities, medical director agreements and pain clinic agreements. Physicians who use our surgical facilities also use other facilities or hospitals and may choose to perform procedures in an office-based setting that might otherwise be performed at our surgical facilities. In recent years, pain management and gastrointestinal procedures have been performed increasingly in
22
an office-based setting. Although physicians who own interests in our surgical facilities are subject to agreements restricting ownership of competing facilities, these agreements may not restrict procedures performed in a physician office or in other unrelated facilities. Also, these agreements restricting ownership of competing facilities are difficult to enforce, and we may be unsuccessful in preventing physicians who own interests in our surgical facilities from acquiring interests in competing facilities.
In addition, the physicians who use our surgical facilities may choose not to accept patients who pay for services through certain third-party payors, which could reduce our revenues. From time to time, we may have disputes with physicians who use our surgical facilities and/or own interests in our surgical facilities or our company. Our revenues and profitability could be significantly reduced if we lost our relationship with one or more key physicians or groups of physicians, or if such physicians or groups reduce their use of our surgical facilities. In addition, any damage to the reputation of a key physician or group of physicians or the failure of these physicians to provide quality medical care or adhere to professional guidelines at our surgical facilities could damage our reputation, subject us to liability and significantly reduce our revenues.
We cannot predict the effect that healthcare reform and other changes in government programs may have on our business, financial condition or results of operations.
The Affordable Care Act was signed into law on March 23, 2010, and March 30, 2010, respectively. The Affordable Care Act dramatically alters the United States healthcare system and are intended to decrease the number of uninsured Americans and reduce overall healthcare costs. The Affordable Care Act attempts to achieve these goals by, among other things, requiring most Americans to obtain health insurance, expanding Medicare and Medicaid eligibility, reducing Medicare and Medicaid payments, expanding the Medicare program's use of value-based purchasing programs, tying hospital payments to the satisfaction of certain quality criteria, and bundling payments to hospitals and other providers. The Affordable Care Act also contains a number of measures that are intended to reduce fraud and abuse in the Medicare and Medicaid programs, such as requiring the use of recovery audit contractors in the Medicaid program expanding the scope of the federal False Claims Act and generally prohibiting physician-owned hospitals from adding new physician owners or increasing the number of beds and operating rooms for which they are licensed. The Affordable Care Act provides for additional enforcement tools, cooperation between agencies, and funding for enforcement. It is difficult to predict the impact the Affordable Care Act will have on the Company's operations given the delay in implementing regulation, pending court challenges, and possible amendment or repeal of elements of the Affordable Care Act. However, depending on how they are ultimately interpreted, amended and implemented, the Affordable Care Act could have an adverse effect on our business, financial condition and results of operations.
If we fail to comply with legislative and regulatory rules relating to privacy and security of patient health information and standards for electronic transactions, we may experience delays in payment of claims and increased costs and be subject to substantial fines.
HIPAA mandates the adoption of privacy, security and integrity standards related to patient information. HIPAA also standardizes the method for identifying providers, employers, health plans and patients. We believe that we are in compliance with the HIPAA regulations. However, if we fail to comply with the requirements of HIPAA, we could be subject to significant penalties under a tiered penalty system with penalties of up to $50,000 per violation with a maximum civil penalty of $1.5 million in a calendar year for violations of the same requirement.
If we fail to comply with laws and regulations relating to the operation of our surgical facilities, we could suffer penalties or be required to make significant changes to our operations.
We are subject to many laws and regulations at the federal, state and local government levels in which we operate. These laws and regulations require that our surgical facilities meet various licensing, certification and other requirements.
If we fail or have failed to comply with applicable laws and regulations, we could suffer civil or criminal penalties, including becoming the subject of cease and desist orders, the loss of our licenses to operate and disqualification from Medicare, Medicaid and other government-sponsored healthcare programs.
In pursuing our growth strategy, we may seek to expand our presence into new geographic markets. In new geographic markets, we may encounter laws and regulations that differ from those applicable to our current operations. If we are unable to comply with these legal requirements in a cost-effective manner, we may be unable to expand geographically.
Our revenues will decline if federal or state programs reduce our Medicare or Medicaid payments or if managed care companies reduce reimbursement amounts. In addition, the financial condition of payors and healthcare cost containment initiatives may limit our revenues and profitability.
In 2010, we derived 24% of our revenues from the Medicare and Medicaid programs. The Medicare and Medicaid programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations concerning patient eligibility requirements, funding levels and the method of calculating payments or reimbursements, among other things; requirements for utilization review; and federal and state funding restrictions, all of which could materially increase or decrease payments from these government programs in the future, as well as affect the timing of payments to our facilities.
We are unable to predict the effect of future government healthcare funding policy changes on our operations. If the rates paid by governmental payers are reduced, if the scope of services covered by governmental payers is limited or if we, or one or more of our subsidiaries' hospitals, are excluded from participation in the Medicare or Medicaid program or any other government healthcare program, there could be a material adverse effect on our business, financial condition, results of operations or cash flows.
23
During the past several years, healthcare payors, such as federal and state governments, insurance companies and employers, have undertaken initiatives to revise payment methodologies and monitor healthcare costs. As part of their efforts to contain healthcare costs, payors increasingly are demanding discounted fee structures or the assumption by healthcare providers of all or a portion of the financial risk relating to paying for care provided, often in exchange for exclusive or preferred participation in their benefit plans. We expect efforts to impose greater discounts and more stringent cost controls by government and other payors to continue, thereby reducing the payments we receive for our services. In addition, these payors have instituted policies and procedures to substantially reduce or limit the use of inpatient services.
The amount of our provision for doubtful accounts is based on our assessments of historical collection trends, business and economic conditions, trends in federal and state governmental and private employer health coverage and other collection indicators. A continuation in trends that results in increasing the proportion of accounts receivable being comprised of uninsured accounts and deterioration in the collectability of these accounts could adversely affect our collections of accounts receivable, results of operations and cash flows. As enacted, the Affordable Care Act seeks to decrease, over time, the number of uninsured individuals. Among other things, the Affordable Care Act will, beginning in 2014, expand Medicaid and incentivize employers to offer, and require individuals to carry, health insurance or be subject to penalties. However, there have been a number of court challenges to the law, and several courts have ruled that the requirement for individuals to carry health insurance is unconstitutional. This ruling is subject to appeal as are other cases that have been dismissed or have ruled the law constitutional. It is difficult to predict the full impact of the Affordable Care Act due to its complexity, lack of implementing regulations and interpretive guidance, gradual and potentially delayed implementation, pending court challenges, and possible repeal and/or amendment, as well as our inability to foresee how individuals and businesses will respond to the choices afforded them by the Affordable Care Act.
Our surgical facilities do not satisfy all of the requirements for any of the safe harbors under the federal Anti-Kickback Statute. If we fail to comply with the federal Anti-Kickback Statute, we could be subject to criminal and civil penalties, loss of licenses and exclusion from the Medicare and Medicaid programs, which may result in a substantial loss of revenues.
The Anti-Kickback Statute, prohibits the offer, payment, solicitation or receipt of any form of remuneration in return for referring, ordering, leasing, furnishing, purchasing or arranging for or recommending or inducing the ordering, purchasing or leasing of items or services payable by Medicare, Medicaid, or any other federally funded healthcare program. The Anti-Kickback Statute is very broad in scope, and many of its provisions have not been uniformly or definitively interpreted by existing case law or regulations. Violations of the Anti-Kickback Statute may result in substantial civil or criminal penalties, including criminal fines of up to $25,000 and civil penalties of up to $50,000 for each violation, plus three times the remuneration involved or the amount claimed and exclusion from participation in the Medicare and Medicaid programs. The exclusion, if applied to our surgical facilities, could result in significant reductions in our revenues and could have a material adverse effect on our financial condition and results of operations. In addition, many of the states in which we operate have also adopted laws, similar to the Anti-Kickback Statute, that prohibit payments to physicians in exchange for referrals, some of which apply regardless of the source of payment for care. These statutes typically impose criminal and civil penalties as well as loss of licenses. No state or federal regulatory actions have been taken against our surgical facilities under anti-kickback statutes during the time we have owned or managed the facilities. Management is not aware of any such actions prior to our acquisition or management of these surgical facilities.
Regulations implement various “safe harbors” to the Anti-Kickback Statute. Business arrangements that meet the requirements of the safe harbors are deemed to be in compliance with the Anti-Kickback Statute. Business arrangements that do not meet the safe harbor requirements do not necessarily violate the Anti-Kickback Statute, but may be subject to scrutiny by the federal government to determine compliance. However, the structure of the partnerships and limited liability companies operating our surgical facilities, as well as our business arrangement involving a physician network, do not satisfy all of the requirements of the safe harbor and, therefore, are not immune from government review or prosecution.
If we fail to comply with physician self-referral laws as they are currently interpreted or may be interpreted in the future, or if other legislative restrictions are issued, we could incur a significant loss of reimbursement revenues.
The federal physician self-referral law, commonly referred to as the Stark Law, prohibits a physician from making a Medicare or Medicaid reimbursed referral for a “designated health service” to an entity if the physician or a member of the physician's immediate family has a “financial relationship” with the entity. The list of “designated health services” under the Stark Law does not include ambulatory surgery services, but it does include services such as clinical laboratory services, and certain imaging services that may be provided by an ASC. Under the current Stark Law and related regulations, services provided at an ASC are not covered by the statute, even if those services include imaging, laboratory services or other Stark designated health services, provided that (i) the ASC does not bill for these services separately, or (ii) if the center is permitted to bill separately for these services, they are specifically exempted from Stark Law prohibitions. These are generally radiology and other imaging services integral to performance of surgical procedures that meet certain requirements and certain outpatient prescription drugs. Services provided at our facilities licensed as hospitals are covered by the Stark Law, but referrals for such services are exempt from the Stark Law under its “whole hospital exception.” Certain services provided by our managed physician network are covered by the Stark Law, but referrals for those services are exempt from the Stark Law under its “in-office ancillary services exception,” among others.
The Stark Law and similar state statutes are subject to different interpretations with respect to many important provisions. Violations of these self-referral laws may result in substantial civil or criminal penalties, including treble damages for amounts improperly claimed, civil monetary penalties of up to $15,000 per prohibited service billed, up to $100,000 per prohibited circumvention scheme and exclusion from participation in the Medicare and Medicaid and other federal and state healthcare programs. Exclusion of our ambulatory
24
surgery centers or hospitals from these programs through future judicial or agency interpretation of existing laws or additional legislative restrictions on physician ownership or investments in healthcare entities could result in a significant loss of reimbursement revenues. We cannot provide assurances that CMS will not undertake other rulemaking to address additional revisions to the Stark Law regulations. If future rules modify the provisions of the Stark Law regulations that are applicable to our business, our revenues and profitability could be materially adversely affected and could require us to modify our relationships with our physician and healthcare system partners.
Healthcare reform has limited our ability to own and operate our hospitals.
Five of our owned surgical facilities are licensed as hospitals. As discussed herein, the Stark Law currently includes an exception relating to physician ownership of a hospital, provided that the physician's ownership interest is in the whole hospital and the physician is authorized to perform services at the hospital known as the Whole Hospital Exception. Physician investment in our facilities licensed as hospitals currently meets this requirement. The Whole Hospital Exception was addressed in the Affordable Care Act, which provides, among other things: (i) a prohibition on hospitals from having any physician ownership unless the hospital already had physician ownership as of March 23, 2010 and a Medicare provider agreement in effect on December 31, 2010; (ii) a limitation on the percentage of the total value of the physician ownership in the hospital to such percentage as of March 23, 2010; (iii) a requirement for written disclosures of physician ownership interests, along with an annual report to the government detailing such ownership; and (iv) severe restrictions on the ability of a hospital subject to the whole hospital exception to add operating rooms, procedure rooms and beds. While our hospitals were grandfathered at the dates of enactment of the Affordable Care Act, they are subject to the above restrictions, which could have an adverse effect on our financial condition and results of operations. If future legislation prohibiting physician referrals to hospitals in which the physicians own an interest were enacted by Congress, our financial condition and results of operations could be materially adversely affected.
We may be subject to actions for false and other improper claims.
Federal and state government agencies, as well as private payors, have heightened and coordinated civil and criminal enforcement efforts as part of numerous ongoing investigations of the cost reporting and billing practices of healthcare organizations and their quality of care and financial relationships with referral sources. In addition, the OIG, and the U.S. Department of Justice have, from time to time, undertaken national enforcement initiatives that focus on specific billing practices or other suspected areas of abuse.
The U.S. government is authorized to impose criminal, civil and administrative penalties on any person or entity that files a false claim for payment from the Medicare or Medicaid programs and other federal and state healthcare programs. Claims filed with private insurers can also lead to criminal and civil penalties, including, but not limited to, penalties relating to violations of federal mail and wire fraud statutes, as well as penalties under the anti-fraud provisions of HIPAA. While the criminal statutes are generally reserved for instances of fraudulent intent, the U.S. government is applying its criminal, civil and administrative penalty statutes in an ever-expanding range of circumstances. For example, the government has taken the position that a pattern of claiming reimbursement for unnecessary services violates these statutes if the claimant merely should have known the services were unnecessary, even if the government cannot demonstrate actual knowledge. The government has also taken the position that claiming payment for low-quality services is a violation of these statutes if the claimant should have known that the care was substandard. The Fraud Enforcement and Recovery Act of 2009 further expanded the scope of the False Claims Act to create liability for knowingly and improperly avoiding or decreasing an obligation to pay money to the federal government and the Affordable Care Act created federal False Claims Act liability for the knowing failure to report and return an overpayment within 60 days of the identification of the overpayment or the date by which a corresponding cost report is due, whichever is later.
We are also subject to various state insurance statutes and regulations that prohibit us from submitting inaccurate, incorrect or misleading claims. Although we believe that our operations comply with both federal and state laws, they may nevertheless be the subject of a whistleblower lawsuit or may otherwise be challenged or scrutinized by governmental authorities. A determination that we have violated these laws could have a material adverse effect on our financial condition or results of operations.
We are subject to increasingly stringent governmental regulation, and may be subjected to allegations that we have failed to comply with governmental regulations which could result in sanctions and even greater scrutiny that reduce our revenues and profitability.
All participants in the healthcare industry are required to comply with many laws and regulations at the federal, state and local government levels. These laws and regulations require that our facilities meet various requirements, including those relating to our relationships with physicians and other referral sources, the adequacy and quality of medical care, equipment, personnel, operating policies and procedures, billing and cost reports, payment for services and supplies, maintenance of adequate records, privacy, compliance with building codes and environmental protection, among other matters. Many of the laws and regulations applicable to the healthcare are complex, and, in public statements, governmental authorities have taken positions on issues for which little official interpretation was previously available. Some of these positions appear to be inconsistent with common practices within the industry but have not previously been challenged. Moreover, some government investigations that have in the past been conducted under the civil provisions of federal law are now being conducted as criminal investigations under the Medicare fraud and abuse laws.
The healthcare industry has seen a number of ongoing investigations related to patient referrals, physician recruiting practices, cost reporting and billing practices, laboratory and home healthcare services, physician ownership of hospitals and other healthcare providers, and joint ventures involving hospitals and physicians. The Affordable Care Act provides for additional enforcement tools, cooperation between agencies, and funding for enforcement. Federal and state government agencies have announced heightened and coordinated civil and criminal enforcement efforts. In addition, the OIG (which is responsible for investigating fraud and abuse activities in government programs) and the U.S. Department of Justice periodically establish targeted enforcement initiatives that focus on specific billing practices or other areas that are highly susceptible to fraud and abuse. The OIG reported savings and expected recoveries for federal healthcare programs of more
25
than $25.9 billion for FFY 2010 as a result of its enforcement activities.
Hospitals continue to be one of the primary focal areas of the OIG and other governmental fraud and abuse programs. In January 2005, the OIG issued Supplemental Compliance Program Guidance for Hospitals that focuses on hospital compliance risk areas. Some of the risk areas highlighted by the OIG include correct outpatient procedure coding, revising admission and discharge policies to reflect current CMS rules, submitting appropriate claims for supplemental payments such as pass-through costs and outlier payments and a general discussion of the fraud and abuse risks related to financial relationships with referral sources. Each FFY, the OIG also publishes a General Work Plan that provides a brief description of the activities that the OIG plans to initiate or continue with respect to the programs and operations of HSS and details the areas that the OIG believes are prone to fraud and abuse. In addition, the claims review strategies used by the RACs generally include a review of high dollar claims, including inpatient hospital claims. As a result, during the three year RAC demonstration program, a large majority of the total amounts recovered by RACs came from hospitals.
The laws and regulations with which we must comply are complex and subject to change. In the future, different interpretations or enforcement of these laws and regulations could subject our practices to allegations of impropriety or illegality or could require us to make changes in our facilities, equipment, personnel, services, capital expenditure programs and operating expenses. If we fail to comply with applicable laws and regulations, we could suffer civil or criminal penalties, including the loss of our licenses to operate our hospitals and our ability to participate in the Medicare, Medicaid and other federal and state healthcare programs.
If a federal or state agency asserts a different position or enacts new laws or regulations regarding illegal remuneration under the Medicare, Medicaid or other governmental programs, we may be subject to civil and criminal penalties, experience a significant reduction in our revenues or be excluded from participation in the Medicare, Medicaid or other governmental programs.
Any change in interpretations or enforcement of existing or new laws and regulations could subject our current practices to allegations of impropriety or illegality, or could require us to make changes in our surgical facilities, equipment, personnel, services, pricing, capital expenditure programs and operating expenses, which could have a material adverse effect on our financial condition and results of operations.
Additionally, new federal or state laws may be enacted that would cause our relationships with physician investors to become illegal or result in the imposition of penalties against us or our surgical facilities. If any of our business arrangements with physician investors were deemed to violate the Anti-Kickback Statute, the Stark Law or similar laws, or if new federal or state laws were enacted rendering these arrangements illegal, our financial condition and results of operations would be materially adversely affected.
If laws governing the corporate practice of medicine or fee-splitting change, we may be required to restructure some of our relationships, which may result in a significant loss of revenues and divert other resources.
The laws of various states in which we operate or may operate in the future do not permit business corporations to practice medicine, to exercise control over or employ physicians who practice medicine or to engage in various business practices, such as fee-splitting with physicians (i.e., sharing in a percentage of professional fees). The interpretation and enforcement of these laws vary significantly from state to state. We provide management services to a physician network. If our arrangements with this network were deemed to violate state corporate practice of medicine, fee-splitting or similar laws, or if new laws are enacted rendering our arrangements illegal, we may be required to restructure these arrangements, which may result in a significant loss of revenues and divert other resources.
The loss of certain physicians can have a disproportionate impact on certain of our facilities.
Generally, the top referring physicians within each of our facilities represent a large share of our revenues and admissions. The loss of one or more of these physicians - even if temporary - could cause a material reduction in our revenues, which could take significant time to replace given the difficulty and cost associated with recruiting and retaining physicians.
We make significant loans to, and are generally liable for debts and other obligations of, the partnerships and limited liability companies that own and operate some of our surgical facilities.
We own and operate our surgical facilities through 16 limited partnerships and 38 limited liability companies. Local physicians, physician groups and health systems also own an interest in all but one of these partnerships and limited liability companies. In the partnerships in which we are the general partner, we are liable for 100% of the debts and other obligations of the partnership, even if we do not own all of the partnership interests. For the majority of our surgical facilities, indebtedness at the partnership level is funded through intercompany loans that we provide. Through many of these loans, which totaled approximately $43.8 million as of December 31, 2010, we have a security interest in the partnership’s or limited liability company's assets. However, our financial condition and results of operations would be materially adversely affected if our surgical facilities are unable to repay these intercompany loans.
Our senior secured credit facility and the indenture governing our senior notes allow us to borrow funds that we can lend to the partnerships and limited liability companies in which we own an interest. Although most of our intercompany loans are secured by the assets of the partnership, the physicians and physician groups that own an interest in these partnerships and limited liability companies generally do not guarantee a pro rata amount of this debt or the other obligations of these partnerships and limited liability companies.
We also guarantee the third-party debts and other obligations of many of the non-consolidated partnerships and limited liability companies in which we own an interest. As of December 31, 2010, we had approximately $1.7 million of off-balance sheet guarantees of non-consolidated third-party debt in connection with these surgical facilities. In some instances, the physicians and/or physician groups have
26
also guaranteed their pro-rata share of the indebtedness to secure the financing.
If our operations in New York are found not to be in compliance with New York law, we may be unable to continue or expand our operations in New York.
We own an interest in a limited liability company which provides administrative services to an ambulatory surgery center located in New York. Laws in the State of New York require that corporations have natural persons as stockholders to be approved by the New York Department of Health as a licensed healthcare facility. Accordingly, we are not able to own interests in a limited partnership or limited liability company that owns an interest in a healthcare facility located in New York. Laws in the State of New York also prohibit the delegation of certain management functions by a licensed healthcare facility. The law does permit a licensed facility to lease premises and obtain various services from non-licensed entities. However, it is not clear what types of delegation constitute a violation. Although we believe that our operations and relationships in New York are in compliance with applicable laws, if New York regulatory authorities or a third-party asserts a contrary position, we may be unable to continue or expand our operations in New York.
If regulations change, we may be obligated to purchase some or all of the ownership of our physician partners or renegotiate some of our partnership and operating agreements with our physician partners and management agreements with surgical facilities.
Upon the occurrence of various fundamental regulatory changes or changes in the interpretation of existing regulations, we may be obligated to purchase all of the ownership of the physician investors in most of the partnerships or limited liability companies that own and operate our surgical facilities. The purchase price that we would be required to pay for the ownership is typically based on either a multiple of the surgical facility’s EBITDA, as defined in our partnership and operating agreements with these surgical facilities, or the fair market value of the ownership as determined by a third-party appraisal. The physician investors in some of our surgical facilities can require us to purchase their interests in exchange for cash or shares of our common stock if these regulatory changes occur. In addition, some of our partnership agreements with our physician partners and management agreements with surgical facilities require us to attempt to renegotiate the agreements upon the occurrence of various fundamental regulatory changes or changes in the interpretation of existing regulations and provide for termination of the agreements if renegotiations are not successful.
Regulatory changes that could create purchase or renegotiation obligations include changes that:
▪ | make illegal the referral of Medicare or other patients to our surgical facilities by physician investors; |
▪ | create a substantial likelihood that cash distributions to physician investors from the partnerships or limited liability companies through which we operate our surgical facilities would be illegal; |
▪ | make illegal the ownership by the physician investors of interests in the partnerships or limited liability companies through which we own and operate our surgical facilities; or |
▪ | require us to reduce the aggregate percentage of physician investor ownership in our hospitals. |
We do not control whether or when any of these regulatory events might occur. In the event we are required to purchase all of the physicians’ ownership, our existing capital resources would not be sufficient for us to meet this obligation. These obligations and the possible termination of our partnership and management agreements would have a material adverse effect on our financial condition and results of operations.
If we become subject to large malpractice and related legal claims, we could be required to pay significant damages, which may not be covered by insurance.
In recent years, physicians, hospitals and other healthcare providers have become subject to an increasing number of legal actions alleging malpractice, product liability or related legal theories. Many of these actions involve large monetary claims and significant defense costs. We maintain liability insurance in amounts that we believe are appropriate for our operations. Currently, we maintain professional and general liability insurance that provides coverage on a claims made basis of $1.0 million per occurrence and $3.0 million in annual aggregate coverage per surgical facility. In addition, physicians who provide professional services in our surgical facilities are required to maintain separate malpractice coverage with similar minimum coverage limits. We also maintain business interruption insurance and property damage insurance, as well as an additional umbrella liability insurance policy in the aggregate amount of $20.0 million. However, this insurance coverage may not cover all claims against us. Insurance coverage may not continue to be available at a cost allowing us to maintain adequate levels of insurance. If one or more successful claims against us were not covered by or exceeded the coverage of our insurance, our financial condition and results of operations could be adversely affected.
We face intense competition for physicians, nurses, strategic relationships, acquisitions and managed care contracts, which may result in a decline in our revenues, profitability and market share.
The healthcare business is highly competitive. We compete with other healthcare providers, primarily hospitals and other surgical facilities, in attracting physicians to utilize our surgical facilities, nurses and medical staff to support our surgical facilities, and in contracting with managed care payors in each of our markets. There are unaffiliated hospitals in each market in which we operate. These hospitals have established relationships with physicians and payors. In addition, other companies either currently are in the same or similar business of developing, acquiring and operating surgical facilities or may decide to enter our business. Many of these companies have greater resources than we do, including financial, marketing, staff and capital resources. We also may compete with some of these companies for entry into strategic relationships with healthcare systems and healthcare professionals. In addition, many physician groups develop surgical facilities without a corporate partner, utilizing consultants who perform services for a fee and do not take an equity interest in the ongoing operations of the facility. In recent years, more physicians are choosing to perform procedures, including pain management and gastrointestinal procedures, in an office-based setting rather than in a surgical facility. If we are unable to compete effectively with any of these entities or
27
groups, we may be unable to implement our business strategies successfully and our financial position and results of operations could be adversely affected.
Our surgical facilities are sensitive to regulatory, economic and other conditions of the states where they are located. In addition, three of our surgical facilities account for a significant portion of our patient service revenues.
Our revenues are particularly sensitive to regulatory, economic and other conditions in the states of Texas and Florida. As of December 31, 2010, we owned (with physician investors or healthcare systems) and operated six surgical facilities in Texas and seven surgical facilities in Florida. The surgical facilities in Texas represented about 14% of our patient service revenues during 2010 and 17% during 2009, and the surgical facilities in Florida represented about 9% of our patient service revenues during 2010 and 11% during 2009.
In addition, our facilities in Idaho Falls, Idaho; Houma, Louisiana; and Durango, Colorado generated approximately 15%, 5%, and 6%, respectively, of our patient service revenues during 2010, and 0%, 6%, and 6%, respectively, during 2009. We acquired our facility in Idaho Falls, Idaho during 2010. If these facilities are adversely affected by regulatory, economic and other conditions, or if these facilities do not perform effectively, our financial condition and results of operations will be adversely affected. None of our remaining surgical facilities accounted for more than 5% of our revenues during 2010 or 2009.
We depend on our senior management, and we may be adversely affected if we lose any member of our senior management.
We are highly dependent on our senior management, including Richard E. Francis, Jr., our chairman of the board and chief executive officer, and Clifford G. Adlerz, our president and chief operating officer. We have entered into employment agreements with Messrs. Francis and Adlerz that became effective upon the closing of the Merger. The initial term of each of these agreements was three years from August 23, 2007. The term automatically extends so that the term is three years until terminated. We may terminate each employment agreement for cause. In addition, either party may terminate the employment agreement at any time by giving prior written notice to the other party. We do not maintain “key man” life insurance policies on any of our officers. Because our senior management has contributed greatly to our growth since inception, the loss of key management personnel or our inability to attract, retain and motivate sufficient numbers of qualified management personnel could have a material adverse effect on our financial condition and results of operations.
If we are unable to integrate and manage our information systems effectively, our operations could be disrupted.
Our operations significantly depend on effective information systems. Our information systems and applications require continual maintenance, upgrading and enhancement to meet our operational needs. Moreover, our acquisition activity requires frequent transitions from, and the integration of, various information systems. If we experience difficulties with the transition from information systems or are unable to properly maintain or expand our information systems, we could suffer, among other things, operational disruptions and increases in administrative expenses.
Risks Related to Our Corporate Structure
We may have a special legal responsibility to the holders of ownership interests in the entities through which we own our surgical facilities, which may conflict with the interests of our noteholders and prevent us from acting solely in our own best interests or the interests of our noteholders.
We generally hold our ownership interests in surgical facilities through limited partnerships or limited liability companies in which we maintain ownership along with physicians or physician practice groups. As general partner or manager of these entities, we may have a special responsibility, known as a fiduciary duty, to manage these entities in the best interests of the other interest holders. As a result, we may encounter conflicts between our responsibility to the other interest holders and our responsibility to enhance the value of our company. For example, we have entered into management agreements to provide management services to our surgical facilities in exchange for a fee. Disputes may arise as to the nature of the services to be provided or the amount of the fee to be paid. In these cases, we are obligated to exercise reasonable, good faith judgment to resolve the disputes and may not be free to act solely in our own best interests or the interests of the noteholders. Disputes may also arise between us and our physician investors with respect to a particular business decision or regarding the interpretation of the provisions of the applicable limited partnership agreement or operating agreement. We seek to avoid these disputes but have not implemented any measures to resolve these conflicts if they arise. If we are unable to resolve a dispute on terms favorable or satisfactory to us, our financial condition and results of operations may be adversely affected.
We are a holding company with no operations of our own.
We are a holding company and our ability to service our debt is dependent upon the earnings from the business conducted by our subsidiaries and joint ventures. The effect of this structure is that we will depend on the earnings of our subsidiaries and joint ventures, and the distribution or payment to us of a portion of these earnings to meet our obligations, including those under our senior secured credit facility, the senior notes and any of our other debt obligations. The distributions of those earnings or advances or other distributions of funds by these entities to us, all of which are contingent upon the subsidiaries’ earnings, are subject to various business considerations. In addition, distributions by our subsidiaries could be subject to restrictions contained in the senior secured credit facility and the Indenture covering the Toggle Notes, statutory restrictions, including state laws requiring that such subsidiaries be solvent, or contractual restrictions. Some of our subsidiaries and joint ventures may become subject to agreements that restrict the sale of assets and significantly restrict or prohibit the payment of dividends or the making of distributions, loans or other payments to stockholders, partners or members. The indenture governing the Toggle Notes permits our subsidiaries to enter into agreements with similar prohibitions and restrictions in the future, subject to certain
28
limitations.
We do not have exclusive control over the distribution of cash from our operating entities and may be unable to cause all or a portion of the cash of these entities to be distributed.
All of the surgical facilities in which we have ownership are held through partnerships or limited liability companies. We typically own, directly or indirectly, the general partnership or majority member interests in these entities. The partnership and operating agreements for these entities provide for distribution of available cash, in some cases on a quarterly basis subject in certain cases to requirements that we obtain approval of other equity holders. Many of these agreements also impose limits on the ability of these entities to make loans or transfer assets to us. If we are unable to cause sufficient cash to be distributed from one or more of these entities, our relationships with the physicians who also own an interest in these entities may be damaged and we could be adversely affected, as could our ability to make debt service payments. We may not be able to resolve favorably any dispute regarding cash distribution or other matters with a healthcare system with which we share control of the distributions made by these entities. Further, the failure to resolve a dispute with these healthcare systems could cause an entity in which we own an interest to be dissolved.
We are controlled by principal stockholders whose interests may differ from your interests.
Circumstances may occur in which the interests of our principal stockholders could be in conflict with the interests of the holders of our Toggle Notes. In addition, these stockholders may have an interest in pursuing transactions that, in their judgment, enhance the value of their equity investment in our company, even though those transactions may involve risks to other interest holders.
A majority of the outstanding shares of common stock of our parent company are held by the Crestview funds. As a result of their stock ownership, the Crestview funds control us and have the power to elect a majority of our directors, appoint new management and approve any action requiring the approval of the holders of common stock, including adopting amendments to our certificate of incorporation and approving acquisitions or sales of all or substantially all of our assets. The directors elected by the Crestview funds have the ability to control decisions affecting our capital structure, including the issuance of additional capital stock, the implementation of stock repurchase programs and the declaration of dividends.
Item 1B. Unresolved Staff Comments
None.
Item 2. Properties
Our corporate headquarters are located in Nashville, Tennessee in approximately 44,000 square feet of leased office space, under a ten-year lease that commenced on November 1, 2002. Upon expiration of the initial ten-year term, the lease may be renewed for two additional five-year periods. To exercise the renewal option, we must give notice at least nine months prior to the expiration of the lease term in question.
Our surgical facilities typically are located on real estate leased by the partnership or limited liability company that operates the facility. These leases generally have initial terms of ten years, but range from two to 15 years. Most of the leases contain options to extend the lease period for up to ten additional years. The surgical facilities are generally responsible for property taxes, property and casualty insurance and routine maintenance expenses. Two of our surgical facilities are located on real estate owned by the limited partnership or limited liability company that owns the surgical facility. We generally guarantee the lease obligations of the partnerships and limited liability companies that own our surgical facilities.
Additional information about our surgical facilities and our other properties can be found in Item 1 of this report under the caption, “Business — Operations.”
Item 3. Legal Proceedings
We are, from time to time, subject to claims and suits arising in the ordinary course of business, including claims for damages for personal injuries, breach of management contracts and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages, that may not be covered by insurance.
Item 4. [Removed and reserved]
29
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
We are wholly owned by Symbion Holdings Corporation which is owned by Crestview and certain affiliated funds managed by Crestview and co-investors. There is no public trading market for our equity securities or those of Holdings. As of March 25, 2011, there were 10 holders of Holdings common stock.
Item 6. Selected Financial Data
The following selected consolidated financial and other data should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 and our audited consolidated financial statements and the related notes included elsewhere in this report. The selected consolidated statement of operations data set forth below for the years ended December 31, 2010, 2009 and 2008, and the selected consolidated balance sheet data set forth below at December 31, 2010 and 2009, are derived from our audited consolidated financial statements that are included elsewhere in this report. The selected consolidated statement of operations data set forth below for the years ended December 31, 2007 and 2006, and the selected consolidated balance sheet data set forth below at December 31, 2008, 2007 and 2006, are derived from our audited consolidated financial statements that are not included in this report.
The historical results presented below are not necessarily indicative of the results to be expected for any future period.
Year Ended December 31, | |||||||||||||||||||
2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||
(in thousands) | |||||||||||||||||||
Consolidated Statement of Operations Data: | |||||||||||||||||||
Revenues | $ | 406,050 | $ | 336,944 | $ | 321,484 | $ | 291,640 | $ | 275,269 | |||||||||
Cost of revenues | 290,145 | 239,403 | 215,872 | 196,147 | 174,636 | ||||||||||||||
General and administrative expense | 22,464 | 21,448 | 23,923 | 31,872 | 24,407 | ||||||||||||||
Depreciation and amortization | 18,900 | 16,807 | 14,845 | 12,335 | 11,555 | ||||||||||||||
Provision for doubtful accounts | 6,638 | 2,881 | 3,559 | 4,081 | 3,676 | ||||||||||||||
Income on equity investments | (2,901 | ) | (2,318 | ) | (1,504 | ) | (16 | ) | (2,423 | ) | |||||||||
Impairment and loss on disposal of long-lived assets | 1,053 | 3,505 | 1,872 | 372 | 1,161 | ||||||||||||||
Gain on sale of long-lived assets and other gains | (1,964 | ) | (248 | ) | (975 | ) | (915 | ) | (1,794 | ) | |||||||||
Proceeds from insurance settlements, net | — | (430 | ) | — | (161 | ) | (410 | ) | |||||||||||
Litigation settlements, net | (35 | ) | — | 893 | — | (588 | ) | ||||||||||||
Business combination remeasurement gains | (3,169 | ) | — | — | — | — | |||||||||||||
Merger transaction expenses | — | — | — | 7,522 | — | ||||||||||||||
Total operating expenses | 331,131 | 281,048 | 258,485 | 251,237 | 210,220 | ||||||||||||||
Operating income | 74,919 | 55,896 | 62,999 | 40,403 | 65,049 | ||||||||||||||
Interest expense, net | (48,037 | ) | (44,958 | ) | (43,415 | ) | (20,006 | ) | (7,202 | ) | |||||||||
Income before income taxes and discontinued operations | 26,882 | 10,938 | 19,584 | 20,397 | 57,847 | ||||||||||||||
Provision for income taxes | 7,787 | 7,762 | 13,464 | 3,178 | 12,115 | ||||||||||||||
Income from continuing operations | 19,095 | 3,176 | 6,120 | 17,219 | 45,732 | ||||||||||||||
(Loss) income from discontinued operations, net of taxes | (964 | ) | (5,899 | ) | (3,097 | ) | 558 | 711 | |||||||||||
Net income (loss) | 18,131 | (2,723 | ) | 3,023 | 17,777 | 46,443 | |||||||||||||
Less: Net income attributable to noncontrolling interests | (26,871 | ) | (19,731 | ) | (23,821 | ) | (23,179 | ) | (27,650 | ) | |||||||||
Net (loss) income attributable to Symbion, Inc. | $ | (8,740 | ) | $ | (22,454 | ) | $ | (20,798 | ) | $ | (5,402 | ) | $ | 18,793 | |||||
Cash Flow Data — continuing operations: | |||||||||||||||||||
Net cash provided by operating activities | $ | 68,769 | $ | 60,284 | $ | 60,933 | $ | 51,243 | $ | 54,372 | |||||||||
Net cash used in investing activities | (53,150 | ) | (11,144 | ) | (32,921 | ) | (38,848 | ) | (64,486 | ) | |||||||||
Net cash provided by (used in) financing activities | 9,583 | (42,778 | ) | (31,718 | ) | 2,467 | 6,966 | ||||||||||||
Other Data: | |||||||||||||||||||
EBITDA(1) | $ | 65,200 | $ | 57,094 | $ | 57,034 | $ | 47,284 | $ | 52,186 | |||||||||
EBITDA as a % of revenues | 16.1 | % | 16.9 | % | 17.7 | % | 16.2 | % | 19.0 | % | |||||||||
Number of surgical facilities operated as of the end of period(2) | 62 | 67 | 66 | 58 | 56 | ||||||||||||||
30
As of December 31, | |||||||||||||||||||
2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||
(in thousands) | |||||||||||||||||||
Consolidated Balance Sheet Data: | |||||||||||||||||||
Working capital | $ | 77,302 | $ | 40,782 | $ | 52,272 | $ | 70,617 | $ | 56,643 | |||||||||
Total assets | 970,397 | 790,726 | 783,564 | 768,813 | 503,806 | ||||||||||||||
Total long-term debt, less current maturities | 507,417 | 444,758 | 440,258 | 428,870 | 136,476 | ||||||||||||||
Total Symbion, Inc. stockholders’ equity | 185,426 | 193,413 | 211,206 | 233,286 | 285,279 | ||||||||||||||
(1) | When we use the term “EBITDA,” we are referring to net income (loss) plus (a) (loss) income from discontinued operations, net of taxes (b) income tax expense, (c) interest expense, net, (d) depreciation and amortization, (e) non-cash (gains) losses, net of noncontrolling interests, and (f) non-cash stock option compensation, and less (g) net income attributable to noncontrolling interests. Noncontrolling interest represents the interest of third parties, such as physicians, and in some cases, healthcare systems that own an interest in surgical facilities that we consolidate for financial reporting purposes. Our operating strategy is to apply a market-based approach in structuring our partnerships with individual market dynamics driving the structure. We believe that it is helpful to investors to present EBITDA as defined above because it excludes the portion of net income attributable to these third-party interests and clarifies for investors our portion of EBITDA generated by our surgical facilities and other operations. |
(2) | Includes surgical facilities that we manage but in which we do not have an ownership interest. |
We use EBITDA as a measure of liquidity. We have included it because we believe that it provides investors with additional information about our ability to incur and service debt and make capital expenditures. We also use EBITDA, with some variation in the calculation, to determine compliance with some of the covenants under the senior secured credit facility, as well as to determine the interest rate and commitment fee payable under the senior secured credit facility.
EBITDA is not a measurement of financial performance or liquidity under GAAP. It should not be considered in isolation or as a substitute for net income, operating income, cash flows from operating, investing or financing activities, or any other measure calculated in accordance with generally accepted accounting principles. The items excluded from EBITDA are significant components in understanding and evaluating financial performance and liquidity. Our calculation of EBITDA may not be comparable to similarly titled measures reported by other companies.
31
The following table reconciles EBITDA to net cash provided by operating activities — continuing operations:
Year Ended December 31, | |||||||||||||||||||
2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||
(in thousands) | |||||||||||||||||||
EBITDA | $ | 65,200 | $ | 57,096 | $ | 57,034 | $ | 47,284 | $ | 52,186 | |||||||||
Depreciation and amortization | (18,900 | ) | (16,807 | ) | (14,845 | ) | (12,335 | ) | (11,555 | ) | |||||||||
Non-cash gains (losses), net of noncontrolling interests | 3,084 | (2,827 | ) | (897 | ) | 543 | 633 | ||||||||||||
Non-cash stock option compensation expense | (1,336 | ) | (1,297 | ) | (2,114 | ) | (10,746 | ) | (3,865 | ) | |||||||||
Interest expense, net | (48,037 | ) | (44,958 | ) | (43,415 | ) | (20,006 | ) | (7,202 | ) | |||||||||
Provision for income taxes | (7,787 | ) | (7,762 | ) | (13,464 | ) | (3,178 | ) | (12,115 | ) | |||||||||
Net income attributable to noncontrolling interests | 26,871 | 19,731 | 23,821 | 23,179 | 27,650 | ||||||||||||||
Merger transaction expenses | — | — | — | (7,522 | ) | ||||||||||||||
(Loss) income from discontinued operations, net of taxes | (964 | ) | (5,899 | ) | (3,097 | ) | 558 | 711 | |||||||||||
Net income (loss) | 18,131 | (2,723 | ) | 3,023 | 17,777 | 46,443 | |||||||||||||
Loss (income) from discontinued operations | 964 | 5,899 | 3,097 | (558 | ) | (711 | ) | ||||||||||||
Depreciation and amortization | 18,900 | 16,807 | 14,845 | 12,335 | 11,555 | ||||||||||||||
Amortization of deferred financing costs | 2,004 | 2,004 | 4,477 | 2,194 | 506 | ||||||||||||||
Non-cash payment-in-kind interest option | 26,079 | 23,263 | 17,616 | — | — | ||||||||||||||
Non-cash recognition of other comprehensive loss into earnings | 2,732 | 2,853 | — | — | — | ||||||||||||||
Non-cash credit risk adjustment of financial instruments | 189 | 1,629 | — | — | — | ||||||||||||||
Non-cash stock option compensation expense | 1,336 | 1,297 | 2,114 | 10,746 | 3,865 | ||||||||||||||
Non-cash (gains) losses | (4,080 | ) | 2,827 | 897 | (543 | ) | (633 | ) | |||||||||||
Deferred income taxes | 10,979 | 8,682 | 13,718 | 15,854 | (1,556 | ) | |||||||||||||
Equity in earnings of unconsolidated affiliates, net of distributions received | 50 | (207 | ) | 333 | (16 | ) | (2,423 | ) | |||||||||||
Provision for doubtful accounts | 6,638 | 2,881 | 3,559 | 4,081 | 3,676 | ||||||||||||||
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions: | — | ||||||||||||||||||
Accounts receivable | (14,886 | ) | (4,383 | ) | (3,278 | ) | (256 | ) | (2,955 | ) | |||||||||
Other assets and liabilities | (267 | ) | (545 | ) | 532 | (10,371 | ) | (3,395 | ) | ||||||||||
Net cash provided by operating activities — continuing operations | $ | 68,769 | $ | 60,284 | $ | 60,933 | $ | 51,243 | $ | 54,372 | |||||||||
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with Item 6. “Selected Financial Data” and our audited consolidated financial statements and related notes included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. For additional information regarding some of the risks and uncertainties that affect our business and the industry in which we operate, please read Item 1A. “Risk Factors” found elsewhere in this report. Our actual results may differ materially from those estimated or projected in any of these forward-looking statements.
Executive Overview
We own and operate a national network of short stay surgical facilities in 27 states. Our surgical facilities, which include ambulatory surgery centers and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics, pain management, gastroenterology and ophthalmology. Some of our hospitals also offer additional services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, physical therapy and wound care. We own our surgical facilities in partnership with physicians and in some cases healthcare systems in the markets and communities we serve. We apply a market-based approach in structuring our partnerships with individual market dynamics driving the structure. We believe this approach aligns our interests with those of our partners. As of December 31, 2010, we owned and operated 54 surgical facilities, including 49 ambulatory surgery centers, four surgical hospitals and one general acute care hospital with a surgical and obstetrics focus. We also managed eight additional ASCs. We owned a majority interest in 29 of the 54 surgical facilities and consolidated 49 of these facilities for financial reporting purposes. In addition to our surgical facilities, we also managed one physician network throughout 2010 in a market in which we operate an ASC.
We have benefited from both the growth in overall outpatient surgery cases as well as the migration of surgical procedures from the hospital to the surgical facility setting. Advancements in medical technology, such as lasers, arthroscopy and enhanced endoscopic techniques, have reduced the trauma of surgery and the amount of recovery time required by patients following a surgical procedure. Improvements in anesthesia also have shortened the recovery time for many patients and have reduced post-operative side effects such as
32
pain, nausea and drowsiness. These medical advancements have enabled more patients to undergo surgery in a surgical facility setting.
We continue to focus on improving the performance of our same store facilities and acquiring facilities on a selective basis that we believe have favorable growth potential. On April 9, 2010, we acquired a 54.5% ownership interest in a general acute care hospital with a surgical and obstetrics focus, located in Idaho Falls, Idaho. This acquisition provides us with the opportunity to expand into a new market, and the results of the facility are consolidated for financial reporting purposes. Effective July 1, 2010, we acquired an incremental, controlling ownership interest of 37.0% in one of our surgical facilities located in Chesterfield, Missouri for $18.8 million. Subsequent to the acquisition, we held a 50.0% ownership interest in this facility. As a result of this acquisition, we began consolidating the facility in the third quarter of 2010.
Revenues
Our revenues consist of patient service revenues, physician service revenues and other service revenues. Our patient service revenues relate to fees charged for surgical or diagnostic procedures performed at surgical facilities that we consolidate for financial reporting purposes. Physician service revenues are revenues from physician networks consisting of reimbursed expenses, plus participation in the excess of revenues over expenses of the physician networks, as provided for in our service agreements with our physician networks. Other service revenues consist of management and administrative service fees derived from the non-consolidated facilities that we account for under the equity method, management of surgical facilities in which we do not own an interest, and management services we provide to physician networks for which we are not required to provide capital or additional assets.
The following tables summarize our revenues by service type as a percentage of total revenues for the periods indicated:
Year Ended December 31, | ||||||||
2010 | 2009 | 2008 | ||||||
Patient service revenues | 97 | % | 96 | % | 96 | % | ||
Physician service revenues | 1 | 2 | 2 | |||||
Other service revenues | 2 | 2 | 2 | |||||
Total | 100 | % | 100 | % | 100 | % | ||
Payor Mix
The following table sets forth by type of payor the percentage of our patient service revenues generated in the periods indicated:
Year Ended December 31, | ||||||||
2010 | 2009 | 2008 | ||||||
Private Insurance | 69 | % | 71 | % | 72 | % | ||
Government | 25 | 24 | 22 | |||||
Self-pay | 4 | 4 | 4 | |||||
Other | 2 | 1 | 2 | |||||
Total | 100 | % | 100 | % | 100 | % | ||
Case Mix
We primarily operate multi-specialty facilities where physicians perform a variety of procedures in specialties, including orthopedics, pain management, gastroenterology and ophthalmology, among others. We believe this diversification helps to protect us from any adverse pricing and utilization trends in any individual procedure type and results in greater consistency in our case volume.
The following table sets forth the percentage of cases in each specialty performed at surgical facilities which we consolidate for financial reporting purposes for the periods indicated
Year Ended December 31, | ||||||||
2010 | 2009 | 2008 | ||||||
Ear, nose and throat | 5.6 | % | 5.6 | % | 6.5 | % | ||
Gastrointestinal | 29.4 | 28.7 | 28.8 | |||||
General surgery | 4.2 | 4.3 | 4.0 | |||||
Obstetrics/gynecology | 2.8 | 2.9 | 3.1 | |||||
Ophthalmology | 15.7 | 16.7 | 15.2 | |||||
Orthopedic | 16.9 | 16.3 | 16.1 | |||||
Pain management | 14.0 | 14.0 | 14.3 | |||||
Plastic surgery | 3.3 | 3.1 | 3.5 | |||||
Other | 8.1 | 8.4 | 8.5 | |||||
Total | 100.0 | % | 100.0 | % | 100.0 | % | ||
33
Case Growth
Same Store Information
We define same store facilities as those facilities that were operating throughout the respective years ended December 31, 2010 and 2009. The following same store facility table includes both consolidated surgical facilities included in continuing operations that are included in our revenue and non-consolidated surgical facilities that are not reported in our revenue, as we account for these surgical facilities using the equity method. This same store facilities table is presented to allow comparability to other companies in our industry for the periods indicated:
Year Ended December 31, | |||||||
2010 | 2009 | ||||||
Cases | 251,300 | 254,678 | |||||
Case growth | (1.3 | )% | N/A | ||||
Net patient service revenue per case | $ | 1,516 | $ | 1,469 | |||
Net patient service revenue per case growth | 3.2 | % | N/A | ||||
Number of same store surgical facilities | 52 | N/A | |||||
The following same store facility table is presented for purposes of explaining changes in our condensed consolidated financial results and accordingly excludes non-consolidated surgical facilities that are not reported in our revenue:
Year Ended December 31, | |||||||
2010 | 2009 | ||||||
Cases | 226,251 | 230,018 | |||||
Case growth | (1.6 | )% | N/A | ||||
Net patient service revenue per case | $ | 1,358 | $ | 1,345 | |||
Net patient service revenue per case growth | 1.0 | % | N/A | ||||
Number of same store surgical facilities | 46 | N/A | |||||
Consolidated Information
The following table sets forth information for all surgical facilities included in continuing operations that we consolidate for financial reporting purposes for the periods indicated. Accordingly, the table includes surgical facilities that we have acquired, developed or disposed of since January 1, 2009.
Year Ended December 31, | |||||||
2010 | 2009 | ||||||
Cases | 237,772 | 232,079 | |||||
Case growth | 2.5 | % | N/A | ||||
Net patient service revenue per case | $ | 1,656 | $ | 1,391 | |||
Net patient service revenue per case growth | 19.1 | % | N/A | ||||
Number of surgical facilities operated as of end of the period(1) | 62 | 62 | |||||
Number of consolidated surgical facilities | 49 | 47 | |||||
(1) | Includes surgical facilities that we manage but in which we have no ownership. |
34
Operating Trends
We are dependent upon private and government third-party sources of payment for the services we provide. The amounts that our surgical facilities and networks receive in payment for their services may be adversely affected by market and cost factors as well as other factors over which we have no control, including Medicare, Medicaid, and state regulations and the cost containment and utilization decisions and reduced reimbursement schedules of third-party payors. See Item 1. “Business — Sources of Revenue”.
Our operating income margin for the year ended December 31, 2010 increased to 18.4% from 16.5% during the year ended December 31, 2009. The margin in 2010 reflects, among other things, a $3.2 million gain as a result of remeasuring our existing equity interest in our surgical facility located in Chesterfield, Missouri and a $1.9 million gain from debt extinguishments at two of our facilities. Comparatively, our operating income margin for 2009 included a $2.4 million impairment charge related to our equity method investment located in Arcadia, California. Excluding non-cash gains and charges, our operating income margin was 17.4% for both 2010 and 2009.
Acquisitions and Developments
2010 Activities
Effective July 1, 2010, we acquired an incremental, controlling ownership interest of 37.0% in one of our surgical facilities located in Chesterfield, Missouri for $18.8 million. Subsequent to the acquisition, we held a 50.0% ownership interest in the facility. As part of the acquisition, we consolidated $4.8 million of third-party facility debt on our balance sheet. We subsequently restructured this debt using borrowings from our Revolving Facility. As a result of this acquisition, we hold a controlling interest in this facility. The acquisition was treated as a business combination, and we began consolidating the facility for financial reporting purposes in the third quarter of 2010. We financed the aggregate purchase price with proceeds from our Revolving Facility.
Effective April 9, 2010, we acquired an ownership of 54.5% in a general acute care hospital with a surgical and obstetrics focus located in Idaho Falls, Idaho for approximately $31.9 million plus the assumption of approximately $6.1 million of debt and other obligations of $48.0 million, which we consolidate on our balance sheet. The other obligations include a financing obligation of $48.0 million payable to the hospital facility lessor for the land, buildings and improvements of the facility. We financed the acquisition with borrowings from our Revolving Facility. We consolidate this facility for financial reporting purposes.
2009 Activities
Effective February 28, 2009, we acquired an incremental ownership of 18.0% in our surgical facility located in Westlake Village, California, for a purchase price of $416,000, financed with cash from operations. We account for this investment under the equity method. Prior to the acquisition, we owned 1.0% of this facility.
Effective May 1, 2009, we acquired a 91.8% ownership interest in a surgical hospital in Austin, Texas for $350,000 plus the assumption of $2.6 million of debt. Subsequently, we reduced our ownership in this facility to 47.0%. The purchase price was financed with cash from operations. We consolidate this surgical facility for financial reporting purposes. We also entered into a management agreement with this facility.
Effective September 1, 2009, we acquired an ownership of 28.8% in a surgical facility located in Gresham, Oregon for $525,000. The purchase price was financed with cash from operations. We account for this investment under the equity method. We also entered into a management agreement with this facility.
Also during the first quarter of 2009, we opened one surgical facility that was under development as of December 31, 2008. We consolidate this surgical facility for financial reporting purposes.
2008 Activities
Effective January 1, 2008, we acquired incremental ownership in three of our existing surgical facilities located in California. We acquired incremental ownership of 10.7% in each of our two surgical facilities located in Beverly Hills, California for an aggregate of $2.5 million and 6.4% incremental ownership in our surgical facility located in Encino, California for $2.0 million. Prior to the acquisition, we owned 55.1% and 57.0% of the two Beverly Hills, California surgical facilities and 55.5% of the Encino, California surgical facility. The aggregate purchase price was financed with cash from operations.
Effective February 21, 2008, we acquired ownership in five surgical facilities specializing in spine, orthopedic and pain management procedures located in Boulder, Colorado; Honolulu, Hawaii; Bristol and Nashville, Tennessee; and Seattle, Washington for an aggregate of $5.8 million plus the assumption of $4.7 million in debt. We acquired ownership ranging from 20.0% to 50.0% in these surgical facilities. One of the five facilities that we acquired in 2008 was a newly developed surgical facility that opened in the fourth quarter of 2007. Four of these surgical facilities are consolidated for financial reporting purposes. The aggregate purchase price was financed with cash from operations. We also entered into management agreements with each of these surgical facilities.
Effective May 31, 2008, we acquired additional management rights and an incremental ownership in two of our existing surgical facilities located in California for an aggregate purchase price of $3.4 million, financed with cash from operations. We acquired an incremental ownership of 18.0% in our surgical facility located in Arcadia, California for $304,000 and an incremental ownership of 16.7% in our surgical facility located in Irvine, California for an aggregate of $3.1 million. The aggregate purchase price was financed with cash from
35
operations.
Effective August 1, 2008, we acquired an incremental ownership of 18.5% in our surgical facility located in Irvine, California for a purchase price of $5.1 million, financed with cash from operations. Through this acquisition we obtained a controlling interest in this facility, and we began consolidating the facility for financial reporting purposes during the third quarter of 2008.
During 2008, we opened four of the five surgical facilities that were under development as of December 31, 2007. We consolidate one of these surgical facilities for financial reporting purposes and account for three as investments under the equity method.
Discontinued Operations and Divestitures
We evaluate our portfolio of surgical facilities to ensure the facilities are performing as we expect. During 2010, we committed to a plan to divest our interest in four facilities that we consolidated for financial reporting purposes. In September 2010, we sold our interest in a surgical facility located in Orlando, Florida for net proceeds of $1.3 million and recognized a loss of $2.2 million, which includes an accrual of $1.7 million for future contractual obligations under a facility operating lease. As of December 31, 2010, the lease liability was $1.4 million. In October 2010, we sold our interest in a surgical facility located in Duncanville, Texas for net proceeds of $1.0 million and recognized a gain of $256,000. In December 2010, we sold our interest in surgical facilities located in Hammond, Louisiana and Vincennes, Indiana for net proceeds of $583,000 and $591,000, respectively and recognized a gain of $109,000 and a loss of $275,000, respectively. All of the aforementioned divestitures were included in losses from discontinued operations. These facilities' assets, liabilities, revenues, expenses and cash flows have been classified as discontinued operations for all periods presented.
During the fourth quarter of 2010, we took one facility located in San Antonio, Texas, previously listed as held for sale, off the market as we have been unable to dispose of the facility under terms we deemed acceptable to our stockholders. As a result, we have reclassified the results of operations for this surgical facility from discontinued operations to continuing operations for all periods presented.
In February 2009, we ceased operations at our surgical facility located in Englewood, Colorado. We recorded a loss on the disposal of $5.9 million, which includes an accrual of $4.6 million for future contractual obligations under a facility operating lease. We terminated this contractual lease obligation in July 2010. We paid cash of $1.2 million to settle the $3.6 million balance remaining on the obligation. A $2.4 million gain is included in the loss from discontinued operations as of December 31, 2010.
Revenues, (loss) gain on operations before income taxes, the income tax provision (benefit), the (loss) gain on the sale from discontinued operations, net of taxes, and the income (loss) from discontinued operations, net of taxes, for the following periods indicated, were as follows (in thousands):
Year Ended December 31, | |||||||||||||||||||
2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||
Revenues | $ | 8,697 | $ | 14,548 | $ | 17,879 | $ | 22,468 | $ | 29,245 | |||||||||
(Loss) gain on operations before income taxes | (1,337 | ) | (18 | ) | (953 | ) | (128 | ) | 540 | ||||||||||
Income tax provision (benefit) | 5 | 41 | (1,383 | ) | (293 | ) | (351 | ) | |||||||||||
Gain (loss) on sale, net of taxes | 378 | (5,840 | ) | (3,527 | ) | 393 | (180 | ) | |||||||||||
(Loss) income from discontinued operations, net of taxes | $ | (964 | ) | $ | (5,899 | ) | $ | (3,097 | ) | $ | 558 | $ | 711 | ||||||
Effective February 1, 2010, we disposed of our ownership interest in our surgical facility located in Arcadia, California. We recorded an impairment charge related to this equity method investment of $2.4 million in 2009. Effective July 10, 2009, we disposed of our ownership interest in our surgical facility located in Temple, Texas. A loss of $273,000 was recorded in the quarter ended June 30, 2009. Because both of these investments were accounted for under the equity method, the results of operations for these facilities are not reported as discontinued operations. The loss on disposal of these facilities is included in impairment and loss on disposal of long-lived assets.
Critical Accounting Policies
Our significant accounting policies and practices are described in Note 3 of our consolidated financial statements included elsewhere in this report. In preparing our consolidated financial statements in conformity with accounting principles generally accepted in the United States, our management must make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Certain accounting estimates are particularly sensitive because of their complexity and the possibility that future events affecting them may differ materially from our current judgments and estimates. Our actual results could differ from those estimates. We believe that the following critical accounting policies are important to the portrayal of our financial condition and results of operations and require our management’s subjective or complex judgment because of the sensitivity of the methods, assumptions and estimates used. This listing of critical accounting policies is not intended to be a comprehensive list of all of our accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by generally accepted accounting principles in the United States, with no need for management’s judgment regarding accounting policy.
Consolidation and Control
36
Our consolidated financial statements include our accounts and those of our wholly owned subsidiaries, as well as our interests in surgical facilities that we control through our ownership of a majority voting interest or other rights granted to us by contract as the sole general partner or manager to manage and control the business. The rights of the limited partners or minority members in these surgical facilities are generally limited to those that protect their ownership, including the right to approve of the issuance of new ownership interests, and those that protect their financial interests, including the right to approve the acquisition or divestiture of significant assets or the incurrence of debt that physician limited partners or members are required to guarantee on a pro rata basis based upon their respective ownership, or that exceeds 20.0% of the fair market value of the surgical facility’s assets. All significant intercompany balances and transactions, including management fees from consolidated surgical facilities, are eliminated in consolidation.
We also hold non-controlling interests in some surgical facilities over which we exercise significant influence. Significant influence includes financial interests, duties, rights and responsibilities for the day-to-day management of the surgical facility. These non-controlling interests are accounted for under the equity method.
We also consider the relevant sections of the Financial Accounting Standards Board’s Accounting Standards Codification, Topic 810, Consolidation, to determine if we are the primary beneficiary of (and therefore should consolidate) any entity whose operations we do not control with voting rights. At December 31, 2010, we consolidate two entities because we are the primary beneficiary.
Revenue Recognition
Our revenues are comprised of patient service revenues, physician service revenues and other service revenues. Our patient service revenues relate to fees charged for surgical or diagnostic procedures performed at surgical facilities that we consolidate for financial reporting purposes. These fees are billed either to the patient or a third-party payor. Our fees vary depending on the procedure, but usually include all charges for usage of an operating room, a recovery room, special equipment, supplies, nursing staff and medications. Also, in a very limited number of our surgical facilities, we charge for anesthesia services. Our fees normally do not include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by the physicians to the patient or third-party payor. We recognize patient service revenues on the date of service, net of estimated contractual adjustments and discounts for third-party payors, including Medicare and Medicaid. Changes in estimated contractual adjustments and discounts are recorded in the period of change.
Physician service revenues are revenues from physician networks consisting of reimbursed expenses, plus participation in the excess of revenues over expenses of the physician networks, as provided for in our service agreements with our physician networks. Reimbursed expenses include the costs of personnel, supplies and other expenses incurred to provide the management services to the physician networks. We recognize physician service revenues in the period in which reimbursable expenses are incurred and in the period in which we have the right to receive a percentage of the amount by which a physician network’s revenues exceed its expenses. Physician service revenues are based on net billings with any changes in estimated contractual adjustments reflected in service revenues in the subsequent period.
Our other service revenues consist of management and administrative service fees derived from non-consolidated surgical facilities that we account for under the equity method, management of surgical facilities in which we do not own an interest and management services we provide to physician networks for which we are not required to provide capital or additional assets. The fees we derive from these management arrangements are based on a pre-determined percentage of the revenues of each surgical facility and physician network. We recognize other service revenues in the period in which services are rendered.
Allowance for Contractual Adjustments and Doubtful Accounts
Our patient service revenues and receivables from third-party payors are recorded net of estimated contractual adjustments and allowances from third-party payors, which we estimate based on the historical trend of our surgical facilities’ cash collections and contractual write-offs, accounts receivable agings, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, we expect that any such changes would be minimal and, therefore, would not have a material effect on our financial condition or results of operations.
We estimate our allowances for bad debts using similar information and analysis. While we believe that our allowances for contractual adjustments and bad debts are adequate, if the actual write-offs are significantly different from our estimates, it could have a material adverse effect on our financial condition and results of operations. Because in most cases, we have the ability to verify a patient’s insurance coverage before services are rendered and because we have entered into contracts with third-party payors which account for a majority of our total revenues, the out-of-period contractual adjustments have been minimal. Our net accounts receivable reflected allowances for doubtful accounts of $10.1 million, $9.0 million and $14.0 million, at December 31, 2010, 2009 and 2008, respectively.
The following table summarizes our days sales outstanding for the periods indicated:
Year Ended December 31, | ||||||||
2010 | 2009 | 2008 | ||||||
Days sales outstanding | 48 | 38 | 38 | |||||
The increase in days sales outstanding is primarily attributable to the acquisition of the incremental, controlling ownership interest in one of our surgical facilities located in Chesterfield, Missouri. This surgical facility has a high concentration of cases associated with legal proceedings which routinely have an extended collection cycle.
37
Our collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage our patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. Each surgical facility is responsible for analyzing accounts receivable to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.
At a consolidated level, we review the standard aging schedule, by facility, to determine the appropriate provision for doubtful accounts by monitoring changes in our consolidated accounts receivable by aged schedule, day’s sales outstanding and bad debt expense as a percentage of revenues. At a consolidated level, we do not review a consolidated aging by payor. Regional and local employees review each surgical facility’s aged accounts receivable by payor schedule. These employees have a closer relationship with the payors and have a more thorough understanding of the collection process for that particular surgical facility. Furthermore, this review is supported by an analysis of the actual net revenues, contractual adjustments and cash collections received. If our internal collection efforts are unsuccessful, we further review patient accounts with balances of $25 or more. We then classify the accounts based on any external collection efforts we deem appropriate. An account is written-off only after we have pursued collection with legal or collection agency assistance or otherwise deemed an account to be uncollectible. Typically, accounts will be outstanding a minimum of 120 days before being written-off.
The following table summarizes our accounts receivable aging, net of contractual adjustments but before our allowance for doubtful accounts and certain other allowances, for consolidated surgical facilities as of the periods indicated (in thousands):
Year Ended December 31, | |||||||||||||
2010 | 2009 | ||||||||||||
Amount | % of Total | Amount | % of Total | ||||||||||
Current | $ | 31,110 | 41 | % | $ | 20,627 | 41 | % | |||||
31 to 60 days | 12,882 | 17 | 9,188 | 18 | |||||||||
61 to 90 days | 6,907 | 9 | 4,170 | 8 | |||||||||
91 to 120 days | 4,795 | 6 | 2,589 | 5 | |||||||||
121 to 150 days | 3,641 | 5 | 1,787 | 4 | |||||||||
Over 150 days | 17,319 | 22 | 11,950 | 24 | |||||||||
Total | $ | 76,654 | 100 | % | $ | 50,311 | 100 | % | |||||
We recognize that final reimbursement of outstanding accounts receivable is subject to final approval by each third-party payor. However, because we have contracts with our third-party payors and we verify the insurance coverage of the patient before services are rendered, the amounts that are pending approval from third-party payors are minimal. Amounts are classified outside of self-pay if we have an agreement with the third-party payor or we have verified a patient’s coverage prior to services rendered. It is our policy to collect co-payments and deductibles prior to providing services. It is also our policy to verify a patient’s insurance 72 hours prior to the patient’s procedure. Because our services are primarily non-emergency, our surgical facilities have the ability to control these procedures. Our patient service revenues from self-pay as a percentage of total revenues for the years ended December 31, 2010, 2009 and 2008 were approximately 4% in each respective period.
Income Taxes
We use the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. If a net operating loss carryforward exists, we make a determination as to whether that net operating loss carryforward will be utilized in the future. A valuation allowance will be established for certain net operating loss carryforwards where their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that we will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If these estimates and related assumptions change in the future, we will be required to adjust our deferred tax valuation allowances.
Long-Lived Assets, Goodwill and Intangible Assets
Long-lived assets, including property, plant and equipment, comprise a significant portion of our total assets. We evaluate the carrying value of long-lived assets when impairment indicators are present or when circumstances indicate that impairment may exist. When events, circumstances or operating results indicate that the carrying values of certain long-lived assets and the related identifiable intangible assets might be impaired, we assess whether the carrying value of the assets will be recovered through undiscounted future cash flows expected to be generated from the use of the assets and their eventual disposition. If the assessment indicates that the recorded carrying value will not be recoverable, that cost will be reduced to estimated fair value. Estimated fair value will be determined based on a discounted future cash flow analysis.
Goodwill represents our single largest asset, and is a significant portion of our total assets. We review goodwill and indefinite lived intangible assets annually, as of December 31, or more frequently if certain indicators arise. We review goodwill at the reporting unit level,
38
which we have determined to be the consolidated results of Symbion, Inc. We compare the carrying value of the net assets of the reporting unit to the net present value of the estimated discounted future cash flows of the reporting unit. If the carrying value exceeds the net present value of the estimated discounted future cash flows, an impairment indicator exists and an estimate of the impairment loss is calculated. The fair value calculation includes multiple assumptions and estimates, including the projected cash flows and discount rates applied. Changes in these assumptions and estimates could result in goodwill impairment that could materially adversely impact our financial position and results of operations.
As previously discussed, the Company was acquired in a leveraged buy-out transaction on August 23, 2007. We accounted for the Merger using the purchase method of accounting. As a result, we recorded goodwill of $509.8 million.
We performed our annual goodwill impairment assessment by developing a fair value estimate of the business enterprise as of December 31, 2010 using a discounted cash flows approach. We corroborated the results of our fair value estimate using a market-based approach. As we do not have publicly traded equity from which to derive a market value, an assessment of peer-company trading data was performed, whereby management selected comparable peers based on growth and leverage ratios, as well as industry specific characteristics. Management estimated a reasonable market value of the Company as of December 31, 2010 based on earnings multiples and trading data of the Company's peers. This market-based approach was then used to assess the reasonableness of the discounted cash flows approach. The result of our annual goodwill impairment test at December 31, 2010 indicated no potential impairment.
Due to the sensitivity of the business enterprise value model, and the potential for further deterioration in the market, more specifically the surgical facility and healthcare industries, we will continually monitor the trading market of our peers, as well as our discrete future cash flow forecast. While we do not anticipate such a change, if projected future cash flows become less favorable than those projected by management, an assessment of possible impairments may become necessary that could have a material non-cash impact on our financial position and results of operations.
Results of Operations
The following table summarizes certain statements of operations items for each of the three years ended December 31, 2010, 2009 and 2008. The table also shows the percentage relationship to revenues for the periods indicated:
2010 | 2009 | 2008 | ||||||||||||||||||
Amount | % of Revenues | Amount | % of Revenues | Amount | % of Revenues | |||||||||||||||
(in thousands) | ||||||||||||||||||||
Revenues | $ | 406,050 | 100.0 | % | $ | 336,944 | 100.0 | % | $ | 321,484 | 100.0 | % | ||||||||
Cost of revenues | 290,145 | 71.5 | 239,403 | 71.1 | 215,872 | 67.1 | ||||||||||||||
General and administrative expense | 22,464 | 5.5 | 21,448 | 6.4 | 23,923 | 7.4 | ||||||||||||||
Depreciation and amortization | 18,900 | 4.7 | 16,807 | 5.0 | 14,845 | 4.6 | ||||||||||||||
Provision for doubtful accounts | 6,638 | 1.6 | 2,881 | 0.9 | 3,559 | 1.1 | ||||||||||||||
Income on equity investments | (2,901 | ) | (0.7 | ) | (2,318 | ) | (0.7 | ) | (1,504 | ) | (0.5 | ) | ||||||||
Impairment and loss on disposal of long-lived assets | 1,053 | 0.3 | 3,505 | 1.0 | 1,872 | 0.6 | ||||||||||||||
Gain on sale of long-lived assets | (1,964 | ) | (0.5 | ) | (248 | ) | (0.1 | ) | (975 | ) | (0.3 | ) | ||||||||
Proceeds from insurance settlements, net | — | — | (430 | ) | (0.1 | ) | — | — | ||||||||||||
Litigation settlements, net | (35 | ) | (0.0 | ) | — | — | 893 | 0.3 | ||||||||||||
Business remeasurement gains | (3,169 | ) | (0.8 | ) | — | — | — | — | ||||||||||||
Total operating expenses | 331,131 | 81.6 | 281,048 | 83.5 | 258,485 | 80.3 | ||||||||||||||
Operating income | 74,919 | 18.4 | 55,896 | 16.5 | 62,999 | 19.7 | ||||||||||||||
Interest expense, net | (48,037 | ) | (11.8 | ) | (44,958 | ) | (13.3 | ) | (43,415 | ) | (13.5 | ) | ||||||||
Income before income taxes and discontinued operations | 26,882 | 6.6 | 10,938 | 3.2 | 19,584 | 6.2 | ||||||||||||||
Provision for income taxes | 7,787 | 1.9 | 7,762 | 2.3 | 13,464 | 4.2 | ||||||||||||||
Income from continuing operations | 19,095 | 4.7 | 3,176 | 0.9 | 6,120 | 2.0 | ||||||||||||||
Loss from discontinued operations, net of taxes | (964 | ) | (0.2 | ) | (5,899 | ) | (1.8 | ) | (3,097 | ) | (1.0 | ) | ||||||||
Net income (loss) | 18,131 | 4.5 | (2,723 | ) | (0.9 | ) | 3,023 | 1.0 | ||||||||||||
Less: Net income attributable to noncontrolling interests | (26,871 | ) | (6.6 | ) | (19,731 | ) | (5.9 | ) | (23,821 | ) | (7.4 | ) | ||||||||
Net loss attributable to Symbion, Inc. | $ | (8,740 | ) | (2.1 | )% | $ | (22,454 | ) | (6.8 | )% | $ | (20,798 | ) | (6.4 | )% | |||||
Year Ended December 31, 2010 Compared To Year Ended December 31, 2009
Overview. In 2010, our revenues increased 20.5% to $406.1 million from $336.9 million for 2009. We incurred a net loss
39
attributable to Symbion, Inc. for the year ended December 31, 2010 of $(8.7 million) compared to $(22.5 million) for the year ended December 31, 2009. Our financial results for 2010 compared to 2009 reflect the addition of one surgical facility which we consolidate for financial reporting purposes. Also, we acquired an incremental, controlling ownership interest of a surgical facility which was previously recorded as an equity method investment. As a result of this acquisition, we hold a controlling interest in the facility and began consolidating the facility for financial reporting purposes in 2010.
Additionally, we disposed of one surgical facility which we accounted for using the equity method and four facilities which we consolidated for financial reporting purposes as of December 31, 2009. As of December 31, 2010, the financial results of these four disposed facilities for the year ended December 31, 2010, and all comparative periods, are reported as discontinued operations. For purposes of this management's discussion of our consolidated financial results, we consider same store facilities as those facilities that were operating throughout the respective periods listed below.
Revenues. Revenues for the year ended December 31, 2010 compared to December 31, 2009 were as follows (in thousands):
2010 | 2009 | Dollar Variance | Percent Variance | |||||||||||
Patient service revenues: | ||||||||||||||
Same store revenues | $ | 307,154 | $ | 309,555 | $ | (2,401 | ) | (0.8 | )% | |||||
Revenues from other surgical facilities | 86,669 | 13,231 | 73,438 | 555.0 | ||||||||||
Total patient service revenues | 393,823 | 322,786 | 71,037 | 22.0 | ||||||||||
Physician service revenues | 5,800 | 6,464 | (664 | ) | (10.3 | ) | ||||||||
Other service revenues | 6,427 | 7,694 | (1,267 | ) | (16.5 | ) | ||||||||
Total revenues | $ | 406,050 | $ | 336,944 | $ | 69,106 | 20.5 | % | ||||||
Patient service revenues at same store facilities decreased 0.8% for the year ended December 31, 2010 compared to 2009, primarily as a result of a 1.6% decrease in cases, partially offset by a 1.0% increase in net revenue per case. This decrease in case volume is attributable to weak economic conditions experienced primarily during the first quarter of 2010. Revenues from other surgical facilities increased as a result of surgical facilities and additional incremental, controlling ownership interests acquired since January 1, 2009. The decrease in other service revenues is a result of the sale of our equity investment located in Arcadia, California. We previously earned a management fee from this facility, which is reflected in the 2009 period. Also contributing to the decrease is the consolidation of our previously held equity interest in one of our facilities located in Chesterfield, Missouri. Our management fee earned at this facility is eliminated as an inter-company transaction for 2010.
Cost of Revenues. Cost of revenues for the year ended December 31, 2010 compared to 2009 were as follows (in thousands):
2010 | 2009 | Dollar Variance | Percent Variance | |||||||||||
Same store cost of revenues | $ | 223,118 | $ | 224,779 | $ | (1,661 | ) | (0.7 | )% | |||||
Cost of revenues from other surgical facilities | 67,027 | 14,624 | 52,403 | 358.3 | % | |||||||||
Total cost of revenues | $ | 290,145 | $ | 239,403 | $ | 50,742 | 21.2 | % | ||||||
As a percentage of same store revenues including physician services and other revenues, same store cost of revenues increased to 69.9% for the year ended December 31, 2010 compared to 69.4% for the year ended December 31, 2009. This increase is primarily the result of an increase in supplies expense related to an increase in orthopedic cases, which typically have higher implant costs. Cost of revenues from other surgical facilities increased by $52.4 million. This increase is attributable to surgical facilities acquired and incremental, controlling ownership interests acquired since January 1, 2009. As a percentage of revenues, total cost of revenues increased to 71.5% for 2010 compared to 71.1% for 2009.
General and Administrative Expense. General and administrative expense increased to $22.5 million for the year ended December 31, 2010 from $21.4 million for the year ended December 31, 2009. As a percentage of revenues, general and administrative expenses decreased to 5.5% for 2010 from 6.4% for 2009. This decrease is attributable to our leveraging corporate overhead costs while continuing to increase revenue through recent acquisitions.
Depreciation and Amortization. Depreciation and amortization expense for the year ended December 31, 2010 was $18.9 million compared to $16.8 million for the year ended December 31, 2009. This increase is primarily attributable to depreciation expense related to surgical facilities and additional incremental, ownership interests acquired since January 1, 2009. As a percentage of revenues, depreciation and amortization expense decreased to 4.7% for 2010 from 5.0% for 2009. Same store depreciation and amortization expense decreased to $15.9 million for 2010 from $16.4 million in 2009, primarily as a result of fully depreciated assets remaining in service.
Provision for Doubtful Accounts. Provision for doubtful accounts increased to $6.6 million for the year ended December 31, 2010 from $2.9 million for the year ended December 31, 2009. This increase is primarily attributable to surgical facilities acquired and incremental, controlling ownership interests acquired since January 1, 2009. As a percentage of revenues, the provision for doubtful accounts increased to 1.6% for 2010 from 0.9% for 2009.
40
Income on Equity Investments. Income on equity investments represents the net income of certain investments we have in surgical facilities. These surgical facilities are not consolidated for financial reporting purposes. Income on equity investments increased to $2.9 million for the year ended December 31, 2010 from $2.3 million for the year ended December 31, 2009.
Impairment and Loss on Disposal of Long-Lived Assets. We recognized a loss on the disposal of long-lived assets of $1.1 million during the year ended December 31, 2010. Included in this loss is an impairment charge of $816,000 related to our equity method investment located in Gresham, Oregon.
Gain on Sale of Long-Lived Assets and Other Gains. We recognized a gain on the extinguishment of facility level, third- party debt of $1.9 million for the year ended December 31, 2010.
Business Combination Remeasurement Gains. Effective July 1, 2010, we acquired an incremental, controlling ownership of 37.0% in our surgical facility located in Chesterfield, Missouri for $18.8 million. We recognized a gain of $3.2 million as a result of remeasuring our existing equity ownership interest in this facility held before the incremental acquisition of controlling ownership interests as required under generally accepted accounting principals.
Operating Income. Operating income increased to $74.9 million for the year ended December 31, 2010 from $55.9 million for the year ended December 31, 2009. This change is primarily attributable to surgical facilities acquired and incremental, controlling ownership interests acquired since January 1, 2009. Also contributing to this increase is a $3.2 million gain due to the remeasurement of an existing equity investment and a $1.9 million gain recognized on the extinguishment of facility level, third-party debt during 2010. Comparatively, our operating income for 2009 includes an impairment charge of $2.4 million related to our equity investment located in Arcadia, California. Excluding non-cash gains and losses in 2010 and 2009, our operating income margin was 17.4% for both 2010 and 2009.
Interest Expense, Net of Interest Income. Interest expense, net of interest income, increased to $48.0 million for the year ended December 31, 2010 from $45.0 million for the year ended December 31, 2009. Interest expense increased $1.3 million as a result of our borrowings under our revolving credit facility during 2010, and $1.8 million due to our election to pay interest on the Toggle Notes in kind, whereby the outstanding principal amount of debt has increased $25.0 million since December 31, 2009. Offsetting these increases in interest expense is a net reduction in interest expense of $2.1 million as a result of the mark-to-market recording of our previous interest rate swap and the impact of recognizing the remaining swap liability previously recorded in other comprehensive loss into earnings.
Provision for Income Taxes. Tax expense of $7.8 million for the years ended December 31, 2010 and December 31, 2009 is primarily due to the recording of non-cash deferred income tax expense related to our partnership investments.
Loss from Discontinued Operations, Net of Taxes. Loss from discontinued operations for the year ended December 31, 2010 of $964,000 includes the operating results of four surgical facilities which we disposed of during the year.
Net Income Attributable to Noncontrolling Interests. Net income attributable to noncontrolling interests increased to $26.9 million for the year ended December 31, 2010 compared to $19.7 million for the year ended December 31, 2009. As a percentage of revenues, net income attributable to noncontrolling interests increased to 6.6% for December 31, 2010 from 5.9% for 2009. This increase is primarily attributable to surgical facilities acquired and incremental, controlling ownership interests acquired since January 1, 2009.
Year Ended December 31, 2009 Compared to Year Ended December 31, 2008
Overview. In 2009, our revenues increased 4.8% to $336.9 million from $321.5 million for 2008. We incurred a net loss attributable to Symbion, Inc. for the year ended December 31, 2009 of $(22.5 million) compared to $(20.8 million) for the year ended December 31, 2008. Our financial results for 2009 compared to 2008 reflect the addition of one surgical facility which we consolidate for financial reporting purposes and one surgical facility we account for using the equity method. Additionally, we disposed of two surgical facilities which we accounted for using the equity method and one facility reported as discontinued operations as of December 31, 2008.
Revenues. Revenues for the year ended December 31, 2009 compared to December 31, 2008 were as follows (in thousands):
2009 | 2008 | Dollar Variance | Percent Variance | |||||||||||
Patient service revenues: | ||||||||||||||
Same store revenues | $ | 288,680 | $ | 290,459 | $ | (1,779 | ) | (0.6 | )% | |||||
Revenues from other surgical facilities | 34,107 | 14,994 | 19,113 | 127.5 | ||||||||||
Total patient service revenues | 322,787 | 305,453 | 17,334 | 5.7 | ||||||||||
Physician service revenues | 6,464 | 6,547 | (83 | ) | (1.3 | ) | ||||||||
Other service revenues | 7,693 | 9,484 | (1,791 | ) | (18.9 | ) | ||||||||
Total revenues | $ | 336,944 | $ | 321,484 | $ | 15,460 | 4.8 | % | ||||||
Patient service revenues at same store facilities decreased 0.6% for the year ended December 31, 2009 compared to 2008, primarily as a result of our 0.3% decrease in cases combined with a 0.3% decrease in net revenue per case. The decrease in other service revenues results from a scheduled reduction in management fees from one of our physician networks.
41
Cost of Revenues. Cost of revenues for the year ended December 31, 2009 compared to 2008 were as follows (in thousands):
2009 | 2008 | Dollar Variance | Percent Variance | ||||||||
Same store cost of revenues | 210,095 | 206,377 | 3,718 | 1.8 | % | ||||||
Cost of revenues from other surgical facilities | 29,308 | 9,495 | 19,813 | 208.7 | |||||||
Total cost of revenues | 239,403 | 215,872 | 23,531 | 10.9 | % | ||||||
As a percentage of same store revenues, including physician service revenues and other service revenues, same store cost of revenues increased to 69.4% for the year ended December 31, 2009 compared to 67.3% for the year ended December 31, 2008. This increase is primarily the result of an increase in supplies expense related to an increase in ophthalmology cases which are predominantly reimbursed by Medicare and involve higher cost lenses. Cost of revenues from other surgical facilities increased by $19.8 million. This increase is primarily attributable to surgical facilities acquired or developed since January 1, 2008. The acquisition of the surgical hospital in Austin, Texas negatively impacted our operating margins by 1.3%. As a percentage of revenues, total cost of revenues increased to 71.1% for 2009 compared to 67.1% for 2008.
General and Administrative Expense. General and administrative expense decreased to $21.4 million for the year ended December 31, 2009 from $23.9 million for the year ended December 31, 2008. As a percentage of revenues, general and administrative expenses were 6.4% for 2009 and 7.4% for 2008. This decrease is attributable to a reduction in incentive compensation and other employee benefits.
Depreciation and Amortization. Depreciation and amortization expense for the year ended December 31, 2009 was $16.8 million compared to $14.8 million for the year ended December 31, 2008. This increase is primarily attributable to depreciation expense at facilities acquired or developed since January 1, 2008. As a percentage of revenues, depreciation and amortization expense increased to 5.0% for 2009 from 4.6% for 2008. Same store depreciation and amortization expense increased to $14.2 million for 2009 from $13.4 million in 2008, primarily as a result of asset additions at certain facilities.
Provision for Doubtful Accounts. Provision for doubtful accounts decreased 19.4% to $2.9 million for the year ended December 31, 2009 from $3.6 million for the year ended December 31, 2008. As a percentage of revenues, the provision for doubtful accounts decreased to 0.9% for 2009 from 1.1% for 2008. On a same store basis, the provision for doubtful accounts decreased to 0.8% of revenue for 2009 compared to 1.2% for 2008.
Income on Equity Investments. Income on equity investments represents the net income of certain investments we have in surgical facilities. These surgical facilities are not consolidated for financial reporting purposes. Income on equity investments increased to $2.3 million for the year ended December 31, 2009 from $1.5 million for the year ended December 31, 2008. The increase in income on equity investments for 2009 compared to 2008 is primarily attributable to facilities acquired and developed since January 1, 2008.
Impairment and Loss on Disposal of Long-Lived Assets. During the third quarter of 2009, we recorded an impairment charge of $2.4 million related to our equity method investment located in Arcadia, California. Also included in 2009 is a loss of $273,000 related to the disposal of our ownership interest in our surgical facility located in Temple, Texas. The remaining loss is attributable to asset disposals at various facilities.
Gain on Sale of Long-Lived Assets. We recognized a gain on the sale of long-lived assets for the year ended December 31, 2009 of $248,000. For the year ended December 31, 2008, our gain of $975,000 primarily represented the gain we recognized on the sale of a portion of our ownership in certain surgical facilities to physician investors. In accordance with the guidance of Accounting Standards Codification 810, Consolidation, these gains and losses are no longer reflected in the statement of operations but are considered equity transactions beginning in 2009.
Operating Income. Operating income decreased to $55.9 million for the year ended December 31, 2009 from $63.0 million for the year ended December 31, 2008. This decrease is partially attributable to a $2.4 million impairment charge related to our equity method investment located in Arcadia, California. Excluding the impairment charge, operating income decreased to 17.3% for the 2009 period from 19.6% for the 2008 period. This decrease is also attributable to a negative operating margin impact of 1.3% related to the acquisition of the surgical hospital in Austin, Texas. In addition, same store cost of revenues increased 1.8% as a percentage of same store revenue primarily as a result of an increase in supplies expense related to an increase in ophthalmology cases, which are predominantly reimbursed by Medicare and involve higher cost lenses.
Interest Expense, Net of Interest Income. Interest expense, net of interest income, increased to $45.0 million for the year ended December 31, 2009 from $43.4 million for the year ended December 31, 2008. Included in interest expense for the year ended December 31, 2009 is $1.9 million of net additional interest as a result of discontinuing hedge accounting treatment related to our interest rate swap in January 2009 and the mark-to-market adjustment of the interest rate swap instrument to fair market value. Interest expense also increased as a result of our election of the PIK option related to the Toggle Notes, whereby the outstanding principal amount of debt has increased $22.3 million since December 31, 2008. The increase in interest expense is offset by a reduction in amortization of deferred financing costs of $2.5 million in 2009 compared to 2008, which was a result of the accelerated amortization of costs as a result of the bridge facility repayment.
Provision for Income Taxes. The provision for income taxes decreased to $7.8 million for the year ended December 31, 2009 from
42
$13.5 million for the year ended December 31, 2008. Tax expense in 2009 is primarily due to the recording of non-cash deferred income tax expense related to our partnership investments.
Loss from Discontinued Operations, Net of Taxes. Loss from discontinued operations for the year ended December 31, 2009 of $5.9 million includes a loss on the disposal of the Englewood, Colorado facility of $5.9 million. Included in this loss is $4.6 million accrued for future contractual obligations under a facility operating lease.
Income Attributable to Noncontrolling Interests. Net income attributable to noncontrolling interests decreased to $19.7 million for the year ended December 31, 2009 compared to $23.8 million for the year ended December 31, 2008. As a percentage of revenues, net income attributable to noncontrolling interests decreased to 5.9% for 2009 from 7.4% for 2008. A decrease of $1.4 million is attributable to our acquisition of the surgical facility in Austin, Texas. The remaining decrease is attributable to our overall decrease in operating income.
Quarterly Results of Operations
The following tables present a summary of our unaudited quarterly consolidated results of operations for each of the four quarters in 2010 and 2009. The unaudited financial statements include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of such information when read in conjunction with our audited consolidated financial statements and related notes. Our quarterly operating results have varied in the past, may continue to do so and are not necessarily indicative of results for any future period.
2010 | |||||||||||||||
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | ||||||||||||
(in thousands) (unaudited) | |||||||||||||||
Consolidated Statement of Operations Data: | |||||||||||||||
Revenues | $ | 83,545 | $ | 103,463 | $ | 104,821 | $ | 114,221 | |||||||
Operating expenses: | |||||||||||||||
Salaries and benefits | 24,347 | 29,079 | 29,486 | 30,683 | |||||||||||
Supplies | 18,158 | 23,086 | 24,009 | 27,606 | |||||||||||
Professional and medical fees | 5,666 | 6,963 | 7,792 | 8,651 | |||||||||||
Rent and lease expense | 6,222 | 6,069 | 6,075 | 6,183 | |||||||||||
Other operating expenses | 6,810 | 7,421 | 7,932 | 7,907 | |||||||||||
Cost of revenues | 61,203 | 72,618 | 75,294 | 81,030 | |||||||||||
General and administrative expense | 5,232 | 5,937 | 5,521 | 5,774 | |||||||||||
Depreciation and amortization | 4,084 | 4,912 | 5,009 | 4,895 | |||||||||||
Provision for doubtful accounts | 1,213 | 1,987 | 2,026 | 1,412 | |||||||||||
Income on equity investments | (628 | ) | (876 | ) | (668 | ) | (729 | ) | |||||||
(Gain) loss on impairment and disposal of long-lived assets | 1,061 | 91 | (3,572 | ) | (1,660 | ) | |||||||||
Litigation settlements, net | (36 | ) | (8 | ) | — | 9 | |||||||||
Total operating expenses | 72,129 | 84,661 | 83,610 | 90,731 | |||||||||||
Operating income | 11,416 | 18,802 | 21,211 | 23,490 | |||||||||||
Interest expense, net | (10,731 | ) | (12,211 | ) | (12,668 | ) | (12,427 | ) | |||||||
Income before income taxes and discontinued operations | 685 | 6,591 | 8,543 | 11,063 | |||||||||||
Provision for income taxes | 1,609 | 610 | 1,762 | 3,806 | |||||||||||
(Loss) income from continuing operations | (924 | ) | 5,981 | 6,781 | 7,257 | ||||||||||
Loss from discontinued operations, net of taxes | (280 | ) | (82 | ) | (339 | ) | (263 | ) | |||||||
Net (loss) income | (1,204 | ) | 5,899 | 6,442 | 6,994 | ||||||||||
Less: Net income attributable to noncontrolling interests | (4,444 | ) | (6,957 | ) | (6,159 | ) | (9,311 | ) | |||||||
Net (loss) income attributable to Symbion, Inc. | $ | (5,648 | ) | $ | (1,058 | ) | $ | 283 | $ | (2,317 | ) | ||||
43
The following table reconciles EBITDA to net cash provided by operating activities — continuing operations:
2010 | |||||||||||||||
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | ||||||||||||
(in thousands) (unaudited) | |||||||||||||||
EBITDA | $ | 12,441 | $ | 17,173 | $ | 16,842 | $ | 18,744 | |||||||
Depreciation and amortization | (4,084 | ) | (4,912 | ) | (5,009 | ) | (4,895 | ) | |||||||
Non-cash gains (losses) | (1,061 | ) | (91 | ) | 3,572 | 664 | |||||||||
Non-cash stock option compensation expense | (324 | ) | (325 | ) | (353 | ) | (334 | ) | |||||||
Interest expense, net | (10,731 | ) | (12,211 | ) | (12,668 | ) | (12,427 | ) | |||||||
Provision for income taxes | (1,609 | ) | (610 | ) | (1,762 | ) | (3,806 | ) | |||||||
Net income attributable to noncontrolling interests | 4,444 | 6,957 | 6,159 | 9,311 | |||||||||||
(Income) loss on discontinued operations, net of taxes | (280 | ) | (82 | ) | (339 | ) | (263 | ) | |||||||
Net (loss) income | (1,204 | ) | 5,899 | 6,442 | 6,994 | ||||||||||
Income (loss) from discontinued operations | 280 | 82 | 339 | 263 | |||||||||||
Depreciation and amortization | 4,084 | 4,975 | 5,072 | 4,769 | |||||||||||
Amortization of deferred financing costs | 501 | 499 | 501 | 503 | |||||||||||
Non-cash payment-in-kind interest option | 6,230 | 6,437 | 6,597 | 6,815 | |||||||||||
Non-cash stock option compensation expense | 324 | 325 | 353 | 334 | |||||||||||
Non-cash recognition of other comprehensive loss into earnings | 826 | 826 | 826 | 254 | |||||||||||
Non-cash credit risk adjustment of financial instruments | 89 | 100 | — | — | |||||||||||
Non-cash (gains) losses | 1,061 | 91 | (3,572 | ) | (1,660 | ) | |||||||||
Deferred income taxes | 1,828 | 2,505 | 1,138 | 5,508 | |||||||||||
Equity in earnings of unconsolidated affiliates, net of distributions received | (70 | ) | (259 | ) | 272 | 107 | |||||||||
Provision for doubtful accounts | 1,236 | 1,964 | 2,070 | 1,368 | |||||||||||
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions: | |||||||||||||||
Accounts receivable | (109 | ) | (4,395 | ) | (688 | ) | (9,694 | ) | |||||||
Other assets and liabilities | 3,859 | (3,393 | ) | (2,224 | ) | 1,491 | |||||||||
Net cash provided by operating activities — continuing operations | $ | 18,935 | $ | 15,656 | $ | 17,126 | $ | 17,052 | |||||||
Other Data: | |||||||||||||||
Number of surgical facilities included in continuing operations, as of the end of period(1) | 61 | 62 | 62 | 62 | |||||||||||
44
2009 | |||||||||||||||
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | ||||||||||||
(in thousands) (unaudited) | |||||||||||||||
Consolidated Statement of Operations Data: | |||||||||||||||
Revenues | $ | 81,513 | $ | 85,901 | $ | 84,357 | $ | 85,173 | |||||||
Operating expenses: | |||||||||||||||
Salaries and benefits | 22,544 | 23,444 | 24,649 | 24,100 | |||||||||||
Supplies | 16,135 | 18,394 | 18,476 | 18,645 | |||||||||||
Professional and medical fees | 4,535 | 6,141 | 5,516 | 5,782 | |||||||||||
Rent and lease expense | 5,576 | 5,910 | 6,252 | 6,709 | |||||||||||
Other operating expenses | 6,361 | 6,329 | 7,035 | 6,870 | |||||||||||
Cost of revenues | 55,151 | 60,218 | 61,928 | 62,106 | |||||||||||
General and administrative expense | 5,876 | 5,468 | 4,697 | 5,407 | |||||||||||
Depreciation and amortization | 4,222 | 4,100 | 4,236 | 4,249 | |||||||||||
Provision for doubtful accounts | 813 | 947 | 1,056 | 65 | |||||||||||
Income on equity investments | (185 | ) | (466 | ) | (712 | ) | (955 | ) | |||||||
(Gain) loss on impairment and disposal of long-lived assets | (333 | ) | (169 | ) | 2,563 | 1,196 | |||||||||
Litigation settlements, net | — | — | (150 | ) | (280 | ) | |||||||||
Total operating expenses | 65,544 | 70,098 | 73,618 | 71,788 | |||||||||||
Operating income | 15,969 | 15,803 | 10,739 | 13,385 | |||||||||||
Interest expense, net | (11,046 | ) | (10,886 | ) | (11,952 | ) | (11,074 | ) | |||||||
Income (loss) before income taxes and discontinued operations | 4,923 | 4,917 | (1,213 | ) | 2,311 | ||||||||||
Provision for income taxes | 1,337 | 1,391 | 1,936 | 3,098 | |||||||||||
Income (loss) from continuing operations | 3,586 | 3,526 | (3,149 | ) | (787 | ) | |||||||||
(Loss) income from discontinued operations, net of taxes | (6,043 | ) | 6 | 170 | (32 | ) | |||||||||
Net (loss) income | (2,457 | ) | 3,532 | (2,979 | ) | (819 | ) | ||||||||
Less: Net income attributable to noncontrolling interests | (6,556 | ) | (5,428 | ) | (4,065 | ) | (3,682 | ) | |||||||
Net loss attributable to Symbion, Inc. | $ | (9,013 | ) | $ | (1,896 | ) | $ | (7,044 | ) | $ | (4,501 | ) | |||
45
The following table reconciles EBITDA to net cash provided by operating activities — continuing operations:
2009 | |||||||||||||||
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | ||||||||||||
(in thousands) (unaudited) | |||||||||||||||
EBITDA | $ | 13,695 | $ | 14,975 | $ | 13,849 | $ | 14,577 | |||||||
Depreciation and amortization | (4,291 | ) | (4,165 | ) | (4,299 | ) | (4,052 | ) | |||||||
Non-cash (losses) gains | 333 | (111 | ) | (2,548 | ) | (501 | ) | ||||||||
Non-cash stock option compensation expense | (324 | ) | (324 | ) | (326 | ) | (323 | ) | |||||||
Interest expense, net | (11,046 | ) | (10,886 | ) | (11,954 | ) | (11,072 | ) | |||||||
Provision for income taxes | (1,337 | ) | (1,391 | ) | (1,936 | ) | (3,098 | ) | |||||||
Net income attributable to noncontrolling interests | 6,556 | 5,428 | 4,065 | 3,682 | |||||||||||
Loss on discontinued operations, net of taxes | (6,043 | ) | 6 | 170 | (32 | ) | |||||||||
Net income (loss) | (2,457 | ) | 3,532 | (2,979 | ) | (819 | ) | ||||||||
Income from discontinued operations | 6,043 | (6 | ) | (170 | ) | 32 | |||||||||
Depreciation and amortization | 4,291 | 4,165 | 4,299 | 4,052 | |||||||||||
Amortization of deferred financing costs | 499 | 501 | 501 | 503 | |||||||||||
Non-cash payment-in-kind interest option | 5,556 | 5,743 | 5,884 | 6,080 | |||||||||||
Non-cash stock option compensation expense | 324 | 324 | 326 | 323 | |||||||||||
Non-cash recognition of other comprehensive loss into earnings | 637 | 637 | 637 | 942 | |||||||||||
Non-cash credit risk adjustment of financial instruments | — | 708 | 813 | 108 | |||||||||||
Non-cash losses (gains) | (333 | ) | 111 | 2,548 | 501 | ||||||||||
Deferred income taxes | 1,876 | 1,586 | 2,119 | 3,101 | |||||||||||
Equity in earnings of unconsolidated affiliates, net of distributions received | 125 | (167 | ) | (175 | ) | 10 | |||||||||
Provision for doubtful accounts | 841 | 972 | 1,057 | 11 | |||||||||||
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions: | — | — | |||||||||||||
Accounts receivable | (459 | ) | (435 | ) | (936 | ) | (2,553 | ) | |||||||
Other assets and liabilities | 1,238 | 1,829 | (2,550 | ) | (1,062 | ) | |||||||||
Net cash provided by operating activities — continuing operations | $ | 18,181 | $ | 19,500 | $ | 11,374 | $ | 11,229 | |||||||
Other Data: | |||||||||||||||
Number of consolidated surgical facilities included in continuing operations, as of the end of period (1) | 63 | 63 | 63 | 63 | |||||||||||
(1) Includes surgical facilities that we manage but in which have no ownership.
Liquidity and Capital Resources
Operating Activities
The principal source of our operating cash flows is the collection of patient receivables. Collection efforts for patient receivables are conducted by our personnel at each facility or in centralized service offices for areas in which there are multiple facilities. Each of our surgical facilities bill for services as performed, usually within several days following the procedure. Bad debt reserves are established in increasing percentages by aging category based on historical collection experience. Generally, the entire balance of all accounts remaining uncollected 180 days after the date of service are written off as bad debt and sent to an outside collection agency. Net amounts received from collection agencies are recorded as recoveries of bad debts. Our operating cash flows, including changes in accounts payable and other current liabilities, are impacted by the timing of payments to our vendors. In 2010, 2009 and 2008, we did not make any significant changes to the timing of our payments to vendors.
During the year ended December 31, 2010, we generated operating cash flow from continuing operations of $68.8 million compared to $60.3 million for the year ended December 31, 2009. The increase is primarily due to surgical facilities acquired and incremental, controlling ownership interests acquired since January 1, 2009.
At December 31, 2010, we had working capital of $77.3 million compared to $40.8 million at December 31, 2009. This increase is primarily attributable to surgical facilities acquired and additional incremental, controlling interests acquired since January 1, 2009.
46
Investing Activities
Net cash used in investing activities from continuing operations during the year ended December 31, 2010 was $53.2 million, including $44.1 million for acquisitions, net of cash acquired. Also during 2010, purchases of property and equipment totaled $8.7 million. Cash used in investing activities in 2010 was funded with borrowings under our Revolving Facility and cash from operations.
Net cash used in investing activities from continuing operations during the year ended December 31, 2009 was $11.1 million, including $9.6 million related to purchases of property and equipment. During 2009, we acquired $126,000 of cash through acquisitions which were consolidated for financial reporting purposes. Cash used in investing activities in 2009 was funded primarily from cash from operations.
Net cash used in investing activities from continuing operations during the year ended December 31, 2008 was $32.9 million, including $15.7 million of payments related to acquisitions and $15.7 million related to purchases of property and equipment. The $15.7 million of property and equipment purchases includes construction projects at several of our surgical facilities. Cash used in investing activities in 2008 was funded primarily from cash from operations and proceeds from the Merger financing.
Financing Activities
Net cash used in financing activities from continuing operations during the year ended December 31, 2010 was $9.6 million. During 2010, we made scheduled principal payments on our senior secured credit facility totaling $10.6 million. Also during 2010, we elected to exercise the PIK option by increasing the principal amount in lieu of making scheduled interest payments of $25.0 million on our Toggle Notes. We also made distributions to noncontrolling interest holders of $26.3 million during 2010. To fund our acquisition activity during 2010, we utilized $56.0 million of our available borrowings under our Revolving Facility.
Net cash used in financing activities from continuing operations during the year ended December 31, 2009 was $42.8 million. During 2009, we made scheduled principal payments on our senior secured credit facility totaling $3.8 million. Also during 2009, we elected to exercise the PIK option by increasing the principal amount in lieu of making scheduled interest payments of $23.3 million on our Toggle Notes. We also made distributions to noncontrolling interest holders of $25.0 million during the year ended December 31, 2009.
Net cash used in financing activities from continuing operations during the year ended December 31, 2008 was $31.7 million. During 2008, we made scheduled principal payments on our senior secured credit facility totaling $2.5 million and voluntary principal payments of $11.0 million. Also during 2008, we elected to exercise the PIK option by increasing the principal amount in lieu of making scheduled interest payments of $4.9 million on our Toggle Notes, as well as $4.9 million on our retired bridge facility. Additionally, we incurred $4.7 million of deferred finance cost related to the issuance of the Toggle Notes. We also made distributions to noncontrolling interest holders of $23.4 million during the year ended December 31, 2008.
Long-Term Debt
The Company’s long-term debt is summarized as follows (in thousands):
2010 | 2009 | ||||||
Senior secured credit facility | $ | 277,500 | $ | 232,125 | |||
Senior PIK toggle notes | 232,000 | 206,967 | |||||
Notes payable to banks | 19,104 | 14,323 | |||||
Secured term loans | 2,918 | 2,510 | |||||
Capital lease obligations | 5,090 | 8,951 | |||||
536,612 | 464,876 | ||||||
Less current maturities | (29,195 | ) | (20,118 | ) | |||
$ | 507,417 | $ | 444,758 | ||||
Senior Secured Credit Facility
On August 23, 2007, in conjunction with the Merger, we entered into a $350.0 million senior secured credit facility with a syndicate of banks. The senior secured credit facility extends credit in the form of two term loans of $125.0 million each (the first, the “Tranche A Term Loan” and the second, the “Tranche B Term Loan”) and a $100.0 million revolving, swingline and letter of credit facility (the “Revolving Facility”). The swingline facility is limited to $10.0 million and the swingline loans are available on a same-day basis. The letter of credit facility is limited to $10.0 million. We are the borrower under the senior secured credit facility, and all of our wholly owned subsidiaries are guarantors. Under the terms of the senior secured credit facility, entities that become wholly owned subsidiaries must also guarantee the debt.
The Tranche A Term Loan matures on August 23, 2013, the Tranche B Term Loan matures on August 23, 2014 and the Revolving Facility matures on August 23, 2013. The Tranche A Term Loan required quarterly principal payments of $4.7 million from December 31, 2010 through September 30, 2011, quarterly payments of $6.3 million from December 31, 2011 through September 30, 2012, quarterly payments of $18.1 million from December 31, 2012 through June 30, 2013 and a balloon payment of $12.6 million on August 23, 2013. The
47
Tranche B Term Loan requires quarterly principal payments of $312,500 through June 30, 2014 and a balloon payment of $111.1 million on August 23, 2014.
At our option, the term loans bear interest at the lender’s alternate base rate in effect on the applicable borrowing date plus an applicable alternate base rate margin, or Eurodollar rate in effect on the applicable borrowing date, plus an applicable Eurodollar rate margin. Both the applicable alternate base rate margin and applicable Eurodollar rate margin will vary depending upon the ratio of our total indebtedness to consolidated EBITDA.
The senior secured credit facility permits us to declare and pay dividends only in additional shares of stock, except for the following exceptions. Restricted subsidiaries, as defined in the credit agreement, may declare and pay dividends ratably with respect to their capital stock. We may declare and pay cash dividends or make other distributions to Holdings provided the proceeds are used by Holdings to (i) purchase or redeem equity interest of Holdings acquired by former or current employees, consultants or directors of Holdings, the Company or any restricted subsidiary or (ii) pay principal or interest on promissory notes that were issued in lieu of cash payments for the repurchase or redemption of such equity instruments, provided that the aggregate amount of such dividends or other distributions shall not exceed $3.0 million in any fiscal year. Any unused amounts that are permitted to be paid under this provision are available to be carried over to subsequent fiscal years provided that certain conditions are met. We may also make payments to Holdings to pay franchise taxes and other fees required to maintain its corporate existence provided such payments do not exceed $3.0 million in any calendar year and also make payments in the amount necessary to enable Holdings to pay income taxes directly attributable to the operations of the Company and to make $1.0 million in annual advisory and management agreement payments. We may also make additional payments to Holdings in an aggregate amount not to exceed $5.0 million throughout the term of the senior secured credit facility.
As of December 31, 2010, the amount outstanding under the senior secured credit facility was $277.5 million with an interest rate on the borrowings of 3.5%. The $100.0 million Revolving Facility includes a non-use fee of 0.5% of the portion of the facility not used. We pay this fee quarterly. As of December 31, 2010, the amount available under the Revolving Facility was $44.0 million.
Interest Rate Swap
On November 2, 2010, we entered into an interest rate swap agreement to protect against certain interest rate fluctuations of the LIBOR rate on $100.0 million of our variable rate debt under the senior secured credit facility. The effective date of the interest rate swap was December 31, 2010, and it is scheduled to expire on December 31, 2012. The interest rate swap effectively fixes our LIBOR interest rate on the $100.0 million of variable rate debt at a rate of 0.85%. We have recognized the fair value of our interest rate swap as a long-term liability of approximately $314,000 at December 31, 2010. We have designated our current interest rate swap as a cash flow hedge instrument. As of December 31, 2010, we have determined the hedge to be effective.
In October 2007, we entered into an interest rate swap agreement to protect against certain interest rate fluctuations of the LIBOR rate on $150.0 million of our variable rate debt under our senior secured credit facility. The effective date of the interest rate swap was October 31, 2007, and it expired on October 31, 2010. The interest rate swap effectively fixed our LIBOR interest rate on the $150.0 million of variable rate debt at a rate of 4.7%. We recognized the fair value of the interest rate swap as a current liability of approximately $5.0 million at December 31, 2009. Due to the dramatic decrease in LIBOR rates, we elected an interest term for the January 2009 interest election period under the terms of the our secured credit facility, which differs from that of the swap instrument. As a result, we discontinued hedge accounting treatment for our previous interest rate swap in 2009. In January 2009, we began recognizing a ratable portion of the $7.0 million in accumulated other comprehensive income as additional interest expense over the remaining life of the previous swap instrument. Also beginning in January 2009, we began recording into earnings the mark-to-market adjustment to reflect the fair value of the previous hedging instrument. Our mark to market adjustment for 2010 and 2009 resulted in a reduction of interest expense of $5.2 million and $3.6 million, respectively. We recognized $3.8 million of interest expense related to the ratable reduction of the balance in accumulated other comprehensive income during 2009 and the remaining $3.2 million during 2010.
Senior PIK Toggle Notes
On June 3, 2008, we completed a private offering of $179.9 million aggregate principal amount of the Toggle Notes. The notes issued in the private offering were subsequently exchanged for Toggle Notes registered under the Securities Act of 1933, as amended, in an exchange offer. Interest on the Toggle Notes is due on February 23 and August 23 of each year. The Toggle Notes will mature on August 23, 2015. For any interest period through August 23, 2011, we may elect to pay interest on the Toggle Notes (i) in cash, (ii) in kind, by increasing the principal amount of the notes or issuing new notes (referred to as “PIK interest”) for the entire amount of the interest payment or (iii) by paying interest on 50% of the principal amount of the Toggle Notes in cash and 50% in PIK interest. Cash interest on the Toggle Notes accrues at the rate of 11.0% per annum. PIK interest on the Toggle Notes accrues at the rate of 11.75% per annum. We elect to pay cash interest or to exercise the PIK option in advance of the interest period.
Since August 23, 2008, we have elected the PIK option of the Toggle Notes in lieu of making scheduled interest payments for various interest periods. As a result, the principal due on the Toggle Notes increased by $52.1 million from the issuance of the Toggle Notes to December 31, 2010. On August 23, 2010, we elected the PIK option of the Toggle Notes in lieu of making scheduled interest payments for the interest period from August 24, 2010 to February 23, 2011. We have accrued $9.7 million in interest in other accrued expenses as of December 31, 2010. As of December 31, 2010, the amount outstanding under the Toggle Notes was $232.0 million.
The Toggle Notes are unsecured senior obligations and rank equally with other existing and future senior indebtedness, senior to all future subordinated indebtedness and effectively junior to all secured indebtedness to the extent of the value of the collateral securing such indebtedness. Certain existing subsidiaries have guaranteed the Toggle Notes on a senior basis, as required by the indenture. The indenture
48
also requires that certain of our future subsidiaries guarantee the Toggle Notes on a senior basis. Each guarantee is unsecured and ranks equally with senior indebtedness of the guarantor, senior to all of the guarantor’s subordinated indebtedness and effectively junior to its secured indebtedness to the extent of the value of the collateral securing such indebtedness.
The indenture governing the Toggle Notes contains various restrictive covenants, including financial covenants that limit our ability and the ability of the subsidiaries to borrow money or guarantee other indebtedness, grant liens, make investments, sell assets, pay dividends or engage in transactions with affiliates.
At December 31, 2010, we were in compliance with all material covenants required by each of the senior secured credit facility and the Toggle Notes.
Notes Payable to Banks
Certain of our subsidiaries have outstanding bank indebtedness, which is collateralized by the real estate and equipment owned by the surgical facilities to which the loans were made. The outstanding balance of this indebtedness as of December 31, 2010 and December 31, 2009 was $19.1 million and $14.3 million, respectively. The various bank indebtedness agreements contain covenants to maintain certain financial ratios and also restrict encumbrance of assets, creation of indebtedness, investing activities and payment of distributions.
Capital Lease Obligations
We are liable to various vendors for several equipment leases. The outstanding balance related to these capital leases at December 31, 2010 and December 31, 2009 was $5.1 million and $9.0 million, respectively.
Summary
We believe we have sufficient liquidity in the next 12 to 18 months as described above. Nevertheless, we continue to monitor the state of the financial and credit markets and our current and expected liquidity and capital resource needs, and intend to continue to explore various financing alternatives to improve our capital structure, including by reducing debt, extending maturities or relaxing financial covenants. These may include new equity or debt financings or exchange offers with our existing security holders (including exchanges of debt for debt or equity) and other transactions involving our outstanding securities, given their secondary market trading prices. We cannot assure you, if we pursue any of these transactions, that we will be successful in completing a transaction on attractive terms, or at all.
Contractual Obligations and Commercial Commitments
The following table summarizes our contractual obligations by period as of December 31, 2010 (in thousands):
Payments Due by Period | |||||||||||||||||||
Total | Less Than 1 Year | 1-3 Years | 4-5 Years | After 5 Years | |||||||||||||||
Contractual Obligations: | |||||||||||||||||||
Long-term debt | $ | 531,522 | $ | 26,804 | $ | 158,674 | $ | 114,044 | $ | 232,000 | |||||||||
Capital lease obligations | 5,090 | 2,391 | 2,474 | 225 | — | ||||||||||||||
Operating lease obligations | 127,769 | 22,675 | 40,236 | 25,287 | 39,571 | ||||||||||||||
Other financing obligations(1) | 48,224 | (227 | ) | (18 | ) | 1,174 | 47,295 | ||||||||||||
Total | $ | 712,605 | $ | 51,643 | $ | 201,366 | $ | 140,730 | $ | 318,866 | |||||||||
(1) Other financing obligations are payable to the hospital facility lessor at our facility located in Idaho Falls, Idaho relating to the land, building and improvements.
Inflation
For the past three years, inflation and changing prices have not significantly affected our operating results or the markets in which we operate.
Recent Accounting Pronouncements
In June 2009, the FASB issued changes to the accounting for variable interest entities. These changes require an enterprise: (i) to perform an analysis to determine whether the enterprise’s variable interest or interests give it a controlling financial interest in a variable interest entity; (ii) to require ongoing reassessments of whether an enterprise is the primary beneficiary of a variable interest entity; (iii) to eliminate the quantitative approach previously required for determining the primary beneficiary of a variable interest entity; (iv) to add an additional reconsideration event for determining whether an entity is a variable interest entity when any changes in facts and circumstances occur such that holders of the equity investment at risk, as a group, lose the power from voting rights or similar rights of those investments to
49
direct the activities of the entity that most significantly impact the entity’s economic performance; and (v) to require enhanced disclosures that will provide users of financial statements with more transparent information about an enterprise’s involvement in a variable interest entity. These changes became effective for us on January 1, 2010. The adoption of this standard did not have a material impact on our consolidated results of operations or financial condition.
In August 2010, the FASB issued ASU No. 2010-24, “Health Care Entities” (Topic 954): Presentation of Insurance Claims and Related Insurance Recoveries. This ASU eliminates the practice of netting claim liabilities with expected related insurance recoveries for balance sheet presentation. Claim liabilities are to be determined with no regard for recoveries and presented on the balance sheet on a gross basis. Expected insurance recoveries are presented separately. ASU 2010-24 is effective January 1, 2011, and is not expected to impact our results of operations or cash flows.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to market risk related to changes in prevailing interest rates. Historically, we have not held or issued derivative financial instruments other than the use of a variable-to-fixed interest rate swap for a portion of our senior credit facility. We do not use derivative instruments for speculative purposes. Our outstanding debt to commercial lenders is generally based on a predetermined percentage above LIBOR or the lenders’ prime rate. At December 31, 2010, $277.5 million of our total long-term debt was subject to variable rates of interest, while the remaining $259.1 million of our total long-term debt was subject to fixed rates of interest. A hypothetical 100 basis point increase in market interest rates would result in additional annual interest expense of approximately $2.8 million. The fair value of our total long-term debt, based on quoted market prices as of December 31, 2010, is approximately $491.9 million.
Item 8. Financial Statements and Supplementary Data
Information with respect to this item is contained in our consolidated financial statements beginning with the Index on page F-1 of this report.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
(a) | Evaluation of Disclosure Controls and Procedures. We carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Exchange Act Rule 13a-15. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us (including our consolidated subsidiaries) in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported in a timely basis. |
(b) | Management’s Report on Internal Control over Financial Reporting. Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Exchange Act Rule 13a-15(f). Our internal control system was designed to provide reasonable assurance to our management and Board of Directors regarding the preparation and fair presentation of published financial statements. |
During 2010, we acquired an ownership interest in a general acute care hospital with a surgical and obstetrics focus in Idaho Falls, Idaho which we consolidate for financial reporting purposes. Related to this acquisition, our consolidated balance sheet as of December 31, 2010 includes $79.4 million of total assets, excluding goodwill, and our consolidated statement of operations for the year ended December 31, 2010 includes $58.7 million and $5.0 million of total revenues and net income, respectively. We have excluded this acquisition from management's assessment of internal control over financial reporting.
Management has assessed the effectiveness of our internal control over financial reporting using the criteria set forth in “Internal Control - Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on management’s assessment and those criteria, management concluded that our internal control over financial reporting was effective as of December 31, 2010.
(c) | Changes in Internal Control Over Financial Reporting. There has been no change in our internal control over financial reporting that occurred during the fourth quarter of 2010 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. |
Limitations on the Effectiveness of Controls
Our management, including the Chief Executive Officer and the Chief Financial Officer, recognizes that any set of controls and procedures, no matter how well-designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, with the Company have been detected. These inherent limitations include the
50
realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of controls. For these reasons, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Item 9B. Other Information
None.
51
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Directors and Executive Officers
MANAGEMENT
The following list identifies the name, age and position(s) of our executive officers, key employees and directors:
Name | Age | Position | ||
Richard E. Francis, Jr. | 57 | Chairman of the Board, Chief Executive Officer and Director | ||
Clifford G. Adlerz | 57 | President, Chief Operating Officer and Director | ||
Teresa F. Sparks | 42 | Senior Vice President of Finance, Chief Financial Officer | ||
Kenneth C. Mitchell | 61 | Senior Vice President of Mergers and Acquisitions | ||
R. Dale Kennedy | 63 | Senior Vice President of Management Services and Secretary | ||
Thomas S. Murphy, Jr. | 51 | Director | ||
Robert V. Delaney | 53 | Director | ||
Quentin Chu | 34 | Director | ||
Kurt E. Bolin | 52 | Director | ||
Craig R. Callen | 55 | Director |
Directors are re-elected annually by the shareholders of the Company (most recently as of March 25, 2011) pursuant to a written consent in lieu of annual meeting. Each director shall hold office until a successor is elected or until the directors death or resignation.
Richard E. Francis, Jr. has served as the Chairman of the Board since May 2002 and as Chief Executive Officer and a director since 1996. Mr. Francis also served as President from 1996 to May 2002. Mr. Francis served from 1992 to 1995 as Senior Vice President, Development of HealthTrust, Inc. From 1990 to 1992, Mr. Francis served as Regional Vice President, Southern Region for HealthTrust, where he oversaw operations of 11 hospitals. Mr. Francis’ experience in the healthcare industry as well as his leadership of the Company and his role as a director since its founding in 1996 provides the Board with a unique and deeper insight into our business, challenges and opportunities.
Clifford G. Adlerz has served as President since May 2002 and as Chief Operating Officer and a director since 1996. Mr. Adlerz also served as Secretary from 1996 to May 2002. Mr. Adlerz served as Regional Vice President, Midsouth Region for HealthTrust, Inc. from 1992 until its merger with HCA Inc. in May 1995, at which time he became Division Vice President of HCA and served in that position until September 1995. Mr. Adlerz served as Chief Executive Officer of South Bay Hospital in Sun City, Florida from 1987 to 1992. Mr. Adlerz’s experience in the healthcare industry as well as his leadership of the Company and his role as a director since its founding in 1996 provides the Board with a unique and deeper insight into our business, challenges and opportunities.
Teresa F. Sparks has served as Chief Financial Officer and Senior Vice President of Finance since August 2007. Ms. Sparks served as Corporate Controller from the Company’s inception in 1996 to August 2007 and was named Vice President in December 2002. Previously, she served as Assistant Controller for HealthWise of America, Inc., a managed care organization. Prior to joining HealthWise of America, Ms. Sparks was a senior healthcare auditor for Deloitte & Touche LLP, Nashville, Tennessee.
Kenneth C. Mitchell has served as Senior Vice President of Mergers and Acquisitions since August 2007. Mr. Mitchell served as Vice President of Finance from 1996 to December 2002 and as Chief Financial Officer from May 2002 to August 2007. Mr. Mitchell served as Chief Financial Officer of American HealthMark, Inc. from 1989 to 1995 and as Vice President—Controller for HCA Management Company Inc. from 1988 to 1989. Prior to that time, Mr. Mitchell served as Assistant Vice President-Development and Regional Controller for HCA Management Company Inc.
R. Dale Kennedy has served as Secretary since May 2002 and Senior Vice President of Management Services since December 2002. Mr. Kennedy served as Vice President of Management Services from 1996 to December 2002. Mr. Kennedy served as Chief Operations Officer for IPN Network, LLC, a company that managed the business office functions of healthcare entities, from 1991 until 1995. Prior to that time, Mr. Kennedy served in regional financial roles for HealthTrust, Inc. and HCA Inc.
Thomas S. Murphy, Jr. co-founded Crestview Partners in 2004 and has served as a director of the Company since August 2007. He retired from Goldman, Sachs & Co. in 2003 where he was a Partner/Managing Director. Mr. Murphy spent sixteen years in the Investment Banking Division of Goldman, Sachs & Co. Mr. Murphy brings to the board his extensive experience with acquisitions, divestitures, recapitalizations, initial public offerings, bank and high yield financings and private equity investments. In addition to his charitable activities, Mr. Murphy serves on the Board of Directors of FBR Capital Markets Co. and Key Safety Systems, Inc.
Robert V. Delaney joined Crestview as a partner in 2007 and has served as a director of the Company since October 2007. He retired from Goldman, Sachs & Co. in 2003 where he served in a variety of leadership positions including head of the Principal Investment Area in Asia, head of the Principal Investment Area in Japan and head of the Leveraged Finance Group. Mr. Delaney serves on the Board of
52
Directors of Select Energy Systems. Mr. Delaney brings to the board his extensive experience in high yield debt, leveraged loans, restructuring, mergers and acquisitions and principal investing.
Quentin Chu is a Principal at Crestview Partners and has been with the firm since July 2005, after graduating from Harvard Business School. Mr. Chu has served as a director of the Company since August 2007. Prior to attending business school, Mr. Chu was an associate at The Carlyle Group, where he evaluated and executed transactions in the healthcare industry, including pharmaceuticals, medical devices, facility-based providers, managed care and outsourcing. Prior to joining Carlyle, Mr. Chu was an analyst in the healthcare investment banking team at Goldman, Sachs & Co., where he completed a range of mergers and acquisitions and financing assignments for both early stage and Fortune 500 companies. Mr. Chu’s experience in healthcare transactions and finance provides the Board greater insight into the healthcare industry and financial strategy.
Kurt E. Bolin is a Principal of Stone Point Capital LLC and has been with the firm since 1997. Mr. Bolin has served as a director of the Company since August 2007. Prior to joining Stone Point Capital, Mr. Bolin was with GE Capital, Inc., where he held various private equity positions from 1986 to 1997, most recently as Managing Director of the Equity Capital Group. In addition to private equity investing, Mr. Bolin’s activities at GE Capital, Inc. included leading the acquisitions of various insurance companies. Mr. Bolin is also a director of Edgewood Partners Holdings, LLC, GENEX Services, Inc. and Wilton Re Holdings Limited. The Board benefits from Mr. Bolin’s experience as a private equity investor and the knowledge he has gained as a board member of various companies.
Craig R. Callen has been a Senior Advisor at Crestview since October 2009 and became a director of the Company in March 2010. From 2004 to 2007, Mr. Callen served as Senior Vice President of Strategic Planning and Business Development and a member of the Executive Committee for Aetna, Inc., responsible for oversight and development of Aetna’s corporate strategy, including mergers and acquisitions. Prior to joining Aetna in 2004, Mr. Callen was a Managing Director and Head of U.S. healthcare investment banking at Credit Suisse First Boston and co-head of healthcare investment banking at Donaldson Lufkin & Jenrette prior to its acquisition by Credit Suisse First Boston. During his 20 year career as an investment banker in the healthcare practice, Mr. Callen successfully completed over 100 transactions for clients and contributed as an advisor to the board of directors and managements of many leading healthcare companies in the United States. Currently, Mr. Callen serves on the Board of Directors of Kinetic Concepts, Inc., and previously served on the Board of Directors of Sunrise Senior Living, Inc. Mr. Callen, through his lengthy and broad focus on the healthcare industry, offers the Board greater insight into industry dynamics as well as investment and acquisitions strategies.
Board Structure and Compensation
Our board is currently composed of 7 members. We do not currently pay our directors any fees.
Audit Committee Financial Expert
Our Audit and Compliance Committee is composed of Quentin Chu and Kurt Bolin. In light of our status as a closely held company and the absence of a public trading market for our common stock, our Board has not designated any member of the Audit and Compliance Committee as an “audit committee financial expert.”
Code of Business Conduct and Ethics
We have adopted a Code of Business Conduct and Ethics. Copies of the Code of Business Conduct and Ethics may be obtained, free of charge, by writing to the Secretary of the Company at: Symbion, Inc., 40 Burton Hills Boulevard, Suite 500, Nashville, Tennessee 37215.
Item 11. Executive Compensation
COMPENSATION DISCUSSION AND ANALYSIS
Symbion is a wholly-owned subsidiary of Symbion Holdings Corporation. The same individuals serve on both Holding’s Board of Directors and our Board of Directors. Senior management is employed by us but has acquired and is eligible to receive equity awards in Holdings.
The Compensation Committee of our Board of Directors is responsible for establishing and administering executive compensation policies and programs within the framework of the committee’s compensation philosophy. Our current Compensation Committee was established by Holdings in February 2008. Our board served as the compensation committee between the consummation of the Merger on August 23, 2007 and the appointment of the committee in February 2008.
Our executive compensation policies are designed to complement and contribute to the achievement of our business objectives. The Compensation Committee’s general philosophy is that executive compensation should:
▪ | Link compensation paid to executives to corporate and individual performance; |
▪ | Provide incentive opportunities that will motivate executives to achieve our long-term objectives; |
▪ | Be competitive within our industry and community and responsive to the needs of our executives; |
▪ | Attract, retain, motivate and reward individuals of the highest quality in the industry with the experience, skills and integrity necessary to promote our success; and |
▪ | Comply with all applicable laws, and be appropriate in light of reasonable and sensible standards of good corporate |
53
governance.
The elements of our executive compensation program include (i) base salary, (ii) annual cash bonus or non-equity incentive compensation, (iii) equity-based compensation, and (iv) other benefits such as participation in our 401(k) plan and the Supplemental Executive Retirement Plan (the “SERP”). Executive officers also receive benefits that our other employees receive including medical, life and disability insurance.
Compensation Process
The Compensation Committee approves salaries and other compensation for our executive officers. The Compensation Committee also reviews and approves, in advance, employment and similar arrangements or payments to be made to any executive officer. For purposes of this discussion, the Named Executive Officers, or NEOs, are the individuals included in the Summary Compensation Table on page 55 of this filing. Salaries and other compensation for all other officers and employees are determined by management in accordance with our compensation policies and plans.
Prior to the Merger, our compensation procedures were similar to those of other similarly situated companies. Our former Compensation Committee retained an independent compensation consultant for advice with respect to specific compensation decisions. Currently, our Compensation Committee is appointed by Holdings’ Board of Directors, which is controlled by Crestview. Accordingly, our Compensation Committee represents the interests of our stockholders and makes decisions independent from our executive officers. Since the Merger, our Compensation Committee generally has continued the levels of compensation that were in place at the time of the Merger with cost of living adjustments it has deemed appropriate. Our Compensation Committee has not otherwise utilized the services of a consulting firm in connection with compensation decisions it has made after the Merger.
The Compensation Committee may delegate to the Chief Executive Officer the authority to make, within the framework of the Compensation Committee’s philosophy or objectives that it has adopted from time to time, compensation decisions with respect to our non-executive employees.
Components of Executive Compensation
Base Salaries
The Compensation Committee reviews the base salaries of our executive officers on an annual basis. Salaries are determined based on a subjective assessment of the nature and responsibilities of the position involved, our performance and the performance of the particular officer, and the officer’s experience and tenure with us. The base salaries for 2010 for our Named Executive Officers were as follows: $472,816 for Mr. Francis, $341,485 for Mr. Adlerz, $223,466 for Ms. Sparks, $223,466 for Mr. Mitchell, and $212,095 for Mr. Kennedy. Messrs. Francis and Adlerz were entitled to increases in salary effective January 1, 2008, to $525,000 and $375,000, respectively, under the terms of their employment agreements but elected to delay implementing this increase to their base salary. Messrs. Francis and Adlerz received no salary increase for 2009 and received the 2% cost of living salary increase that all other employees received in 2010.
Non-Equity Incentive Compensation
Non-equity incentive compensation is intended to motivate executive officers to achieve pre-determined financial or other goals appropriate to each executive officer’s area of responsibility set by the Compensation Committee, consistent with our overall business strategies.
In February 2010, the Compensation Committee established the 2010 Corporate Key Management Incentive Plan for key management employees, including our executive officers. The 2010 plan provides for a cash bonus equal to a percentage of base salary upon achievement of financial indicators selected by our Compensation Committee, including achievement of applicable budgeted EBITDA, development and division performance targets. The amount paid under the plan depends on the level of achievement; provided, however, that no bonus based on Company EBITDA will be paid unless a minimum of 95% of budgeted EBITDA is achieved. The 2010 plan also provides for an additional bonus paid in equity securities in the event that 2010 EBITDA for the Company equaled or exceeded budgeted EBITDA.
For Messrs. Francis and Adlerz, the aggregate cash and equity target bonus was 100% of base salary upon achievement of applicable budgeted EBITDA for the Company. For our other NEOs, the aggregate cash and equity target bonus for 2010 ranged from 45% to 50% of base salary upon achievement of applicable budgeted EBITDA for the Company and, in the case of Mr. Mitchell, development targets. The potential bonus payment to Mr. Mitchell, as the Company's Chief Development Officer, was based 50% on Company EBITDA and 50% on development targets. Upon review of the Company's 2010 financial performance, the Committee determined that Company EBITDA and development performance for the year ended December 31, 2010 exceeded threshhold levels. Accordingly, with respect to the Named Executive Officers, cash bonuses earned for 2010 under this plan were as follows: $189,108 for Mr. Francis, $136,579 for Mr. Adlerz, $44,693 for Ms. Sparks, $60,336 for Mr. Mitchell, and $42,419 for Mr. Kennedy. None of our NEOs received bonuses paid in equity securities for 2010. See “Executive Compensation — Grants of Plan-Based Awards” for additional information on these awards.
In December 2010, the Compensation Committee established the 2011 Corporate Key Management Incentive Plan for key management employees, including our executive officers. The 2011 plan provides for a bonus in cash or equity securities with a value equal to a percentage of base salary upon achievement of financial indicators selected by our Compensation Committee, including achievement of applicable budgeted EBITDA, development and division performance targets. The amount of the award under the plan depends on the level of achievement; provided, however, that no bonus based on Company EBITDA will be paid unless a minimum of 95% of budgeted EBITDA
54
is achieved. For Messrs. Francis and Adlerz, the aggregate cash and equity target bonus is 100% of base salary upon achievement of applicable budgeted EBITDA for the Company. For our other Named Executive Officers, the aggregate cash and equity target bonus for 2011 ranges from 45% to 50% of base salary.
Equity-Based Compensation
Equity-based compensation is intended to align the financial interests of our executive officers’ interests with those of our stockholders. The Compensation Committee believes that equity awards give our executives a stake in our long-term performance and align senior management with our achievement of longer-term financial objectives that enhance stockholder value. The Compensation Committee considers the number of available shares, but has no fixed formula for determining the awards to be granted.
Holdings maintains the 2007 Equity Incentive Plan, which permits grants of stock options and other equity-based awards. On August 31, 2007, the Compensation Committee made an initial award of options to purchase Holdings common stock under this plan to our executive officers and certain other employees. The exercise price of the options equaled the fair market value of Holdings common stock on the date of the grant. The options contain both time and performance based vesting components. Vesting of the time vesting portion of the award is accelerated in the event of a change in control. Vesting of performance vesting options is accelerated if certain conditions are satisfied in connection with a liquidity event. See “Executive Compensation — Potential Payments Upon Termination or Change in Control — Other Effects of Termination of Employment or Change in Control.”
In 2010, options to purchase 93,841 shares of Holdings common stock were granted to employees under the 2007 Equity Incentive Plan. No options or other equity-based awards, however, were granted to our Named Executive Officers in 2010.
Other Benefits
In January 2005, our former Compensation Committee adopted the SERP. The SERP is a nonqualified deferred compensation program for officers and other key employees designated by the Compensation Committee. The SERP is designed and administered in accordance with the requirements of the Internal Revenue Code to defer the taxation on compensation earned by participating employees. Participating employees can elect to defer up to 25% of their base salary and up to 50% of their year-end bonus. For employees who defer at least 2% of their base salary, we will contribute 2% of the employee’s base salary to the SERP. The Compensation Committee in its discretion may make additional contributions based on achievement of performance goals or other company objectives. Employee contributions pursuant to the SERP are 100% vested at all times. Company contributions vest one year after contribution, and immediately upon death, disability or change in control of the Company. Participating employees direct the investment of their accounts in mutual funds or other appropriate investment media that we select. Assets invested pursuant to the SERP are designated for paying SERP benefits but are the property of Symbion and are subject to the claims of our creditors.
The Named Executive Officers are also eligible to participate in our 401(k) plan. The 401(k) plan allows employees to contribute up to the limits imposed by the Internal Revenue Code. Pursuant to the 401(k) plan, we can make a discretionary matching contribution to the plan on behalf of each employee. Typically, our match of employee contributions has been equal to 25% of the first 6% of an employee’s base salary contributed to the plan.
Perquisites
We provide our executive officers with perquisites that we believe are reasonable, competitive and consistent with our overall executive compensation program and that are generally available to our other employees. These perquisites include medical, life and disability insurance.
EXECUTIVE COMPENSATION
Summary Compensation Table
The following table sets forth certain information concerning compensation paid or accrued for the last three years with respect to our Named Executive Officers — the Chief Executive Officer, the Chief Financial Officer and our three other most highly compensated executive officers:
55
Name and Principal Position | Year | Salary | Bonus | Non-Equity Incentive Plan Compensation(1) | All Other Compensation(2) | Total | |||||||||||||||||
Richard E. Francis, Jr. | 2010 | $ | 472,816 | $ | — | $ | 189,108 | $ | 10,818 | $ | 672,742 | ||||||||||||
Chairman of the Board and Chief Executive Officer | 2009 | 463,500 | — | — | 13,405 | 476,905 | |||||||||||||||||
2008 | 463,500 | — | 231,750 | 14,193 | 709,443 | ||||||||||||||||||
Clifford G. Adlerz | 2010 | 341,485 | — | 136,579 | 9,015 | 487,079 | |||||||||||||||||
President and Chief Operating Officer | 2009 | 334,750 | — | — | 10,664 | 345,414 | |||||||||||||||||
2008 | 334,750 | — | 167,375 | 11,414 | 513,539 | ||||||||||||||||||
Teresa F. Sparks | 2010 | 223,466 | — | 44,693 | 6,218 | 274,377 | |||||||||||||||||
Senior Vice President of Finance and Chief Financial Officer | 2009 | 219,078 | — | — | 7,755 | 226,833 | |||||||||||||||||
2008 | 219,078 | — | 54,769 | 8,325 | 282,172 | ||||||||||||||||||
Kenneth C. Mitchell | 2010 | 223,466 | — | 60,336 | 6,218 | 290,020 | |||||||||||||||||
Senior Vice President of Mergers and Acquisitions | 2009 | 219,078 | — | — | 7,771 | 226,849 | |||||||||||||||||
2008 | 219,078 | 28,017 | — | 8,636 | 255,731 | ||||||||||||||||||
R. Dale Kennedy | 2010 | 212,095 | — | 42,419 | 5,949 | 260,463 | |||||||||||||||||
Senior Vice President of Management Services and Secretary | 2009 | 207,930 | — | 28,270 | 7,385 | 243,585 | |||||||||||||||||
2008 | 207,930 | — | 64,978 | 8,368 | 281,276 | ||||||||||||||||||
__________________________
(1) | Represents awards under the 2008, 2009, and 2010 Corporate Key Management Incentive Plans. See “Grants of Plan-Based Awards” below for additional information on the 2010 awards. |
(2) | Represents: |
(a) | Company contributions to the Supplemental Executive Retirement Plan for Mr. Francis of $9,270 for each of 2008, 2009 and 2010, Mr. Adlerz of $6,695 for each of 2008, 2009 and 2010; Ms. Sparks of $4,382 for each of 2008, 2009 and 2010; Mr. Mitchell of $4,382 for each of 2008, 2009 and 2010; and Mr. Kennedy of $4,159 for each of 2008, 2009 and 2010. |
(b) | Company contributions to the 401(k) plan for Mr. Francis of $3,375 for 2008, $2,587 for 2009 and $0 for 2010; Mr. Adlerz of $3,375 for 2008, $2,587 for 2009 and $919 for 2010; Ms. Sparks of $3,064 for 2008, $2,469 for 2009 and $919 for 2010; Mr. Mitchell of $3,375 for 2008, $2,485 for 2009 and $919 for 2010; and Mr. Kennedy of $3,375 for 2008, $2,368 for 2009 and $919 for 2010. |
(c) | Premiums we paid for term life insurance on behalf of each Named Executive Officer of $1,548 for each of 2008, 2009 and 2010, for Mr. Francis; $1,344 for 2008, $1,382 for 2009 and $1,401 for 2010 for Mr. Adlerz; $879 for 2008, $904 for 2009 and $917 for 2010 for Ms. Sparks; $879 for 2008, $904 for 2009 and $917 for 2010 for Mr. Mitchell; and $834 for 2008, $858 for 2009 and $871 for 2010 for Mr. Kennedy. |
Grants of Plan-Based Awards
The following table provides information regarding incentive awards granted during 2010 to our Named Executive Officers under the 2010 Corporate Key Management Incentive Plan, conditioned on achievement of applicable performance targets:
Estimated Payouts Under Incentive Plan Awards(3) | |||||||||||
Threshold(1) | Target(2) | Maximum | |||||||||
Richard E. Francis, Jr. | $ | 189,108 | $ | 472,816 | $ | 472,816 | |||||
Clifford G. Adlerz | 136,579 | 341,485 | 341,485 | ||||||||
Teresa F. Sparks | 44,693 | 111,733 | 111,733 | ||||||||
Kenneth C. Mitchell | 20,112 | 100,560 | 100,560 | ||||||||
R. Dale Kennedy | 42,419 | 106,047 | 106,047 | ||||||||
___________________________________________
(1) | Threshold is based upon minimum level of bonus payout assuming base level of performance is achieved. If base level is not reached, no bonus would be paid under the plan. |
(2) | Target is based upon the expectation of the potential payout of incentive awards when the incentive plan was established. |
56
(3) | Actual awards made under the plan for performance in 2010 are included in the Summary Compensation Table under “Non-Equity Incentive Plan Compensation.” |
Outstanding Equity Awards at Fiscal Year-End
The following table provides certain information with respect to the Named Executive Officers regarding outstanding equity awards as of December 31, 2010:
Option Awards | ||||||||||||||||
Name | Number of Securities Underlying Unexercised Options (#) (Exercisable) | Number of Securities Underlying Unexercised Options (#) (Unexercisable) | Option Exercise Price ($) | Option Expiration Date | ||||||||||||
Richard E. Francis, Jr. | 135,162 | (1) | — | $ | 1.50 | 5/16/2012 | ||||||||||
76,119 | (1) | — | $ | 1.50 | 12/10/2013 | |||||||||||
24,941 | (1) | — | $ | 1.50 | 12/10/2014 | |||||||||||
29,082 | (1) | — | $ | 1.50 | 1/5/2015 | |||||||||||
21,098 | (1) | — | $ | 1.50 | 1/18/2014 | |||||||||||
344,242 | (2) | 548,255 | (2) | $ | 10.00 | 8/31/2017 | ||||||||||
Clifford G. Adlerz | 108,128 | (1) | — | $ | 1.50 | 5/16/2012 | ||||||||||
60,505 | (1) | — | $ | 1.50 | 12/10/2013 | |||||||||||
15,588 | (1) | — | $ | 1.50 | 12/10/2014 | |||||||||||
18,176 | (1) | — | $ | 1.50 | 1/5/2015 | |||||||||||
15,171 | (1) | — | $ | 1.50 | 1/18/2014 | |||||||||||
229,494 | (3) | 376,136 | (3) | $ | 10.00 | 8/31/2017 | ||||||||||
Teresa F. Sparks | 1,729 | (1) | — | $ | 1.50 | 12/10/2013 | ||||||||||
6,361 | (1) | — | $ | 1.50 | 1/5/2015 | |||||||||||
2,982 | (1) | — | $ | 1.50 | 1/18/2014 | |||||||||||
41,217 | (4) | 93,719 | (4) | $ | 10.00 | 8/31/2017 | ||||||||||
Kenneth C. Mitchell | 9,352 | (1) | — | $ | 1.50 | 12/10/2014 | ||||||||||
10,905 | (1) | — | $ | 1.50 | 1/5/2015 | |||||||||||
4,741 | (1) | — | $ | 1.50 | 1/18/2014 | |||||||||||
41,217 | (4) | 93,719 | (4) | $ | 10.00 | 8/31/2017 | ||||||||||
R. Dale Kennedy | 9,066 | (1) | — | $ | 1.50 | 5/16/2012 | ||||||||||
41,217 | (4) | 93,719 | (4) | $ | 10.00 | 8/31/2017 | ||||||||||
_________________________________
(1) | Options to purchase Holdings common stock that were received by the Named Executive Officers in exchange for Symbion options that were rolled over in connection with the Merger. |
(2) | Effective August 31, 2007, Mr. Francis received a grant of options to purchase 892,497 shares of Holdings common stock, including 430,302 time vesting options and 462,195 performance vesting options. The time vesting options vest 20% per year on December 31 beginning December 31, 2007. Performance vesting options vest upon a liquidity event based on the extent to which an internal rate of return (“IRR”) is achieved by Crestview. |
(3) | Effective August 31, 2007, Mr. Adlerz received a grant of options to purchase 605,630 shares of Holdings common stock, including 286,868 time vesting options and 318,762 performance vesting options. The time vesting options vest 20% per year on December 31 beginning December 31, 2007. Performance vesting options vest upon a liquidity event based on the extent to which an indicated IRR is achieved by Crestview. |
(4) | Effective August 31, 2007, the Named Executive Officer received a grant of options to purchase 134,936 shares of Holdings common stock, including 51,521 time vesting options and 83,415 performance vesting options. The time vesting options vest 20% per year on December 31 beginning December 31, 2007. Performance vesting options vest upon a liquidity event based on the extent to which an indicated IRR is achieved by Crestview. |
Option Exercises and Stock Vested
During 2010, the Named Executive Officers did not exercise any stock options. In addition, no restricted stock or similar awards
57
were outstanding during 2010.
Nonqualified Deferred Compensation
The following table shows the activity during 2010 and the aggregate balances held by each of the Named Executive Officers at December 31, 2010 under our SERP:
Name | Executive Contributions in Last Fiscal Year | Registrant Contributions in Last Fiscal Year(1) | Aggregate Earnings (Losses) in Last Fiscal Year | Aggregate Balance at Last Fiscal Year End | ||||||||||||
Richard E. Francis, Jr. | $ | 9,455 | $ | 9,270 | $ | 34,944 | $ | 193,129 | ||||||||
Clifford G. Adlerz | 6,829 | 6,695 | 11,890 | 106,929 | ||||||||||||
Teresa F. Sparks | 17,877 | 4,382 | (6,235 | ) | 110,840 | |||||||||||
Kenneth C. Mitchell | 4,469 | 4,382 | 12,549 | 81,904 | ||||||||||||
R. Dale Kennedy | 8,484 | 4,159 | 15,252 | 86,731 | ||||||||||||
(1) | Amounts in this column are also reported in the “All Other Compensation” column of the Summary Compensation Table. |
See “Compensation Discussion and Analysis — Components of Executive Compensation — Other Benefits” for additional information about the SERP.
Potential Payments Upon Termination or Change in Control
Employment Agreements. Messrs. Francis and Adlerz entered into new employment agreements with us which became effective on August 23, 2007 upon the consummation of the Merger. The initial term of each of the employment agreements is three years, which is automatically extended so that the term will be three years until terminated. We are able to terminate each employment agreement for cause, including (but not limited to) the executive’s conviction of a felony or gross negligence or internal misconduct in the performance of the executive’s duties to the extent it causes demonstrable harm to us. In addition, either party is able to terminate the employment agreement at any time by giving prior written notice to the other party. However, we would be obligated to pay the executive a severance benefit if we terminated the executive’s employment without cause or if the executive terminated his employment upon the occurrence of certain events specified in the agreement, including (but not limited to) a change in control or our material breach of the agreement which is not cured promptly. The severance benefit is generally equal to three times the executive’s highest base salary and the incentive bonus amount that would be paid for the current year as if the incentive bonus performance goals were fully achieved. Upon a termination of employment as a result of the executive’s disability, we will pay the executive contractual disability benefits. If the executive receives severance payments following a change in control of Symbion that are subject to tax under Section 4999 of the Internal Revenue Code, we will pay additional amounts to offset the effect of such taxes on the executive. Each of the employment agreements also includes a covenant not to compete in which the executive agrees that, during the term of the employment agreement and for a period of one year thereafter, he will not own or work for any other company that is predominantly engaged in the ownership and management of surgery centers.
Severance Plan. We adopted an Executive Change in Control Severance Plan in December 1997, which currently provides for severance benefits for certain senior level employees, including three of the Named Executive Officers, Teresa F. Sparks, Kenneth C. Mitchell and R. Dale Kennedy. Eligible individuals are those identified in the severance plan and whose employment is terminated in connection with a change in the control of the Company, as defined in the severance plan, and who are not offered employment by us or a successor employer that is substantially equivalent to or better than the position held with us immediately prior to the change in control or such position is not maintained for at least 12 months thereafter. The benefits provided to our eligible Named Executive Officers are cash compensation equal to base pay and bonus for 12 months and participation in medical, life, disability and similar benefit plans that are offered to our active employees or those of its successor for a period of 12 months. Cash benefits are paid in a single lump sum within 30 days following termination.
Other Effects of Termination of Employment or Change in Control. In addition to payments pursuant to the employment agreements and the Executive Change in Control Severance Plan described above, upon a termination of employment or change in control:
Supplemental Executive Retirement Plan — Under the SERP, deferrals made by an executive officer are fully vested and nonforfeitable at all times. If the executive officer’s employment ends due to disability, death, retirement or a change in control, the executive officer’s entire account, including earnings, will be fully vested. If the executive officer’s employment ends due to some event other than disability, death, retirement or change in control, the executive officer forfeits all Company contributions that were made less than one year prior to the date of termination.
401(k) Plan — Under our 401(k) plan, contributions made by an executive officer are fully vested and nonforfeitable at all times. Matching contributions that we make for the benefit of an executive officer vest based on the years of service of the executive officer. Each of our current executive officers has been an employee for at least five years and, therefore, all company contributions under our 401(k) plan on behalf of such officers is fully vested and nonforfeitable. There is no provision for additional benefits on a change in control.
Stock Option Awards — Options may be subject to forfeiture depending on the nature of the terminating event. In no event shall an option be exercisable after the expiration date of the option. Upon a change in control or liquidity event, Named Executive Officers have
58
special exercise and vesting rights. These special rights also apply to other option holders.
Death or Disability. In the event of death or disability of a Named Executive Officer, the executive officer or his or her estate has 12 months to exercise any vested options.
Termination With Cause. If a Named Executive Officer’s employment is terminated with cause, then all options held by such officer shall immediately be forfeited and cancelled without any payment or consideration being payable to such officer.
Other Termination by the Company or Resignation. Except in the event of death or disability, an executive officer will have the right to exercise all options for three months following resignation or termination of employment by the Company that is not for cause. The right to exercise is limited to the options that have become vested as of the date of termination.
Change in Control and Liquidity Events. As described above under “Compensation Discussion and Analysis — Components of Executive Compensation — Equity-Based Compensation,” the Company has awarded stock options to executive officers that become vested over a period of time provided that the executive officer continues to be employed by us and stock options that become vested upon achievement of performance goals. The effect of a change in control varies for time vesting options and options that vest upon performance.
Time Vesting Options. In the event of a Change in Control (as defined below) that occurs prior to termination of employment, whether or not the vesting requirements set forth in any form of time vesting option agreement have been satisfied, all such time vesting options that are outstanding at the time of the Change in Control shall become fully vested and exercisable immediately prior to the Change in Control event.
A “Change in Control” is deemed to have occurred (i) in the event that any person, entity or group other than Crestview and its related funds holds (other than pursuant to a registered initial public offering) Holdings stock representing at least 50% of the combined voting power of all outstanding voting equity securities and (ii) in the event of an asset sale by or liquidation or dissolution of Holdings.
Performance Options. Options that vest upon performance become vested only upon a liquidity event that occurs prior to termination of employment. Executive officers have been awarded both “standard” performance vesting options and additional “alternative” performance vesting options.
Change in Control or Liquidity Event Rights on Termination of Employment. Termination of an executive officer’s employment by the Company without cause or upon a resignation for Good Reason will result in the right to exercise options as follows: (i) if termination occurs within 12 months following a Change in Control, the executive officer will be able to fully exercise the time vesting options and, to the extent that the performance conditions are satisfied, performance vesting options for three months following the date of the event; and (ii) if termination occurs within 12 months prior to the execution of an agreement that results in a liquidity event, the executive officer will be able to exercise the time vesting options to the extent that they were vested as of the termination of employment and, to the extent that the performance conditions are satisfied, performance vesting options for three months following the date of a liquidity event; provided, however, that the number of shares that can be acquired on exercise of the performance vesting option will be reduced by one-half if termination of employment is more than six months prior to execution of such agreement.
As it relates to Messrs. Francis and Adlerz, a termination of employment by the executive officer for “Good Reason” occurs following (a) any material breach by the Company of any material provision of the employment agreement; (b) a reduction in base salary or target bonus opportunity; (c) a material diminution in title or level of responsibility, or change in office or reporting relationship; (d) a transfer of the executive’s primary workplace by more than 35 miles; (e) the failure of the executive to be elected or the executive ceases be a member of our board or the board of Symbion (except for cause); or (g) the executive’s resignation for any reason within 120 days following a Change in Control.
For all other Named Executive Officers, “Good Reason” means, during the 12 months following a Change in Control, (a) a reduction in base salary or target bonus opportunity in effect immediately prior to the Change in Control; (b) a material diminution in level of responsibility or, with respect to Ms. Sparks, a material diminution in title in effect immediately prior to the Change in Control; (c) a material reduction in the aggregate value of deferred compensation and health and welfare benefits that were provided immediately prior to the Change in Control; or (d) a transfer of the executive officer’s primary workplace by more than 50 miles.
59
Potential Payments. The following table shows the amounts that each Named Executive Officer would have received if the Named Executive Officer’s employment had been terminated for the reasons indicated effective December 31, 2010:
________________________________
Name | Cash Compensation | Accelerated Vesting of Stock Options | Benefits | Total | |||||||||||||||||||
Richard E. Francis, Jr. | |||||||||||||||||||||||
Termination for cause, voluntary termination or retirement | $ | — | $ | — | $ | 36,368 | (1 | ) | $ | 36,368 | |||||||||||||
Death | — | — | 36,368 | (1 | ) | 36,368 | |||||||||||||||||
Disability | 703,836 | (2) | — | 44,087 | (3 | ) | 747,923 | ||||||||||||||||
Termination by the Company without cause or by the NEO for Good Reason | 2,836,896 | (4) | — | 44,087 | (3 | ) | 2,880,983 | ||||||||||||||||
Change in Control | 3,885,236 | (5) | — | (6) | 44,087 | (3 | ) | 3,929,323 | |||||||||||||||
Clifford G. Adlerz | |||||||||||||||||||||||
Termination for cause, voluntary termination or retirement | — | — | 26,266 | (1 | ) | 26,266 | |||||||||||||||||
Death | — | — | 26,266 | (1 | ) | 26,266 | |||||||||||||||||
Disability | 408,341 | (2) | — | 33,837 | (3 | ) | 442,178 | ||||||||||||||||
Termination by the Company without cause or by the NEO for Good Reason | 2,048,910 | (4) | — | 33,837 | (3 | ) | 2,082,747 | ||||||||||||||||
Change in Control | 2,784,435 | (5) | — | (6) | 33,837 | (3 | ) | 2,818,272 | |||||||||||||||
Teresa F. Sparks | |||||||||||||||||||||||
Termination for cause, voluntary termination or retirement | — | — | 17,189 | (1 | ) | 17,189 | |||||||||||||||||
Death | — | — | 17,189 | (1 | ) | 17,189 | |||||||||||||||||
Disability | — | (2) | — | 17,189 | (1 | ) | 17,189 | ||||||||||||||||
Termination by the Company without cause or by the NEO for Good Reason | — | — | 17,189 | (1 | ) | 17,189 | |||||||||||||||||
Change in Control | 335,199 | (7) | — | (6) | 24,277 | (3 | ) | 359,476 | |||||||||||||||
Kenneth C. Mitchell | |||||||||||||||||||||||
Termination for cause, voluntary termination or retirement | — | — | 17,189 | (1 | ) | 17,189 | |||||||||||||||||
Death | — | — | 17,189 | (1 | ) | 17,189 | |||||||||||||||||
Disability | — | (2) | — | 17,189 | (1 | ) | 17,189 | ||||||||||||||||
Termination by the Company without cause or by the NEO for Good Reason | — | — | 17,189 | (1 | ) | 17,189 | |||||||||||||||||
Change in Control | 324,026 | (7) | — | (6) | 24,277 | (3 | ) | 348,303 | |||||||||||||||
R. Dale Kennedy | |||||||||||||||||||||||
Termination for cause, voluntary termination or retirement | — | — | 16,315 | (1 | ) | 16,315 | |||||||||||||||||
Death | — | — | 16,315 | (1 | ) | 16,315 | |||||||||||||||||
Disability | — | (2) | — | 16,315 | (1 | ) | 16,315 | ||||||||||||||||
Termination by the Company without cause or by the NEO for Good Reason | — | — | 16,315 | (1 | ) | 16,315 | |||||||||||||||||
Change in Control | 318,143 | (7) | — | (6) | 23,357 | (3 | ) | 341,500 | |||||||||||||||
(1) | Represents accrued vacation only. |
(2) | For Messrs. Francis and Adlerz, this represents a disability benefit annual payment equal to 75% of base salary for a maximum period of 36 months, less the amount that is provided under our disability plan that is generally available to all salaried employees. Our other Named Executive Officers are only eligible for disability benefits under our plan available to all salaried employees. |
(3) | Includes accrued vacation and the premiums for medical, life and disability insurance benefits for the period of time the Named Executive Officer is eligible for continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (COBRA) in accordance with the Named Executive Officer’s employment agreement or the Executive Change in Control Severance Plan, as applicable. |
(4) | Represents a severance payment equal to (a) three times the Named Executive Officer’s base salary plus (b) three times the target cash bonus amount for 2010 in accordance with the Named Executive Officer’s employment agreement. |
(5) | Includes the amount described in footnote 4 above plus a “gross up” payment of all excise taxes imposed under Section 4999 of the Code and any federal income and excise taxes that are payable as a result of any reimbursements for Section 4999 excise taxes in accordance with the Named Executive Officer’s employment agreement. The gross up amount is $1,030,151 for Mr. Francis and |
60
$735,525 for Mr. Adlerz. This calculation assumes termination of employment.
(6) | As discussed above, all unvested time vesting options held by an executive officer vest upon a Change in Control. In addition, if specified internal rates of return are achieved upon a liquidity event, then performance vesting options held by executive officers would vest in connection. The fair market value of Holdings common stock on December 31, 2010, as determined under general valuation principles, was less than the exercise price of the unvested options. Therefore, for purposes of this table, no value would have been realized for accelerated vesting of options upon a Change in Control. |
(7) | Represents payment under the Executive Change in Control Severance Plan of one year of annual pay, which includes for each individual, the base pay and the bonus paid to each individual for the preceding year. |
The table above does not include information about vesting of Company contributions under our 401(k) plan or the SERP. Information about such plans can be found under “Other Effects of Termination of Employment or Change in Control” and “Nonqualified Deferred Compensation.”
Director Compensation
None of our directors received compensation for service as a member of our (or Holdings) board or board committees for 2010. They are reimbursed for any expenses incurred in connection with their service.
Compensation Committee Interlocks and Insider Participation
Following the Merger, the Board of Directors of Holdings acted as our Compensation Committee. Beginning in February 2008, the Board of Directors of Holdings appointed Robert V. Delaney and Thomas S. Murphy, Jr., Board representatives of Crestview, as the Compensation Committee. None of the members of the Compensation Committee have at any time been our officer or employee nor have any of the members had any relationship with us requiring disclosure except for the transactions with Crestview described in Item 13. “Certain Relationships and Related Transactions, and Director Independence.”
Compensation Committee Report
The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis with management. Based on our review and discussion with management, we have recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Annual Report on Form 10-K.
Compensation Committee | |
Robert V. Delaney | |
Thomas S. Murphy, Jr. |
61
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
All of our capital stock is owned by our parent company, Holdings. The following table presents information with respect to the beneficial ownership of Holdings’ common stock as of March 25, 2011 by (a) any person or group who beneficially owns more than five percent of Holdings common stock, (b) each of our directors and Named Executive Officers and (c) all directors and executive officers as a group. The percentage shares outstanding provided in the table are based on 24,816,623 shares of our common stock, par value $0.01 per share, outstanding as of March 25, 2011.
_________________________________________
Name of Beneficial Holder | Number of Shares(1) | Percent of Class | ||||
Crestview Funds(2) | 14,500,000 | 58.4 | % | |||
The Northwestern Mutual Life Insurance Company(3) | 4,000,000 | 16.1 | ||||
Trident IV, L.P.(4) | 3,000,000 | 12.1 | ||||
Banc of America Capital Investors V, L.P.(5) | 2,500,000 | 10.1 | ||||
Richard E. Francis, Jr.(6)(7) | 814,240 | 3.2 | ||||
Clifford G. Adlerz(6)(8) | 504,493 | 2.0 | ||||
Teresa F. Sparks(6)(9) | 50,628 | * | ||||
Kenneth C. Mitchell(6)(10) | 62,465 | * | ||||
R. Dale Kennedy(6)(11) | 48,923 | * | ||||
Thomas S. Murphy, Jr.(12) | — | * | ||||
Robert V. Delaney(12) | — | * | ||||
Quentin Chu(12) | — | * | ||||
Craig R. Callen(12) | — | * | ||||
Kurt E. Bolin(4) | — | * | ||||
All directors and executive officers as a group (10 persons) (13) | 1,480,749 | 5.7 | % | |||
* Less than one percent.
(1) | Beneficial ownership includes voting or investment power with respect to securities and includes the shares issuable pursuant to options that are exercisable within 60 days of March 25, 2011. Shares issuable pursuant to options are deemed outstanding in computing the percentage held by the person holding the options but are not deemed outstanding in computing the percentage held by any other person. |
(2) | Consists of shares held directly by Crestview Partners, L.P. and certain related investors (the “Crestview Funds”). The investment committee of Crestview Partners GP, L.P., the general partner of each fund, makes investment decisions on behalf of the investment funds and Barry S. Volpert serves as the chairman of the investment committee. Mr. Volpert has the right to designate, in his discretion, additional persons to serve on the investment committee of Crestview Partners GP, L.P. and, therefore, could be deemed to have beneficial ownership of all the shares of common stock held by the Crestview Funds. However, Mr. Volpert disclaims beneficial ownership of all such shares. The composition of the investment committee of Crestview Partners GP, L.P. changes from time to time. See “Certain Relationships and Related Party Transactions — Shareholder Agreement.” The address of Crestview Partners GP, L.P. is 667 Madison Avenue, New York, New York 10021. |
(3) | Includes shares held directly by The Northwestern Mutual Life Insurance Company and an affiliated fund. The address of The Northwestern Mutual Life Insurance Company is 720 East Wisconsin Avenue, Milwaukee, WI 53202. |
(4) | Includes shares held directly by Trident IV, L.P. and an affiliated fund (the “Trident IV Funds”). Mr. Bolin is a principal of Stone Point Capital LLC, which serves as the investment manager of the Trident IV Funds. Mr. Bolin disclaims beneficial ownership of all such shares, except to the extent of any pecuniary interest therein. The principal address for the Trident IV Funds is c/o Walkers SPV Limited, at Walker House, 87 Mary Street, George Town, Grand Cayman KY1-9002, Cayman Islands. The principal address for Stone Point Capital LLC is 20 Horseneck Lane, Greenwich, Connecticut 06830. |
(5) | The address of Banc of America Capital Investors V, L.P. is 150 North College Street, Suite 2500, Charlotte, North Carolina, 28202. |
(6) | The address of each of Messrs. Francis, Adlerz, Mitchell and Kennedy and Ms. Sparks is 40 Burton Hills Boulevard, Suite 500, Nashville, Tennessee 37215. |
(7) | Includes options to purchase 587,683 shares which were exercisable as of March 25, 2011 or become exercisable within 60 days following March 25, 2011. |
(8) | Includes options to purchase 414,427 shares which were exercisable as of March 25, 2011 or become exercisable within 60 days following March 25, 2011. |
(9) | Represents options to purchase 50,628 shares which were exercisable as of March 25, 2011 or become exercisable within 60 days following March 25, 2011. |
(10) | Represents options to purchase 62,465 shares which were exercisable as of March 25, 2011 or become exercisable within 60 days following March 25, 2011. |
(11) | Represents options to purchase 48,923 shares which were exercisable as of March 25, 2011 or become exercisable within 60 days following March 25, 2011. |
(12) | The address of each of Messrs. Murphy, Delaney, Chu and Callen is 667 Madison Avenue, New York, New York 10021. |
(13) | Includes options to purchase 1,164,126 shares which were exercisable as of March 25, 2011 or become exercisable within 60 days following March 25, 2011. |
62
Equity Compensation Plan Information
The following table provides information as of December 31, 2010 with respect to compensation plans (including individual compensation arrangements) under which shares of the common stock of Holdings are authorized for issuance.
Plan category | Number of securities to be issued upon exercise of outstanding options, warrants and rights | Weighted-average exercise price of outstanding options, warrants and rights | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in second column) | |||||||
Equity compensation plans approved by security holders (1) | 3,372,586 | $ | 7.98 | 183,817 | ||||||
Equity compensation plans not approved by security holders | — | — | — | |||||||
Total | 3,372,586 | $ | 7.98 | 183,817 | ||||||
______________________________
(1) | Represents stock options granted or issuable under the Holdings 2007 Equity Incentive Plan. See additional disclosure at Item 8. “Financial Statements and Supplementary Data - Note 9. Stock Options”. |
Item 13. Certain Relationships and Related Transactions, and Director Independence
Financial Advisory Fees and Agreements
Holdings paid all fees and expenses of the Crestview Funds in connection with the Merger and the related financings. The aggregate amount of all fees payable to the Crestview funds and their affiliates in connection with the Merger and the related financing is approximately $6.3 million, plus out-of-pocket expenses. We have also agreed to pay an affiliate of the Crestview Funds an annual advisory fee of $1.0 million and will reimburse such affiliate for all related disbursements and out-of-pocket expenses pursuant to a management agreement. The agreement also provides that we will pay an affiliate of the Crestview Funds a fee in connection with certain subsequent financing, acquisition, disposition and change of control transactions based on a percentage of the gross transaction value of any such transaction. The management agreement includes customary exculpation and indemnification provisions in favor of the Crestview Funds and their affiliates.
Shareholders Agreement
Holdings, the Crestview Funds, the other co-investors and each of our management shareholders entered into a shareholders’ agreement at the closing of the Merger.
The shareholders agreement provides that Messrs. Francis and Adlerz have the right to be appointed as directors of Holdings (with Mr. Francis as chairman) so long as they are employed in their current positions. Stone Point, which is one of the co-investors, is able to appoint one of our directors and the Crestview Funds have the right to select all of the remaining members of the board of directors of Holdings. In addition, Holdings is required to obtain the consent of the Crestview Funds before taking certain significant actions.
The shareholders agreement restricts transfers of shares of Holdings common stock by the shareholders who are party to the agreement, except to permitted transferees and subject to various other exceptions, and also grants certain tag-along, drag-along and pre-emptive rights, as well as rights of first offer upon certain sales, to the shareholders. The agreement also grants Holdings the right to purchase equity from management shareholders upon their departure from the company at the lesser of fair market value and cost, if the shareholder has been terminated for cause, or at fair market value in other cases.
Finally, the agreement provides customary demand and piggy-back registration rights to the shareholders.
Policies and Procedures with Respect to Related Party Transactions
The charter of the Audit and Compliance Committee requires that the Audit and Compliance Committee approve any proposed related-party transactions and review with management any disclosure relating to related party transactions and potential conflicts of interest. “Related-party transactions” include, but are not limited to, those transactions described in Item 404(a) of Regulation S-K under the federal securities laws.
Director Independence
We do not have securities listed on a national securities exchange or in an automated inter-dealer quotation system of a national securities association and, as such, are not subject to the director independence requirements of such an exchange or association. In addition, based on the listing standards of The NASDAQ Stock Market, the national securities exchange upon which our common stock was traded prior to the Merger, we would be a “controlled company” within the meaning of Rule 5615(c)(1) of the Nasdaq listing rules because Crestview and its affiliates own a majority of the equity of Holdings, and Holdings owns all of our common stock. As a controlled company, we would qualify for exemptions from certain NASDAQ corporate governance rules, including the requirement that the board of directors be composed of a majority of independent directors.
63
Item 14. Principal Accountant Fees and Services
The following table presents fees for professional services rendered by Ernst & Young LLP for the audit of our annual financial statements for 2010 and 2009, and fees billed for other services rendered by Ernst & Young LLP for 2010 and 2009:
2010 | 2009 | ||||||
Audit Fees | $ | 885,559 | $ | 780,642 | |||
Audit-Related Fees | 1,500 | — | |||||
Tax Fees | 191,854 | 186,393 | |||||
Total | $ | 1,078,913 | $ | 967,035 | |||
Audit Fees. These fees were primarily for professional services rendered by Ernst & Young LLP in connection with the audit of our consolidated annual financial statements. The fees also include services related to Securities and Exchange Commission filings.
Audit-Related Fees. For 2010, these fees were for services rendered by Ernst & Young LLP related to a subscription to online accounting services.
Tax Fees. These fees were for services rendered by Ernst & Young LLP for compliance regarding tax filings and for other tax planning and tax advice services.
Pre-approval of Auditor Services
The charter of the Audit and Compliance Committee provides that the Audit and Compliance Committee must pre-approve all services to be provided by the independent auditors prior to the commencement of work. Unless the specific service has been pre-approved with respect to that year, the Audit and Compliance Committee must approve the permitted service before the independent auditors are engaged to perform it. For 2010, all services provided by Ernst & Young LLP were pre-approved by the Audit and Compliance Committee.
All non-audit services were reviewed with the Audit and Compliance Committee, which concluded that the provision of such services by Ernst & Young LLP was compatible with the maintenance of the accounting firm’s independence in the conduct of its auditing functions.
PART IV
Item 15. Exhibits and Financial Statement Schedules
(a) The following documents are filed as part of this report:
(1) Consolidated Financial Statements
The consolidated financial statements required to be included in Part II, Item 8. are indexed on Page F-1 and submitted as a separate section of this report.
(2) Consolidated Financial Statement Schedules
All schedules are omitted because they are not applicable or not required, or because the required information is included in the consolidated financial statements or notes in this report.
64
(3) Exhibits:
No. | Description | ||
2 | Agreement and Plan of Merger, dated as of April 24, 2007, by and among Symbol Acquisition, L.L.C., Symbol Merger Sub, Inc. and Symbion, Inc. (a) | ||
3.1 | Amended Certificate of Incorporation of Symbion, Inc. (b) | ||
3.2 | Amended and Restated Bylaws of Symbion, Inc. (b) | ||
4.1 | Indenture, dated as of June 3, 2008, among Symbion, Inc., the Guarantors named therein and U.S. Bank National Association, as Trustee (b) | ||
4.2 | Form of Notes (included in Exhibit 4.1) | ||
4.3 | Registration Rights Agreement, dated as of June 3, 2007, among Symbion, Inc., the subsidiaries of Symbion, Inc. party thereto as guarantors, and Merrill, Lynch, Pierce, Fenner & Smith Incorporated, Banc of America Securities LLC and Greenwich Capital Markets, Inc. (b) | ||
4.4 | First Supplemental Indenture, dated as of September 18, 2008 among Symbion, Inc., the Guarantors named therein and U.S. Bank National Association, as Trustee (b) | ||
10.1 | Employment Agreement, dated August 23, 2007, between Symbion, Inc. and Richard E. Francis, Jr. (b) (g) | ||
10.2 | Employment Agreement, dated August 23, 2007, between Symbion, Inc. and Clifford G. Adlerz (b) (g) | ||
10.3 | Credit Agreement, dated as of August 23, 2007, among Symbol Holdings Corporation, Symbol Merger Sub, Inc., the Lenders party thereto from time to time, Merrill Lynch Capital Corporation as Administrative Agent and Collateral Agent, Bank of America, N.A. as Syndication Agent, The Royal Bank of Scotland PLC and Fifth Third Bank as Co-Documentation Agents, and Merrill Lynch & Co., Merrill, Lynch, Pierce, Fenner & Smith Incorporated and Banc of America Securities LLC as Joint Lead Arrangers and Joint Lead Bookrunners (c) | ||
10.4 | Lease Agreement, dated June 26, 2001, between Burton Hills IV Partners and Symbion, Inc. (d) | ||
10.5 | First Amendment to Lease Agreement, dated February 9, 2004, between Burton Hills IV Partners and Symbion, Inc. (e) | ||
10.6 | Symbion Holdings Corporation 2007 Equity Incentive Plan (b) (g) | ||
10.7 | Symbion, Inc. Executive Change in Control Severance Plan (b) (g) | ||
10.8 | Symbion Holdings Corporation Compensatory Equity Participation Plan (b) (g) | ||
10.9 | Shareholders Agreement, dated as of August 23, 2007, among Symbion Holdings Corporation and the stockholders of Symbion Holdings Corporation and other persons named therein (b) | ||
10.10 | Advisory Services and Monitoring Agreement, dated as of August 23, 2007, among Symbion, Inc., Symbion Holdings Corporation and Crestview Advisors, L.L.C. (b) | ||
10.11 | Form of Employee Contribution Agreement (b) | ||
10.12 | Symbion, Inc. Supplemental Executive Retirement Plan (f) (g) | ||
10.13 | Management Rights Purchase Agreement, dated as of July 27, 2005, by and among Parthenon Management Partners, LLC, Andrew A. Brooks, M.D., Randhir S. Tuli and SymbionARC Management Services, Inc. (c) | ||
10.14 | Interest Rate Swap Agreement, dated October 31, 2007, between Symbion, Inc and Merrill Lynch Capital Services, Inc. (c) | ||
10.15 | Interest Rate Swap Agreement, dated November 2, 2010, between Symbion, Inc. and Goldman Sachs Bank, USA | ||
21 | Subsidiaries of Registrant | ||
31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||
31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||
32.1 | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||
32.2 | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
_____________________________________________
(a) | Incorporated by reference to exhibits filed with the Registrant’s Current Report on Form 8-K filed April 24, 2007 (File No. 000-50574) |
(b) | Incorporated by reference to exhibits filed with the Registrant’s Registration Statement on Form S-4 (Registration No. 333-153678) |
(c) | Incorporated by reference to exhibits filed with the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2008, as amended (File No. 000-50574) |
(d) | Incorporated by reference to exhibits filed with the Registrant’s Registration Statement on Form S-1 (Registration No. 333-89554) |
(e) | Incorporated by reference to exhibits filed with the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2003 (File No. 000-50574) |
(f) | Incorporated by reference to exhibits filed with the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2005 (File No. 000-50574) |
(g) | Compensation plan or arrangement |
65
Index to Financials
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors
Symbion, Inc.
We have audited the accompanying consolidated balance sheets of Symbion, Inc. as of December 31, 2010 and 2009 and the related consolidated statements of operations, stockholders' equity and cash flows for each of the three years in the period ended December 31, 2010. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company's internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Symbion, Inc. at December 31, 2010 and 2009, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2010, in conformity with U.S. generally accepted accounting principles.
/s/ Ernst & Young LLP |
Nashville, Tennessee
March 25, 2011
F-2
SYMBION, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
December 31, 2010 | December 31, 2009 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 73,458 | $ | 47,749 | |||
Accounts receivable, less allowance for doubtful accounts of $10,051 and $8,980, respectively | 61,825 | 34,991 | |||||
Inventories | 10,798 | 9,361 | |||||
Prepaid expenses and other current assets | 8,634 | 12,292 | |||||
Deferred tax asset | 2 | 432 | |||||
Current assets of discontinued operations | 1,003 | 2,934 | |||||
Total current assets | 155,720 | 107,759 | |||||
Land | 5,713 | 2,938 | |||||
Buildings and improvements | 102,795 | 52,487 | |||||
Furniture and equipment | 70,129 | 53,151 | |||||
Computers and software | 4,757 | 3,785 | |||||
183,394 | 112,361 | ||||||
Less accumulated depreciation | (42,762 | ) | (24,505 | ) | |||
Property and equipment, net | 140,632 | 87,856 | |||||
Intangible assets | 21,817 | 19,480 | |||||
Goodwill | 624,737 | 545,238 | |||||
Investments in and advances to affiliates | 17,824 | 17,652 | |||||
Other assets | 9,633 | 10,660 | |||||
Long-term assets of discontinued operations | 34 | 2,081 | |||||
Total assets | $ | 970,397 | $ | 790,726 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 12,396 | $ | 7,518 | |||
Accrued payroll and benefits | 10,090 | 5,806 | |||||
Other accrued expenses | 25,814 | 30,927 | |||||
Current maturities of long-term debt | 29,195 | 20,118 | |||||
Current liabilities of discontinued operations | 923 | 2,608 | |||||
Total current liabilities | 78,418 | 66,977 | |||||
Long-term debt, less current maturities | 507,417 | 444,758 | |||||
Deferred income tax payable | 51,309 | 40,776 | |||||
Other liabilities | 68,950 | 5,887 | |||||
Long-term liabilities of discontinued operations | 22 | 3,868 | |||||
Noncontrolling interests — redeemable | 36,030 | 31,650 | |||||
Stockholders’ equity: | |||||||
Common stock, 1,000 shares, $0.01 par value, authorized, issued and outstanding at December 31, 2010 and December 31, 2009 | — | — | |||||
Additional paid-in-capital | 240,959 | 242,623 | |||||
Accumulated other comprehensive loss | (314 | ) | (2,731 | ) | |||
Retained deficit | (55,219 | ) | (46,479 | ) | |||
Total Symbion, Inc. stockholders’ equity | 185,426 | 193,413 | |||||
Noncontrolling interests — non-redeemable | 42,825 | 3,397 | |||||
Total equity | 228,251 | 196,810 | |||||
Total liabilities and stockholders’ equity | $ | 970,397 | $ | 790,726 | |||
See Notes to Consolidated Financial Statements.
F-3
SYMBION, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands)
Year Ended December 31, 2010 | Year Ended December 31, 2009 | Year Ended December 31, 2008 | |||||||||
Revenues | $ | 406,050 | $ | 336,944 | $ | 321,484 | |||||
Operating expenses: | |||||||||||
Salaries and benefits | 113,595 | 94,737 | 88,476 | ||||||||
Supplies | 92,859 | 71,650 | 64,263 | ||||||||
Professional and medical fees | 29,072 | 21,974 | 17,557 | ||||||||
Rent and lease expense | 24,549 | 24,447 | 20,927 | ||||||||
Other operating expenses | 30,070 | 26,595 | 24,649 | ||||||||
Cost of revenues | 290,145 | 239,403 | 215,872 | ||||||||
General and administrative expense | 22,464 | 21,448 | 23,923 | ||||||||
Depreciation and amortization | 18,900 | 16,807 | 14,845 | ||||||||
Provision for doubtful accounts | 6,638 | 2,881 | 3,559 | ||||||||
Income on equity investments | (2,901 | ) | (2,318 | ) | (1,504 | ) | |||||
Impairment and loss on disposal of long-lived assets | 1,053 | 3,505 | 1,872 | ||||||||
Gain on sale of long-lived assets and other gains | (1,964 | ) | (248 | ) | (975 | ) | |||||
Proceeds from insurance settlements, net | — | (430 | ) | — | |||||||
Litigation settlements, net | (35 | ) | — | 893 | |||||||
Business combination remeasurement gains | (3,169 | ) | — | — | |||||||
Total operating expenses | 331,131 | 281,048 | 258,485 | ||||||||
Operating income | 74,919 | 55,896 | 62,999 | ||||||||
Interest expense, net | (48,037 | ) | (44,958 | ) | (43,415 | ) | |||||
Income before income taxes and discontinued operations | 26,882 | 10,938 | 19,584 | ||||||||
Provision for income taxes | 7,787 | 7,762 | 13,464 | ||||||||
Income from continuing operations | 19,095 | 3,176 | 6,120 | ||||||||
Loss from discontinued operations, net of taxes | (964 | ) | (5,899 | ) | (3,097 | ) | |||||
Net income (loss) | 18,131 | (2,723 | ) | 3,023 | |||||||
Less: Net income attributable to noncontrolling interests | (26,871 | ) | (19,731 | ) | (23,821 | ) | |||||
Net loss attributable to Symbion, Inc. | $ | (8,740 | ) | $ | (22,454 | ) | $ | (20,798 | ) | ||
See Notes to Consolidated Financial Statements.
F-4
SYMBION, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except share amounts)
Symbion, Inc. Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income (Loss) | Retained Earnings (Deficit) | Noncontrolling Interests-Non-redeemable | Total Shareholders’ Equity | |||||||||||||||||||||
Shares | Amount | |||||||||||||||||||||||||
Balance at December 31, 2007 | 1,000 | $ | — | $ | 238,701 | $ | (2,188 | ) | $ | (3,227 | ) | $ | 5,194 | $ | 238,480 | |||||||||||
Amortized compensation expense related to stock options | — | — | 2,114 | — | — | — | 2,114 | |||||||||||||||||||
Unrealized loss on interest rate swap, net of taxes | — | — | — | (3,396 | ) | — | — | (3,396 | ) | |||||||||||||||||
Distributions to noncontrolling interest holders | — | — | — | — | — | (3,555 | ) | (3,555 | ) | |||||||||||||||||
Acquisitions and disposal of shares of noncontrolling interests | — | — | — | — | — | (356 | ) | (356 | ) | |||||||||||||||||
Other | — | — | — | — | — | 183 | 183 | |||||||||||||||||||
Net loss | — | — | — | — | (20,798 | ) | 4,256 | (16,542 | ) | |||||||||||||||||
Balance at December 31, 2008 | 1,000 | $ | — | $ | 240,815 | $ | (5,584 | ) | $ | (24,025 | ) | $ | 5,722 | $ | 216,928 | |||||||||||
Amortized compensation expense related to stock options | — | — | 1,297 | — | — | — | 1,297 | |||||||||||||||||||
Recognition of interest rate swap liability to earnings, net of taxes | — | — | — | 2,853 | — | — | 2,853 | |||||||||||||||||||
Distributions to noncontrolling interest holders | — | — | — | — | — | (2,966 | ) | (2,966 | ) | |||||||||||||||||
Acquisitions and disposal of shares of noncontrolling interests | — | — | 511 | — | — | 220 | 731 | |||||||||||||||||||
Net loss | — | — | — | — | (22,454 | ) | 421 | (22,033 | ) | |||||||||||||||||
Balance at December 31, 2009 | 1,000 | $ | — | $ | 242,623 | $ | (2,731 | ) | $ | (46,479 | ) | $ | 3,397 | $ | 196,810 | |||||||||||
Amortized compensation expense related to stock options | — | — | 1,336 | — | — | — | 1,336 | |||||||||||||||||||
Recognition of interest rate swap liability to earnings, net of taxes | — | — | — | 2,731 | — | — | 2,731 | |||||||||||||||||||
Distributions to noncontrolling interest holders | — | — | — | — | — | (6,745 | ) | (6,745 | ) | |||||||||||||||||
Acquisitions and disposal of shares of noncontrolling interests | — | — | (3,000 | ) | — | — | 39,722 | 36,722 | ||||||||||||||||||
Unrealized loss on interest rate swap, net of taxes | — | — | — | (314 | ) | — | — | (314 | ) | |||||||||||||||||
Net loss | — | — | — | — | (8,740 | ) | 6,451 | (2,289 | ) | |||||||||||||||||
Balance at December 31, 2010 | 1,000 | $ | — | $ | 240,959 | $ | (314 | ) | $ | (55,219 | ) | $ | 42,825 | $ | 228,251 | |||||||||||
See Notes to Consolidated Financial Statements.
F-5
SYMBION, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Year Ended December 31, 2010 | Year Ended December 31, 2009 | Year Ended December 31, 2008 | |||||||||
Cash flows from operating activities: | |||||||||||
Net income (loss) | $ | 18,131 | $ | (2,723 | ) | $ | 3,023 | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||||||
Loss from discontinued operations | 964 | 5,899 | 3,097 | ||||||||
Depreciation and amortization | 18,900 | 16,807 | 14,845 | ||||||||
Amortization of deferred financing costs | 2,004 | 2,004 | 4,477 | ||||||||
Non-cash payment-in-kind interest option | 26,079 | 23,263 | 17,616 | ||||||||
Non-cash stock option compensation expense | 1,336 | 1,297 | 2,114 | ||||||||
Non–cash recognition of other comprehensive loss into earnings | 2,732 | 2,853 | — | ||||||||
Non–cash credit risk adjustment of financial instruments | 189 | 1,629 | — | ||||||||
Non–cash (gains) losses | (4,080 | ) | 2,827 | 897 | |||||||
Deferred income taxes | 10,979 | 8,682 | 13,718 | ||||||||
Equity in earnings of unconsolidated affiliates, net of distributions received | 50 | (207 | ) | 333 | |||||||
Provision for doubtful accounts | 6,638 | 2,881 | 3,559 | ||||||||
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions: | |||||||||||
Accounts receivable | (14,886 | ) | (4,383 | ) | (3,278 | ) | |||||
Income taxes payable | 2,298 | 1,762 | 1,895 | ||||||||
Other assets and liabilities | (2,565 | ) | (2,307 | ) | (1,363 | ) | |||||
Net cash provided by operating activities — continuing operations | 68,769 | 60,284 | 60,933 | ||||||||
Net cash (used in) provided by operating activities — discontinued operations | (550 | ) | 62 | 1,736 | |||||||
Net cash provided by operating activities | 68,219 | 60,346 | 62,669 | ||||||||
Cash flows from investing activities: | |||||||||||
Payments for acquisitions, net of cash acquired | (44,105 | ) | (126 | ) | (15,695 | ) | |||||
Purchases of property and equipment, net | (8,712 | ) | (9,604 | ) | (15,709 | ) | |||||
Payments from unit activity of unconsolidated facilities | (55 | ) | (724 | ) | — | ||||||
Change in other assets | (278 | ) | (690 | ) | (1,517 | ) | |||||
Net cash used in investing activities — continuing operations | (53,150 | ) | (11,144 | ) | (32,921 | ) | |||||
Net cash used in investing activities — discontinued operations | (19 | ) | (301 | ) | (286 | ) | |||||
Net cash used in investing activities | (53,169 | ) | (11,445 | ) | (33,207 | ) | |||||
Cash flows from financing activities: | |||||||||||
Principal payments on long-term debt | (22,502 | ) | (13,649 | ) | (18,579 | ) | |||||
Repayment of bridge facility | — | — | (179,937 | ) | |||||||
Proceeds from debt issuances | 56,975 | 678 | 13,491 | ||||||||
Proceeds from issuance of Toggle Notes | — | — | 179,937 | ||||||||
Payment of debt issuance costs | — | (203 | ) | (4,739 | ) | ||||||
Distributions to noncontrolling interests | (26,292 | ) | (24,971 | ) | (23,423 | ) | |||||
Proceeds from unit activity of consolidated facilities | 4,708 | 307 | 219 | ||||||||
Other financing activities | (3,306 | ) | (4,940 | ) | 1,313 | ||||||
Net cash provided by (used in) financing activities — continuing operations | 9,583 | (42,778 | ) | (31,718 | ) | ||||||
Net cash provided by (used in) financing activities — discontinued operations | 1,076 | (108 | ) | (106 | ) | ||||||
Net cash provided by (used in) financing activities | 10,659 | (42,886 | ) | (31,824 | ) | ||||||
Net increase (decrease) in cash and cash equivalents | 25,709 | 6,015 | (2,362 | ) | |||||||
Cash and cash equivalents at beginning of period | 47,749 | 41,734 | 44,096 | ||||||||
Cash and cash equivalents at end of period | $ | 73,458 | $ | 47,749 | $ | 41,734 | |||||
See Notes to Consolidated Financial Statements.
F-6
SYMBION, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2010
1. Organization
Symbion, Inc. (the “Company”), through its wholly owned subsidiaries, owns interests in partnerships and limited liability companies that own and operate a national network of short stay surgical facilities in joint ownership with physicians and physician groups, hospitals and hospital systems. As of December 31, 2010, the Company owned and operated 54 surgical facilities, including 49 ambulatory surgery centers and four surgical hospitals, and one general acute care hospital with a surgical and obstetrics focus. The Company also managed eight additional ambulatory surgery centers and one physician network. The Company owns a majority ownership interest in 29 of the 54 surgical facilities and consolidates 49 of these surgical facilities for financial reporting purposes.
On August 23, 2007, the Company was acquired by an investment group led by an affiliate of Crestview Partners, L.P. (“Crestview”). As a result of this merger (the “Merger”), the Company no longer has publicly traded equity securities. The Company is a wholly owned subsidiary of Symbion Holdings Corporation (“Holdings”), which is owned by an investor group that includes affiliates of Crestview, members of the Company’s management and other investors.
2. Significant Accounting Policies and Practices
Basis of Presentation and Use of Estimates
The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and accompanying footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All adjustments are of a normal, recurring nature. Actual results could differ from those estimates.
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate’s business. The physician limited partners and physician minority members of the entities that the Company controls are responsible for the supervision and delivery of medical services. The governance rights of limited partners and minority members are restricted to those that protect their financial interests. Under certain partnership and operating agreements governing these partnerships and limited liability companies, the Company could be removed as the sole general partner or managing member for certain events such as material breach of the partnership or operating agreement, gross negligence or bankruptcy. These protective rights do not preclude consolidation of the respective partnerships and limited liability companies. The consolidated financial statements include the accounts of variable interest entities in which the Company is the primary beneficiary, under the provisions of ASC Topic 810, Consolidation. The variable interest entities are surgical facilities located in the states of Florida and New York. With regard to the New York facility, the Company is the primary beneficiary due to the level of variability within the management service agreement, as well as the obligation and likelihood of absorbing the majority of expected gains and losses. Regarding the Florida facility, the Company has fully guaranteed the facility's debt obligations. The debt obligations are subordinated to such a level that the Company absorbs the majority of the expected gains and losses. The accompanying consolidated balance sheets as of December 31, 2010 and December 31, 2009 include assets of $15.3 million and $14.5 million, respectively, and liabilities of $4.1 million and $4.4 million, respectively, related to the variable interest entities. All significant intercompany balances and transactions are eliminated in consolidation.
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level 1), or inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the accompanying consolidated balance sheets for cash, accounts receivable and accounts payable approximate fair value because of their short-term nature.
F-7
The carrying amount and fair value of the Company’s term loans and revolving facility under its senior secured credit facility and the Toggle Notes as of December 31, 2010 and 2009 were as follows (in thousands):
Carrying Amount December 31, | Fair Value December 31, | ||||||||||||||
2010 | 2009 | 2010 | 2009 | ||||||||||||
Tranche A, term loan | $ | 106,062 | $ | 115,438 | $ | 101,732 | $ | 103,120 | |||||||
Tranche B, term loan | 115,438 | 116,687 | 110,724 | 104,237 | |||||||||||
Revolving facility | 56,000 | — | 53,715 | — | |||||||||||
Senior PIK Toggle Notes | 232,000 | 206,976 | 198,662 | 156,260 | |||||||||||
The fair value of the term loans and revolving facility under the Company's senior secured credit facility and the Toggle Notes were based on quoted prices at December 31, 2010 and 2009. The Company’s long-term debt instruments are discussed further in Note 7.
The Company determines the fair value of its interest rate swap based on the amount at which it could be settled, which is considered to be the exit price. This price is based upon observable market assumptions and appropriate valuation adjustments for credit risk. The Company has categorized its interest rate swap as a Level 2 financial instrument. See Note 7 for further discussion regarding the interest rate swap.
Cash and Cash Equivalents
The Company considers all highly liquid investments with maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.
Accounts Receivable
Accounts receivable consist of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. The Company recognizes that revenues and receivables from government agencies are significant to its operations, but it does not believe that there are significant credit risks associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. Accounts receivable are recorded net of contractual adjustments and allowances for doubtful accounts to reflect accounts receivable at net realizable value. Also, the Company has amounts recorded in other liabilities for third-party settlements of $12.0 million and $0 as of December 31, 2010 and 2009, respectively. The Company does not require collateral for private pay patients. Accounts receivable at December 31, 2010 and December 31, 2009 were as follows (in thousands):
December 31, | |||||||
2010 | 2009 | ||||||
Surgical facilities | $ | 61,211 | $ | 34,394 | |||
Physician networks | 614 | 597 | |||||
Total | $ | 61,825 | $ | 34,991 | |||
The following table sets forth by type of payor the percentage of the Company’s accounts receivable for consolidated surgical facilities as of December 31, 2010 and December 31, 2009:
December 31, | |||||
2010 | 2009 | ||||
Private insurance | 58 | % | 59 | % | |
Government | 18 | 15 | |||
Self-pay | 8 | 13 | |||
Other | 16 | 13 | |||
Total | 100 | % | 100 | % | |
Allowance for Doubtful Accounts
The Company’s policy is to review the standard aging schedule, by surgical facility, to determine the appropriate allowance for doubtful accounts. Patient account balances are reviewed for delinquency based on contractual terms. This review is supported by an analysis of the actual net revenues, contractual adjustments and cash collections received. If the Company’s internal collection efforts are unsuccessful, the Company manually reviews the patient accounts. An account is written off only after the Company has pursued collection with legal or collection agency assistance or otherwise deemed an account to be uncollectible.
F-8
Changes in the allowance for doubtful accounts and the amounts charged to revenues, costs and expenses were as follows (in thousands):
Allowance Balance at Beginning of Period | Charged to Revenues, Costs and Expenses | Other | Allowance Balance at End of Period | ||||||||||||
Year ended December 31: | |||||||||||||||
2008 | $ | 17,144 | $ | 3,559 | $ | (6,720 | ) | $ | 13,983 | ||||||
2009 | 13,983 | 2,881 | (7,884 | ) | 8,980 | ||||||||||
2010 | 8,980 | 6,638 | (5,567 | ) | 10,051 | ||||||||||
Inventories
Inventories, which consist primarily of medical and drug supplies, are stated at the lower of cost or market value. Cost is determined using the first-in, first-out method.
Prepaid and Other Current Assets
A summary of prepaid and other current assets is as follows (in thousands):
2010 | 2009 | ||||||
Prepaid expenses | $ | 5,034 | $ | 4,900 | |||
Other receivables | 3,600 | 7,392 | |||||
$ | 8,634 | $ | 12,292 | ||||
Property and Equipment
Property and equipment are stated at cost, or if obtained through acquisition, at fair value determined on the date of acquisition and depreciated on a straight-line basis over the useful lives of the assets, generally three to five years for computers and software and five to seven years for furniture and equipment. Leasehold improvements are depreciated on a straight-line basis over the shorter of the lease term or the estimated useful life of the assets. Routine maintenance and repairs are charged to expenses as incurred, while expenditures that increase capacities or extend useful lives are capitalized.
Depreciation expense, including the amortization of assets under capital leases, was $18.9 million, $16.8 million and $14.8 million for the periods ended December 31, 2010, 2009 and 2008, respectively.
Impairment of Long-Lived Assets
When events or circumstances indicate that the carrying value of certain property and equipment might be impaired, the Company prepares an expected undiscounted cash flow projection. If the projection indicates that the recorded amounts of the property and equipment are not expected to be recovered, these amounts are reduced to estimated fair value. The cash flow estimates and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. In 2010, the Company recorded an impairment of $897,000 related to its equity method investment located in Gresham, Oregon. In 2009, the Company recorded an impairment charge of $2.4 million related to its equity method investment located in Arcadia, California. These impairment charges are included in the impairment and loss on disposal of long-lived assets.
Goodwill and Other Intangible Assets
Goodwill
Goodwill represents the excess of purchase price over the fair value of net tangible and identifiable intangible assets acquired. The Company tests for impairment annually as of December 31, or more frequently if certain indicators are encountered. See Note 5 for further discussion of our goodwill impairment valuation.
Other Intangible Assets
The Company recorded intangible assets of $19.5 million as a result of the purchase price allocation related to the certificates of need for certain of its facilities. These indefinite-lived assets are not amortized. Effective November 15, 2010, the Company acquired an oncology practice, which is operated within the Company's existing facility located in Idaho Falls, Idaho. As a result of this acquisition, the Company recorded intangible assets related to a non-compete agreement of $2.3 million. This intangible asset will be amortized over a five year term. All of the Company's intangible assets are assessed for possible impairment under the Company's impairment policy, as described in Note 5.
Unfavorable leasehold rights arising from the Merger were $869,000. Amortization of $83,468 was recorded in both 2010 and
F-9
2009. The unamortized balance at December 31, 2010 totaled $591,229. The unfavorable leasehold rights are amortized on a straight-line basis over the life of the applicable lease and reflected as a component of cost of revenues from continuing operations. Scheduled amortization expense for the five years ending December 31, 2011 to 2015 is $83,468 per year.
Noncontrolling Interests
The consolidated financial statements include all assets, liabilities, revenues and expenses of surgical facilities in which the Company has sufficient ownership and rights to allow the Company to consolidate the surgical facilities. Similar to its investments in unconsolidated affiliates, the Company regularly engages in the purchase and sale of equity interests with respect to its consolidated subsidiaries that do not result in a change of control. These transactions are accounted for as equity transactions, as they are undertaken among the Company, its consolidated subsidiaries, and noncontrolling interests, and their cash flow effect is classified within financing activities.
Investments in and Advances to Affiliates
As of December 31, 2010 and 2009, the Company held interests in six and eight surgical facilities, respectively, in which it exercised significant influence. However, the Company does not consolidate these facilities because of a lack of control. The Company accounts for such investments under the equity method. As of both December 31, 2010 and 2009, the Company owned less than 20% of two and three of these surgical facilities, respectively, but exerted significant influence through board of director representation, as well as an agreement to manage the surgical facilities.
Other Assets
Other assets at December 31, 2010 and 2009 included approximately $7.5 million and $9.5 million, respectively, related to deferred financing costs. Deferred financing costs primarily relate to the Company’s senior secured credit facility and the issuance of the Toggle Notes. Deferred financing costs consist of prepaid interest, loan fees and other costs of financing that are amortized over the term of the related financing agreements. The deferred financing costs are amortized as interest expense on the accompanying consolidated statements of operations.
Other Accrued Expenses
A summary of other accrued expenses is as follows (in thousands):
2010 | 2009 | ||||||
Interest payable | $ | 9,865 | $ | 9,945 | |||
Current taxes payable | 6,344 | 5,444 | |||||
Insurance liabilities | 1,540 | 2,651 | |||||
Interest rate swap liability | — | 5,045 | |||||
Other accrued expenses | 8,065 | 7,842 | |||||
$ | 25,814 | $ | 30,927 | ||||
Comprehensive Income
The Company reports other comprehensive income as a measure of changes in stockholders’ equity that results from recognized transactions. The Company entered into an interest rate swap agreement on November 2, 2010. The value of the interest rate swap was recorded as a long term liability of $314,000 at December 31, 2010. The change in the fair value of the interest rate swap was recorded to comprehensive income, net of taxes, in the accompanying consolidated statements of stockholders equity. Comprehensive loss was $314,000, $2.7 million, and $5.6 million, for the years ended December 31, 2010, 2009 and 2008, respectively.
Revenues
Revenues by service type consist of the following for the periods indicated (in thousands):
Year Ended December 31, | |||||||||||
2010 | 2009 | 2008 | |||||||||
Patient service revenues | $ | 393,823 | $ | 322,786 | $ | 305,453 | |||||
Physician service revenues | 5,800 | 6,464 | 6,548 | ||||||||
Other service revenues | 6,427 | 7,694 | 9,483 | ||||||||
Total revenues | $ | 406,050 | $ | 336,944 | $ | 321,484 | |||||
Patient Service Revenues
Approximately 97% of the Company’s revenues are patient service revenues. Patient service revenues are revenues from healthcare procedures performed in each of the facilities that the Company consolidates for financial reporting purposes. The fee charged varies
F-10
depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, supplies, nursing staff and medications. Also, in a very limited number of surgical facilities, the Company charges for anesthesia services. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. Patient service revenues are recognized on the date of service, net of estimated contractual adjustments and discounts for third-party payors, including Medicare and Medicaid. Changes in estimated contractual adjustments and discounts are recorded in the period of change.
Physician Service Revenues
Physician service revenues are revenues from physician networks consisting of reimbursed expenses, plus participation in the excess of revenue over expenses of the physician networks, as provided for in the Company’s service agreements with the Company’s physician networks. Reimbursed expenses include the costs of personnel, supplies and other expenses incurred to provide the management services to the physician networks. The Company recognizes physician service revenues in the period in which reimbursable expenses are incurred and in the period in which the Company has the right to receive a percentage of the amount by which a physician network’s revenues exceed its expenses. Physician service revenues are based on net billings with any changes in estimated contractual adjustments reflected in service revenues in the subsequent period.
Physician service revenues consist of the following for the periods indicated (in thousands):
Year Ended December 31, | |||||||||||
2010 | 2009 | 2008 | |||||||||
Professional services revenues | $ | 17,948 | $ | 18,736 | $ | 18,623 | |||||
Contractual adjustments | (9,183 | ) | (9,414 | ) | (9,294 | ) | |||||
Clinic revenue | 8,765 | 9,322 | 9,329 | ||||||||
Medical group retainage | (2,965 | ) | (2,858 | ) | (2,781 | ) | |||||
Physician service revenues | $ | 5,800 | $ | 6,464 | $ | 6,548 | |||||
Other Service Revenues
Other service revenues consists of management and administrative service fees derived from the non-consolidated surgical facilities that the Company accounts for under the equity method, management of surgical facilities in which the Company does not own an interest and management services the Company provides to physician networks for which the Company is not required to provide capital or additional assets. The fees the Company derives from these management arrangements are based on a pre-determined percentage of the revenues of each surgical facility and physician network. The Company recognizes other service revenues in the period in which services are rendered.
The following table sets forth by type of payor the percentage of the Company’s patient service revenues generated for the periods indicated:
Year Ended December 31, | ||||||||
2010 | 2009 | 2008 | ||||||
Private Insurance | 69 | % | 71 | % | 72 | % | ||
Government | 25 | 24 | 22 | |||||
Self-pay | 4 | 4 | 4 | |||||
Other | 2 | 1 | 2 | |||||
Total | 100 | % | 100 | % | 100 | % | ||
Supplemental Cash Flow Information
The Company made cash income tax payments of $474,000, $288,000 and $409,000 for the years ended December 31, 2010, 2009 and 2008, respectively. The Company made cash interest payments of $22.9 million, $18.2 million and $33.8 million for the years ended December 31, 2010, 2009 and 2008 respectively. The Company made non-cash, in kind interest payments on its Toggle Notes of $26.1 million, $23.3 million and $17.6 million as of December 31, 2010, 2009 and 2008, respectively. The Company entered into capital leases for $516,000, $408,000 and $1.9 million of equipment for the years ended December 31, 2010, 2009 and 2008, respectively.
Recently Issued and Adopted Accounting Guidelines
Adopted
In June 2009, the FASB issued changes to the accounting for variable interest entities. These changes require an enterprise: (i) to perform an analysis to determine whether the enterprise’s variable interest or interests give it a controlling financial interest in a variable interest entity; (ii) to require ongoing reassessments of whether an enterprise is the primary beneficiary of a variable interest entity; (iii) to eliminate the quantitative approach previously required for determining the primary beneficiary of a variable interest entity; (iv) to add an additional reconsideration event for determining whether an entity is a variable interest entity when any changes in facts and circumstances
F-11
occur such that holders of the equity investment at risk, as a group, lose the power from voting rights or similar rights of those investments to direct the activities of the entity that most significantly impact the entity’s economic performance; and (v) to require enhanced disclosures that will provide users of financial statements with more transparent information about an enterprise’s involvement in a variable interest entity. These changes became effective for the Company on January 1, 2010. The adoption of this standard did not have a material impact on the Company's consolidated results of operations or financial condition.
Issued
In August 2010, the FASB issued ASU No. 2010-24, “Health Care Entities” (Topic 954): Presentation of Insurance Claims and Related Insurance Recoveries. This ASU eliminates the practice of netting claim liabilities with expected related insurance recoveries for balance sheet presentation. Claim liabilities are to be determined with no regard for recoveries and presented on the balance sheet on a gross basis. Expected insurance recoveries are presented separately. ASU 2010-24 is effective January 1, 2011, and is not expected to impact the Company's results of operations or cash flows.
Reclassifications
Certain reclassifications have been made to the comparative periods’ financial statements to conform to the 2010 presentation. The reclassifications primarily related to the presentation of discontinued operations and had no impact on the Company’s financial position or results of operations.
3. Acquisitions and Equity Method Investments
On April 9, 2010, the Company completed the acquisition of a 54.5% ownership interest in a 43-bed general acute care hospital with a surgical and obstetrics focus located in Idaho Falls, Idaho. The purchase price for the acquisition was $31.9 million, plus existing third-party indebtedness of $6.1 million and other obligations of $48.0 million, which are consolidated on the Company's balance sheet.
On July 1, 2010, the Company acquired an incremental, controlling ownership interest of 37.0% in one of its surgical facilities located in Chesterfield, Missouri for $18.8 million and began consolidating the facility for financial reporting purposes. Prior to the acquisition date, the Company owned a 13.0% interest in this facility which was accounted for as an equity method investment. The acquisition date fair value of the existing equity interest was $16.3 million and is included in the measurement of the consideration transferred for purposes of allocating the purchase price. The fair value was determined using comparable market multiples. The Company recognized a gain of $3.2 million as a result of remeasuring its existing equity interest in the facility prior to the purchase of the incremental interest. The gain is presented separately as “Business combination remeasurement gains” on the consolidated statement of operations.
The Company has accounted for these acquisitions under the purchase method of accounting. Under the purchase method of accounting, the total purchase price is allocated to the net tangible and intangible assets acquired and liabilities assumed in connection with the acquisition based on their estimated fair values. The preliminary allocation of the purchase price was based upon management's preliminary valuation of the fair value of tangible and intangible assets acquired and liabilities assumed, and such valuation is subject to change.
F-12
The following table summarizes the allocation of the aggregate purchase price of the acquisitions recorded using the purchase method of accounting for the year ended December 31, 2010 (in thousands):
December 31, 2010 | |||
Cash consideration | $ | 50,709 | |
Working capital true-up in escrow | (601 | ) | |
Fair value of the noncontrolling interests | 40,207 | ||
Total consideration | 90,315 | ||
Net assets acquired | |||
Cash | 6,278 | ||
Accounts receivable | 18,649 | ||
Inventories | 1,316 | ||
Prepaid expenses and other current assets | 724 | ||
Property and equipment | 61,410 | ||
Other assets | 557 | ||
Accounts payable | (3,172 | ) | |
Accrued payroll and benefits | (2,425 | ) | |
Other accrued expenses | (667 | ) | |
Current portion of long-term debt | (1,829 | ) | |
Long-term debt, less current maturities | (10,517 | ) | |
Other liabilities (a) | (61,292 | ) | |
Net assets acquired | 9,032 | ||
Excess of purchase price over identifiable net assets acquired | $ | 81,283 | |
(a) | Other liabilities include $48.0 million to record the financing obligation payable to the hospital facility lessor relating to the land, building and improvements. |
Following are the results for the year ended December 31, 2010 and December 31, 2009 as if the acquisitions had occurred on January 1, of the respective periods (in thousands):
Year Ended December 31, 2010 | Year Ended December 31, 2009 | Year Ended December 31, 2008 | |||||||||
Revenues | $ | 432,322 | $ | 413,431 | $ | 403,197 | |||||
Net (loss) income | 22,468 | 8,269 | 4,783 | ||||||||
Net loss attributable to Symbion, Inc | $ | (6,468 | ) | $ | (17,199 | ) | $ | (19,154 | ) | ||
Effective May 1, 2009, the Company acquired a 47.0% ownership interest in a surgical hospital in Austin, Texas for $350,000 plus the assumption of $2.6 million of debt. The acquisition was financed with cash from operations. The Company, as general partner, has the ability to direct the financial affairs of the facility, and as such, this facility is consolidated for financial reporting purposes.
Effective February 21, 2008, the Company acquired ownership in five surgical facilities specializing in spine, orthopedic and pain management procedures located in Boulder, Colorado; Honolulu, Hawaii; Bristol and Nashville, Tennessee; and Seattle, Washington for an aggregate of $5.8 million and the assumption of $4.7 million of debt. The Company acquired an ownership ranging from 20.0% to 50.0% in these surgical facilities. Four of these facilities are consolidated for financial reporting purposes.
These acquisitions were accounted for under the purchase method of accounting, and accordingly, the results of operations of the acquired consolidated businesses are included in the accompanying consolidated financial statements from their respective dates of acquisition. These acquisitions placed the Company in new markets or expanded the Company’s presence in current markets.
The Company also engages in investing transactions that are not business combinations. These transactions primarily consist of acquisitions and sales of non-controlling equity interests in surgical facilities and the investment of additional cash in surgical facilities under development. During the first quarter of 2009, the Company acquired an incremental ownership of 18.0% in its surgical facility located in Westlake Village, California for $416,000. Prior to the acquisition, the Company owned 1.0% of this facility. The acquisition was financed with cash from operations.
Effective September 1, 2009, the Company acquired an ownership of 28.8% in a surgical facility located in Gresham, Oregon for
F-13
$525,000. The acquisition was financed with cash from operations. The Company accounts for this investment under the equity method.
During 2008, the Company acquired an incremental ownership of 16.7% in its surgical facility located in Irvine, California for $3.1 million and an incremental ownership of 18.0% in its surgical facility located in Arcadia, California for $304,000. Prior to the acquisitions, the Company owned 15.3% of the Irvine, California surgical facility and 19.2% of the Arcadia, California surgical facility.
Additionally during 2008, the Company acquired an incremental ownership of 18.5% in its surgical facility located in Irvine, California for $5.1 million. Through this acquisition, the Company obtained a controlling interest in the facility. The acquisition was treated as a business combination and the Company began consolidating the facility for financial reporting purposes in 2008. The Company also acquired an incremental ownership in three other of its existing surgical facilities located in California. The Company acquired an incremental ownership of 10.7% in two surgical facilities located in Beverly Hills, California for an aggregate of $2.5 million and a 6.4% incremental ownership in a surgical facility located in Encino, California for $2.0 million. Prior to the acquisitions, the Company owned 55.1% and 57.0% of the two Beverly Hills, California surgical facilities and 55.5% of the Encino, California surgical facility.
4. Discontinued Operations and Divestitures
The Company evaluates its portfolio of surgical facilities to ensure the facilities are performing as expected. During 2010, the Company committed to a plan to divest its interest in four facilities that are consolidated for financial reporting purposes. In September 2010, the Company sold its interest in a surgical facility located in Orlando, Florida for net proceeds of $1.3 million and recognized a loss of $2.2 million, which includes an accrual of $1.7 million for future contractual obligations under a facility operating lease. As of December 31, 2010, the lease liability was $1.4 million. In October 2010, the Company sold its interest in a surgical facility located in Duncanville, Texas for net proceeds of $1.0 million and recognized a gain of $256,000. In December 2010, the Company sold its interest in surgical facilities located in Hammond, Louisiana and Vincennes, Indiana for net proceeds of $583,000 and $591,000, respectively, and recognized a gain of $109,000 and a loss of $275,000, respectively. All of the aforementioned divestitures were included in losses from discontinued operations. These facilities' assets, liabilities, revenues, expenses and cash flows have been classified as discontinued operations for all periods presented.
During the fourth quarter of 2010, the Company took one facility located in San Antonio, Texas, previously listed as held for sale, off the market. The results of operations for this surgical facility have been reclassified from discontinued operations to continuing operations for all periods presented. Revenues and the net income for the years ended December 31, 2010, 2009 and 2008 related to this facility, which has been recast as continuing operations, are as follows:
Year Ended December 31, | |||||||||||
2010 | 2009 | 2008 | |||||||||
Revenues | $ | 4,457 | $ | 4,381 | $ | 4,584 | |||||
Net income | $ | 67 | $ | 166 | $ | 359 | |||||
In February 2009, the Company ceased operations at its surgical facility located in Englewood, Colorado. A loss was recorded on the disposal of $5.9 million, which included an accrual of $4.6 million for future contractual obligations under a facility operating lease. The Company terminated this contractual lease obligation in July 2010 and paid cash of $1.2 million to settle the $3.6 million balance remaining on the obligation. A $2.4 million gain is included in the loss from discontinued operations as of December 31, 2010.
Revenues, the loss on operations before income taxes, income tax provision (benefit), gain (loss) on sale, net of taxes and the loss from discontinued operations net of taxes for the years ended December 31, 2010, 2009 and 2008 related to discontinued operations were as follows (in thousands):
Year Ended December 31, | |||||||||||
2010 | 2009 | 2008 | |||||||||
Revenues | $ | 8,697 | $ | 14,548 | $ | 17,879 | |||||
Loss on operations, before taxes | $ | (1,337 | ) | $ | (18 | ) | $ | (953 | ) | ||
Income tax provision (benefit) | $ | 5 | $ | 41 | $ | (1,383 | ) | ||||
Gain (loss) on sale, net of taxes | $ | 378 | $ | (5,840 | ) | $ | (3,527 | ) | |||
Loss from discontinued operations, net of taxes | $ | (964 | ) | $ | (5,899 | ) | $ | (3,097 | ) | ||
Effective February 1, 2010, the Company disposed of its ownership interest in its surgical facility located in Arcadia, California. The Company recorded an impairment charge related to this equity method investment of $2.4 million in 2009. Effective July 10, 2009, the Company disposed of its ownership interest in its surgical facility located in Temple, Texas. A loss of $273,000 was recorded in the quarter ended June 30, 2009. Because both of these investments were accounted for under the equity method, the results of operations for these facilities are not reported as discontinued operations. The loss on disposal of these facilities is included in impairment and loss on disposal of long-lived assets.
5. Goodwill and Intangible Assets
The Company tests its goodwill and intangible assets for impairment at least annually, or more frequently if certain indicators arise. The Company tests goodwill at the reporting unit level, which the Company concludes is the consolidated results of Symbion, Inc. The
F-14
Company completed the required annual impairment testing as of December 31, 2010, 2009 and 2008.
During 2010, the Company performed its impairment test by developing a fair value estimate of the business enterprise as of December 31, 2010 using a discounted cash flow approach and corroborated this analysis using a market-based approach. As the Company does not have publicly traded equity from which to derive a market value, an assessment of peer company data was performed whereby the Company selected comparable peers based on growth and leverage ratios, as well as industry specific characteristics. Management estimated a reasonable market value of the Company as of December 31, 2010 based on earnings multiples and trading data of the Company's peers. This market-based approach was then used to corroborate the results of the discounted cash flows approach. No impairment was indicated as of December 31, 2010.
Changes in the carrying amount of goodwill are as follows (in thousands):
Balance at December 31, 2009 | $ | 545,238 | |
Acquisitions | 81,283 | ||
Purchase price allocations | (109 | ) | |
Disposals | (1,675 | ) | |
Balance at December 31, 2010 | $ | 624,737 | |
Purchase price allocations for the period reflect adjustments to the identifiable net assets of acquired facilities. As a result of the acquisition of a 54.5% ownership interest in a general acute care hospital with a surgical and obstetrics focus, located in Idaho Falls, Idaho during the second quarter of 2010, the Company recorded goodwill of $50.2 million. As a result of the acquisition of an incremental, controlling ownership interest in its Chesterfield, Missouri facility during the third quarter of 2010, the Company recorded goodwill of $31.1 million.
Effective December 31, 2010, the Company disposed of its facilities located in Hammond, Louisiana and Vincennes, Indiana, including goodwill of $506,000. Effective October 31, 2010, the Company disposed of its facility located in Duncanville, Texas, including goodwill of $417,000. Effective September 30, 2010, the Company disposed of its facility located in Orlando, Florida, including goodwill of $752,000.
Effective November 15, 2010, the Company acquired an oncology practice, which is operated within the Company's existing facility located in Idaho Falls, Idaho. As a result of this acquisition, the Company recorded intangible assets related to a non-compete agreement of $2.3 million. This intangible asset will be amortized over a five year term. Additionally, the Company has intangible assets related to the certificates of need for certain of its facilities of $19.5 million. These indefinite-lived assets are not amortized, but are assessed for possible impairment under the Company's impairment policy.
6. Operating Leases
The Company leases office space and equipment for its surgical facilities, including surgical facilities under development. The lease agreements generally require the lessee to pay all maintenance, property taxes, utilities and insurance costs. The Company accounts for operating lease obligations and sublease income on a straight-line basis. Contingent obligations of the Company are recognized when specific contractual measures have been met, which is typically the result of an increase in the Consumer Price Index. Lease obligations paid in advance are included in prepaid rent. The difference between actual lease payments and straight-line lease expense over the original lease term, excluding optional renewal periods, is included in deferred rent.
The future minimum lease payments under non-cancelable operating leases at December 31, 2010 are as follows (in thousands):
2011 | $ | 22,675 | |
2012 | 21,510 | ||
2013 | 18,726 | ||
2014 | 15,595 | ||
2015 | 9,692 | ||
Thereafter | 39,571 | ||
Total minimum lease payments | $ | 127,769 | |
Total rent and lease expense was $24.5 million, $24.4 million and $20.9 million for the periods ended December 31, 2010, 2009 and 2008, respectively. The Company incurred rental expense of $5.6 million, $5.6 million and $4.6 million under operating leases with physician investors and an entity that is an affiliate of one of the Company’s former directors for the periods ended December 31, 2010, 2009 and 2008, respectively.
F-15
7. Long-Term Debt
The Company’s long-term debt is summarized as follows (in thousands)
December 31, | |||||||
2010 | 2009 | ||||||
Senior secured credit facility | $ | 277,500 | $ | 232,125 | |||
Senior PIK toggle notes | 232,000 | 206,967 | |||||
Notes payable to banks | 19,104 | 14,323 | |||||
Secured term loans | 2,918 | 2,510 | |||||
Capital lease obligations | 5,090 | 8,951 | |||||
536,612 | 464,876 | ||||||
Less current maturities | (29,195 | ) | (20,118 | ) | |||
$ | 507,417 | $ | 444,758 | ||||
Senior Secured Credit Facility
On August 23, 2007, the Company entered into a $350.0 million senior secured credit facility with a syndicate of banks. The senior secured credit facility extends credit in the form of two term loans of $125.0 million each (the first, the “Tranche A Term Loan” and the second, the “Tranche B Term Loan”) and a $100.0 million revolving, swingline and letter of credit facility (the “Revolving Facility”). The swingline facility is limited to $10.0 million and the swingline loans are available on a same-day basis. The letter of credit facility is limited to $10.0 million. The Company is the borrower under the senior secured credit facility, and all of its wholly owned subsidiaries are guarantors. Under the terms of the senior secured credit facility, entities that become wholly owned subsidiaries must also guarantee the debt.
The Tranche A Term Loan matures on August 23, 2013, the Tranche B Term Loan matures on August 23, 2014 and the Revolving Facility matures on August 23, 2013. The Tranche A Term Loan requires quarterly payments of $4.7 million from December 31, 2010 through September 30, 2011, quarterly payments of $6.3 million from December 31, 2011 through September 30, 2012, quarterly payments of $18.1 million from December 31, 2012 through June 30, 2013 and a balloon payment of $12.6 million on August 23, 2013. The Tranche B Term Loan requires quarterly principal payments of $312,500 through June 30, 2014 and a balloon payment of $111.1 million on August 23, 2014.
At the Company’s option, the term loans bear interest at the lender’s alternate base rate in effect on the applicable borrowing date plus an applicable alternate base rate margin, or Eurodollar rate in effect on the applicable borrowing date, plus an applicable Eurodollar rate margin. Both the applicable alternate base rate margin and applicable Eurodollar rate margin will vary depending upon the ratio of the Company’s total indebtedness to consolidated EBITDA.
The senior secured credit facility permits the Company to declare and pay dividends only in additional shares of its stock except for the following exceptions. Restricted Subsidiaries, as defined in the credit agreement, may declare and pay dividends ratably with respect to their capital stock. The Company may declare and pay cash dividends or make other distributions to Holdings provided the proceeds are used by Holdings to (i) purchase or redeem equity interest of Holdings acquired by former or current employees, consultants or directors of Holdings, the Company or any Restricted Subsidiary or (ii) pay principal or interest on promissory notes that were issued in lieu of cash payments for the repurchase or redemption of such Equity Instruments, provided that the aggregate amount of such dividends or other distributions shall not exceed $3.0 million in any fiscal year. Any unused amounts that are permitted to be paid under this provision are available to be carried over to subsequent fiscal years provided that certain conditions are met. The Company may also make payments to Holdings to pay franchise taxes and other fees required to maintain its corporate existence provided such payments do not exceed $3.0 million in any calendar year and also make payments in the amount necessary to enable Holdings to pay income taxes directly attributable to the operations of the Company and to make $1.0 million in annual advisory and management agreement payments. The Company may also make additional payments to Holdings in an aggregate amount not to exceed $5.0 million throughout the term of the senior secured credit facility.
As of December 31, 2010, the amount outstanding under the senior secured credit facility was $277.5 million with an interest rate on the borrowings of 3.5%. The $100.0 million Revolving Facility includes a non-use fee of 0.5% of the portion of the facility not used. The Company pays this fee quarterly. As of December 31, 2010, the amount available under the Revolving Facility was $44.0 million.
Interest Rate Swap
On November 2, 2010, the Company entered into an interest rate swap agreement to protect the Company against certain interest rate fluctuations of the LIBOR rate on $100.0 million of the Company’s variable rate debt under the senior secured credit facility, with Goldman Sachs, Inc., as counterparty. The effective date of the interest rate swap was December 31, 2010, and it is scheduled to expire on December 31, 2012. The interest rate swap effectively fixes the Company’s LIBOR interest rate on the $100.0 million of variable debt at a rate of 0.85%.
The FASB established a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in
F-16
active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.
The Company determines the fair value of its interest rate swap based on the amount at which it could be settled, which is referred to as the exit price. This price is based upon observable market assumptions and appropriate valuation adjustments for credit risk. The Company has categorized its interest rate swap as Level 2.
The Company does not hold or issue derivative financial instruments for trading purposes. The fair value of the Company’s interest rate swap at December 31, 2010 reflected a liability of approximately $314,000. The interest rate swap reflects a liability balance as of December 31, 2010 because of a decrease in market interest rates since inception.
At inception, the Company designated the interest rate swap as a cash flow hedge instrument. The Company assesses the effectiveness of this cash flow hedge instrument on a quarterly basis. As of December 31, 2010, the Company determined the hedge instrument to be effective.
Senior PIK Toggle Notes
On June 3, 2008, the Company completed a private offering of $179.9 million aggregate principal amount of the 11.00%/11.75% Senior PIK Toggle Notes due 2015. Interest on the Toggle Notes is due February 23 and August 23 of each year. The Toggle Notes will mature on August 23, 2015. For any interest period through August 23, 2011, the Company may elect to pay interest on the Toggle Notes (i) in cash, (ii) in kind, by increasing the principal amount of the notes or issuing new notes (referred to as “PIK interest”) for the entire amount of the interest payment or (iii) by paying interest on 50% of the principal amount of the Toggle Notes in cash and 50% in PIK interest. Cash interest on the Toggle Notes will accrue at the rate of 11.0% per annum. PIK interest on the Toggle Notes will accrue at the rate of 11.75% per annum. The proceeds from the issuance of the Toggle Notes were used exclusively to repay the bridge facility.
Since August 23, 2008, the Company has elected the PIK option of the Toggle Notes in lieu of making scheduled interest payments for various interest periods. As a result, the principal due on the Toggle Notes has increased by $52.1 million from the issuance of the Toggle Notes to December 31, 2010. On August 23, 2010, the Company elected the PIK option of the Toggle Notes in lieu of making scheduled interest payments for the interest period from August 24, 2010 to February 23, 2011. The Company has accrued $9.7 million in interest in other accrued expenses as of December 31, 2010. As of December 31, 2010, the amount outstanding under the Toggle Notes was $232.0 million.
The Toggle Notes are unsecured senior obligations and rank equally with other existing and future senior indebtedness, senior to all future subordinated indebtedness and effectively junior to all secured indebtedness to the extent of the value of the collateral securing such indebtedness. Certain existing subsidiaries have guaranteed the Toggle Notes on a senior basis, as required by the indenture. The indenture also requires that certain of the Company’s future subsidiaries guarantee the Toggle Notes on a senior basis. Each guarantee is unsecured and ranks equally with senior indebtedness of the guarantor, senior to all of the guarantor’s subordinated indebtedness and effectively junior to its secured indebtedness to the extent of the value of the collateral securing such indebtedness.
The indenture governing the Toggle Notes contains various restrictive covenants, including financial covenants that limit the Company’s ability and the ability of the subsidiaries to borrow money or guarantee other indebtedness, grant liens, make investments, sell assets, pay dividends or engage in transactions with affiliates.
At December 31, 2010, the Company was in compliance with all material covenants required by each of the senior secured credit facility and the Toggle Notes.
Notes Payable to Banks
Certain subsidiaries of the Company have outstanding bank indebtedness of $19.1 million which is collateralized by the real estate and equipment owned by the surgical facilities to which the loans were made. The various bank indebtedness agreements contain covenants to maintain certain financial ratios and also restrict encumbrance of assets, creation of indebtedness, investing activities and payment of distributions. During 2010, the Company extinguished certain facility level notes payable to banks. The Company recognized a gain of $1.9 million due to this debt extinguishment.
Capital Lease Obligations
The Company is liable to various vendors for several equipment leases. The outstanding balance related to these capital leases at December 31, 2010 and 2009 was $5.1 million and $9.0 million, respectively. The carrying value of the assets was $5.2 million and $5.7 million as of December 31, 2010 and 2009, respectively.
F-17
Other Long-Term Debt Information
Scheduled maturities of obligations as of December 31, 2010 are as follows (in thousands):
Long-term Debt | Capital Lease Obligations | Total | |||||||||
2011 | $ | 26,804 | $ | 2,391 | $ | 29,195 | |||||
2012 | 101,841 | 1,428 | 103,269 | ||||||||
2013 | 56,833 | 1,046 | 57,879 | ||||||||
2014 | 113,001 | 146 | 113,147 | ||||||||
2015 | 1,043 | 79 | 1,122 | ||||||||
Thereafter | 232,000 | — | 232,000 | ||||||||
$ | 531,522 | $ | 5,090 | $ | 536,612 | ||||||
8. Income Taxes
The Company and its subsidiaries file a consolidated federal income tax return. The partnerships and limited liability companies file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in the taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners. The Company made income tax payments of $474,000 and $288,000 for the periods ended December 31, 2010 and 2009, respectively.
Income tax expense from continuing operations is comprised of the following (in thousands):
Year Ended December 31, 2010 | Year Ended December 31, 2009 | Year Ended December 31, 2008 | |||||||||
Current: | |||||||||||
Federal | $ | (1,763 | ) | $ | (111 | ) | $ | (1,756 | ) | ||
State | 272 | 669 | 441 | ||||||||
Deferred | 9,278 | 7,204 | 14,779 | ||||||||
Income tax expense | $ | 7,787 | $ | 7,762 | $ | 13,464 | |||||
A reconciliation of the provision for income taxes as reported and the amount computed by multiplying the income (loss) before taxes by the U.S. federal statutory rate of 35% was as follows (in thousands):
Year Ended December 31, 2010 | Year Ended December 31, 2009 | Year Ended December 31, 2008 | |||||||||
Tax at U.S. statutory rates | $ | 9,409 | $ | 3,828 | $ | 6,854 | |||||
State income taxes, net of federal tax benefit | 1,328 | 565 | 988 | ||||||||
Change in valuation allowance | 3,720 | 10,260 | 14,468 | ||||||||
Expiration of capital loss carryforwards | 2,666 | — | — | ||||||||
Net income attributable to noncontrolling interests | (9,405 | ) | (6,906 | ) | (8,337 | ) | |||||
Other | 69 | 15 | (509 | ) | |||||||
$ | 7,787 | $ | 7,762 | $ | 13,464 | ||||||
F-18
The components of temporary differences and the approximate tax effects that give rise to the Company’s net deferred tax liability are as follows at December 31 (in thousands):
2010 | 2009 | ||||||
Deferred tax assets: | |||||||
Accrued malpractice reserve | $ | 595 | $ | 678 | |||
Accrued vacation and bonus | 778 | 296 | |||||
Net operating loss carryforwards | 39,157 | 26,116 | |||||
Deferred project costs | 31 | 84 | |||||
Deferred rent | 245 | 979 | |||||
Interest rate swap | 115 | 1,964 | |||||
Capital loss carryforward | 4,639 | 5,619 | |||||
Stock option compensation | 3,519 | 3,139 | |||||
Other deferred assets | 723 | 406 | |||||
Total gross deferred tax assets | 49,802 | 39,281 | |||||
Less: Valuation allowance | (44,053 | ) | (37,371 | ) | |||
Total deferred tax assets | 5,749 | 1,910 | |||||
Deferred tax liabilities: | |||||||
Depreciation on property and equipment | (1,333 | ) | (193 | ) | |||
Amortization of intangible assets | (2,696 | ) | (2,241 | ) | |||
Basis differences of partnerships and joint ventures | (47,781 | ) | (39,150 | ) | |||
Deferred financing costs and OID | (2,905 | ) | (461 | ) | |||
Basis difference on divestitures | (2,158 | ) | — | ||||
Other liabilities | (183 | ) | (209 | ) | |||
Total deferred tax liabilities | (57,056 | ) | (42,254 | ) | |||
Net deferred tax liability | $ | (51,307 | ) | $ | (40,344 | ) | |
As of December 31, 2010, the Company has recorded current deferred tax assets and net non-current deferred tax liabilities of $2,000 and $51.3 million, respectively. The Company had federal net operating loss carryforwards of $88.1 million as of December 31, 2010, which expire between 2027 and 2030. The Company had state net operating loss carryforwards of $193.9 million as of December 31, 2010, which expire between 2010 and 2030. The Company had capital loss carryforwards of $13.3 million as of December 31, 2010, which expire between 2010 and 2015.
The Company recorded a valuation allowance against deferred tax assets at December 31, 2010 and December 31, 2009 totaling $44.1 and $37.4 million, respectively, which represents an increase of approximately $6.7 million. The valuation allowance has been provided for certain deferred tax assets, for which the Company believes it is more likely than not that the assets will not be realized. Included in the change in valuation allowance was a decrease of approximately $681,000 that was recorded to Other Comprehensive Income related to the tax effect of the interest rate swap changes. In addition, approximately $1.9 million of the increase in the valuation allowance was recorded to additional paid in capital as the result of the tax effect of the acquisitions and disposals of shares of noncontrolling interests.
For the year ended December 31, 2010, the Company recorded income tax expense of $4,900 related to discontinued operations.
A reconciliation of the beginning and ending liability for gross unrecognized tax benefits at December 31, 2010 and 2009 is as follows (in thousands).
2010 | 2009 | ||||||
Unrecognized tax benefits balance at January 1 | $ | 3,315 | $ | 44 | |||
Additions based on tax provisions related to the current year | — | 3,094 | |||||
Additions for tax positions of prior years | 386 | 190 | |||||
Reductions for settlements with taxing authorities | (22 | ) | (13 | ) | |||
Reductions for the expiration of statutes of limitations | (101 | ) | |||||
Unrecognized tax benefits balance at December 31 | $ | 3,578 | $ | 3,315 | |||
The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2010 and 2009, the Company had approximately $163,000 and $96,000 of accrued interest and penalties related to uncertain tax positions, respectively.
The Company's U.S. federal and state income tax returns for tax years 2006 and beyond remain subject to examination. During
F-19
2010, the Company was notified that the Internal Revenue Service would commence an audit of the Company's federal income tax returns for the years ended December 31, 2006 through 2009.
The Company believes that it is reasonably possible that the reserve for uncertain tax positions may be reduced by approximately $3.4 million in the coming twelve months principally as a result of the settlement of currently ongoing examinations. The reasonably possible change of $3.4 million is related to the carryback of the Company's net operating loss, and included in other current liabilities in the consolidated balance sheet as of December 31, 2010.
Total amount of accrued liabilities related to uncertain tax positions that would affect the Company's effective tax rate if recognized is $3.5 million as of December 31, 2010 and $3.2 million as of December 31, 2009.
9. Stock Options
Overview
The Company recognizes in the financial statements the cost of employee services received in exchange for awards of equity instruments based on the fair value of those awards.
The Company uses the Black-Scholes option pricing model to value any options awarded subsequent to adoption of ASC 718, Compensation, Stock Compensation. The Black-Scholes option pricing model was developed for use in estimating the fair value of traded options, which have no vesting restrictions and are fully transferable. All option pricing models require the input of highly subjective assumptions including the expected stock price volatility and the expected exercise patterns of the option holders.
The Company is a participant in the Symbion Holdings Corporation 2007 Equity Incentive Plan (the “2007 Plan”). In connection with the Merger, certain members of Predecessor’s management rolled over 974,396 predecessor options into the 2007 Plan. The rollover options were exchanged for 611,799 options under the 2007 Plan. The conversion ratio was determined by the difference between $22.35, the share price paid to stockholders on the merger date, less the exercise price of each option, ignoring options with an exercise price greater than $22.35. The aggregate sum of the difference for each option was divided by $8.50 to determine the number of rollover options. The exercise price of each rollover option is $1.50 per share and the options expire on the expiration date of the original grants.
The Company’s stock option compensation expense estimate can vary in the future depending on many factors, including levels of options and awards granted in the future, forfeitures and when option or award holders exercise these awards and depending on whether performance targets are met and a liquidity event occurs.
On August 31, 2007, Holdings granted 1,302,317 time-vested options and 1,606,535 performance vested options to certain employees of the Company. The maximum contractual term of the options is ten years, or earlier if the employee terminates employment before that time. The time-vested options vest over a five-year period with 20% of the options vesting each year. The Company’s policy is to recognize compensation expense over the straight line method. The performance vested options shall vest and become exercisable upon a liquidity event and the obtainment of internal rate of return targets as defined in the 2007 Plan. No expense has been recorded in the statement of operations for the performance based shares as the conditions for vesting are not probable.
During 2010, the Company issued to certain employees 187,682 options to purchase shares of common stock included in the August 31, 2007 grant, which were reserved for issuance for positions to be filled after the initial grant. During 2009, the Company issued to certain employees 94,417 options included in the August 31, 2007 grant. The Company began expensing these options during the requisite service period.
Valuation Methodology
The fair values of the options were derived using the Black-Scholes option pricing model. In applying the Black-Scholes option pricing model, the Company used the following assumptions:
▪ | Weighted average risk-free interest rate. The risk-free interest rate is used as a component of the fair value of stock options to take into account the time value of money. For the risk-free interest rate, the Company uses the implied yield on United States Treasury zero-coupon issues with a remaining term equal to the expected life, in years, of the options granted. |
▪ | Expected volatility. Volatility, for the purpose of stock-based compensation, is a measurement of the amount that a share price has fluctuated. Expected volatility involves reviewing historical volatility and determining what, if any, change the share price will have in the future. FASB recommended that companies such as Holdings, whose common stock is not publicly traded or had a limited public stock trading history, use average volatilities of similar entities. As a result, the Company has used the average volatilities of some of its competitors as an estimate in determining stock option fair values. |
▪ | Expected life, in years. A clear distinction is made between the expected life of the option and the contractual term of the option. The expected life of the option is considered the amount of time, in years, that the option is expected to be outstanding before it is exercised. Whereas, the contractual term of the stock option is the term the option is valid before it expires. |
▪ | Expected dividend yield. Since issuing dividends will affect the fair value of a stock option, GAAP requires companies to estimate future dividend yields or payments. The Company has not historically issued dividends and does not intend to issue |
F-20
dividends in the future.
▪ | Expected forfeiture rate. The Company uses an estimated forfeiture rate based on historical experience for the respective position held by the option holder. The Company reviews the forfeiture estimate annually in comparison to the actual forfeiture rate experienced. |
The following table summarizes the assumptions used by the Company in the valuation of the time-vested options for the various periods:
Weighted average fair value per share | Weighted average risk-free interest rate | Expected volatility | Expected life, in years | Expected dividend yield | Expected forfeiture rate | |||||||||||||
March 31, 2008 | $ | 4.72 | 4.4 | % | 42.0 | % | 6.5 | — | % | 4.0 | % | |||||||
March 31, 2009 | $ | 0.70 | 0.5 | % | 42.0 | % | 6.5 | — | % | 4.0 | % | |||||||
March 31, 2010 | $ | 2.13 | 2.7 | % | 42.0 | % | 6.5 | — | % | 4.0 | % | |||||||
Pro Forma Net Income
The Company recorded non-cash compensation expense of $1.3 million for each of the years ended December 31, 2010 and 2009 and $2.1 million for the year ended December 31, 2008. After noncontrolling interests and the related tax benefit, the Company recorded a net impact of approximately $818,000 for 2010, $793,000 for 2009 and $1.3 million for 2008.
Outstanding Option Information
The following is a summary of option transactions since the December 31, 2007:
Stock Options | Number of Shares | Weighted Average Exercise Price | Weighted Average Fair Value | Total Fair Value | Aggregate Intrinsic Value | Weighted Average Remaining Contractual term | |||||||||||||||
(in thousands) | (in years) | ||||||||||||||||||||
2008 Activity | |||||||||||||||||||||
Granted | — | — | — | — | — | — | |||||||||||||||
Exercised | — | — | — | — | — | — | |||||||||||||||
Forfeited | 78,527 | — | — | — | — | — | |||||||||||||||
Vested | 275,213 | 10.00 | 4.90 | 1,349 | — | 8.6 | |||||||||||||||
Expired | — | — | — | — | — | — | |||||||||||||||
Outstanding as of December 31, 2008 | 3,442,124 | 8.49 | 5.60 | 19,287 | — | 7.8 | |||||||||||||||
Exercisable at December 31, 2008 | 1,147,475 | 5.47 | 6.99 | 8,017 | 1.52 | 6.6 | |||||||||||||||
2009 Activity | |||||||||||||||||||||
Granted | — | $ | — | $ | — | $ | — | $ | — | — | |||||||||||
Exercised | — | — | — | — | — | — | |||||||||||||||
Forfeited | 69,538 | — | — | — | — | — | |||||||||||||||
Vested | 284,655 | 10.00 | 4.76 | 1,355 | — | 7.7 | |||||||||||||||
Expired | — | — | — | — | — | — | |||||||||||||||
Outstanding as of December 31, 2009 | 3,372,586 | 8.46 | 5.62 | 18,945 | — | 6.5 | |||||||||||||||
Exercisable at December 31, 2009 | 1,432,129 | $ | 6.37 | $ | 6.54 | $ | 9,372 | $ | 0.18 | 6.1 | |||||||||||
2010 Activity | |||||||||||||||||||||
Granted | — | $ | — | $ | — | $ | — | $ | — | — | |||||||||||
Exercised | (19,009 | ) | — | — | — | — | — | ||||||||||||||
Forfeited | 16,307 | — | — | — | — | — | |||||||||||||||
Vested | 284,655 | 10.00 | 4.60 | 1,308,970 | — | 6.9 | |||||||||||||||
Expired | — | — | — | — | — | — | |||||||||||||||
Outstanding as of December 31, 2010 | 3,337,270 | 8.45 | 5.62 | 18,758,498 | — | 5.7 | |||||||||||||||
Exercisable at December 31, 2010 | 1,697,776 | $ | 7.16 | $ | 6.34 | $ | 10,767,383 | $ | — | 5.3 | |||||||||||
F-21
As of December 31, 2010, the total compensation expense related to non-vested time-based awards not yet recognized was $1.5 million. Substantially all of this expense will be recognized over three years.
The following table summarizes information regarding the options outstanding at December 31, 2010:
Options Outstanding | Options Exercisable | ||||||||||||||||||
Exercise Prices | Outstanding as of December 31, 2010 | Weighted-Average Remaining Contractual Life | Weighted-Average Exercise Price | Exercisable as of December 31, 2010 | Weighted-Average Exercise Price | ||||||||||||||
$ | 1.50 | 592,790 | 3.07 | $ | 1.50 | 592,790 | $ | 1.50 | |||||||||||
10.00 | 2,744,480 | 4.22 | 10.00 | 1,104,986 | 10.00 | ||||||||||||||
3,337,270 | — | 7.98 | 1,697,776 | — | |||||||||||||||
Total unvested share awards as of December 31, 2010 are summarized as follows:
Stock Options | Number of Shares | Weighted Average Exercise Price | Weighted Average Fair Value | Total Fair Value | Aggregate Intrinsic Value | Weighted Average Remaining Contractual term | ||||||||||||||
(in thousands) | (in years) | |||||||||||||||||||
Unvested at January 1, 2010 | 1,940,456 | $ | 10.00 | $ | 4.93 | $ | 9,569 | — | 7.8 | |||||||||||
Forfeited | 16,307 | — | — | — | — | — | ||||||||||||||
Vested | 284,655 | 10.00 | 4.60 | 1,309 | — | 6.9 | ||||||||||||||
Unvested at December 31, 2010 | 1,639,494 | 10.00 | 4.23 | 6,940 | — | 4.2 | ||||||||||||||
10. Employee Benefit Plans
Symbion, Inc. 401(k) Plan
The Symbion, Inc. 401(k) Plan (the “401(k) Plan”) is a defined contribution plan whereby employees who have completed six months of service in which they have worked a minimum of 1,000 hours and are age 21 or older are eligible to participate. Employees may enroll in the plan on either January 1 or July 1 of each year. The 401(k) Plan allows eligible employees to make contributions of varying percentages of their annual compensation, up to the maximum allowed amounts by the Internal Revenue Service. Eligible employees may or may not receive a match by the Company of their contributions. The match varies depending on location and is determined prior to the start of each plan year. Generally, employer contributions vest 20% after two years of service and continue vesting at 20% per year until fully vested. The Company’s matching expense for the years ended December 31, 2010, 2009 and 2008 was $665,000, $326,000 and $1.1 million, respectively.
Supplemental Retirement Savings Plan
The Company adopted the supplemental retirement savings plan (the “SERP”) in May 2005. The SERP provides supplemental retirement alternatives to eligible officers and key employees of the Company by allowing participants to defer portions of their compensation. Under the SERP, eligible employees may enroll in the plan before December 31 to be entered in the plan the following year. Eligible employees may defer into the SERP up to 25% of their normal period payroll and up to 50% of their annual bonus. If the enrolled employee contributes a minimum of 2% of his or her base salary into the SERP, the Company will contribute 2% of the enrolled employee’s base salary to the plan and has the option of contributing additional amounts. Periodically, the enrolled employee’s deferred amounts are transferred to a plan administrator. The plan administrator maintains separate non-qualified accounts for each enrolled employee to track deferred amounts. On May 1 of each year, the Company is required to make its contribution to each enrolled employee’s account. Compensation expense recorded by the Company related to the Company’s contribution to the SERP was $44,000, $53,000 and $54,000, for years ended December 31, 2010, 2009 and 2008, respectively.
11. Commitments and Contingencies
Debt and Lease Guaranty on Non-consolidated Entities
The Company has guaranteed $2.0 million of operating lease payments of certain non-consolidated surgical facilities. These operating leases typically have 10 year terms, with optional renewal periods. As of December 31, 2010, the Company has also guaranteed $1.7 million of debt of four non-consolidated surgical facilities. In the event that the Company meets certain financial and debt service benchmarks, the guarantees at these surgical facilities will expire between 2011 and 2017.
Professional, General and Workers’ Compensation Liability Risks
The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. To cover these claims, the Company maintains general liability and professional
F-22
liability insurance in excess of self-insured retentions through a third party commercial insurance carrier in amounts that management believes is sufficient for the Company’s operations, although, potentially, some claims may exceed the scope of coverage in effect. This insurance coverage is on a claims-made basis. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that would have a material adverse effect on the Company’s business, financial condition or results of operations. The Company expenses the costs under the self-insured retention exposure for general and professional liability claims which relate to (i) deductibles on claims made during the policy period, and (ii) an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions for professional liability are based upon actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Based on historical results and data currently available, management does not believe a change in one or more of these assumptions will have a material impact on the Company’s consolidated financial position or results of operations.
Laws and Regulations
Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. Compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company’s practices. It is the Company’s current practice and future intent to cooperate fully with such inquiries. The Company is not aware of any such inquiry that would have a material adverse effect on the Company’s consolidated financial position or results of operations.
Acquired Facilities
The Company, through its wholly owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure itself that no such liabilities exist and obtains indemnification from prospective sellers covering such matters and institutes policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.
The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. The Company believes, however, that it will be able to adjust its operations so as to be in compliance with any regulatory or statutory provision as may be applicable.
Potential Physician Investor Liability
A majority of the physician investors in the partnerships and limited liability companies which operate the Company’s surgical facilities carry general and professional liability insurance on a claims-made basis. Each investee may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.
12. Related Party Transactions
In addition to related party transactions discussed elsewhere in the notes to the accompanying consolidated financial statements, the consolidated financial statements include the following related party transactions. On August 23, 2007, the Company entered into a ten year advisory services and management agreement with Crestview Advisors, L.L.C. The annual management fee is $1.0 million and is payable on August 23 of each year. The Company has prepaid this annual management fee and, for the year ended December 31, 2010, has an asset of $638,356 that is included in prepaid expenses and other current assets.
As of December 31, 2010 and 2009, the Company had $575,000 and $545,000, respectively, payable to physicians at the Company's physician network as a result of cash receipts in excess of expenditures for the related facilities. These amounts are included in other accrued expenses.
F-23
13. Selected Quarterly Financial Data (Unaudited)
The following is selected quarterly financial data for each of the four quarters in 2010 and 2009. Quarterly results are not necessarily representative of operations for a full year.
2010 | |||||||||||||||
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | ||||||||||||
(unaudited and in thousands) | |||||||||||||||
Revenues | $ | 83,545 | $ | 103,463 | $ | 104,821 | $ | 114,221 | |||||||
Cost of revenues | 61,203 | 72,618 | 75,294 | 81,030 | |||||||||||
(Loss) income from continuing operations | (924 | ) | 5,981 | 6,781 | 7,257 | ||||||||||
Net (loss) income | (5,648 | ) | (1,058 | ) | 283 | (2,317 | ) | ||||||||
2009 | |||||||||||||||
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | ||||||||||||
(unaudited and in thousands) | |||||||||||||||
Revenues | $ | 81,513 | $ | 85,901 | $ | 84,357 | $ | 85,173 | |||||||
Cost of revenues | 55,151 | 60,218 | 61,928 | 62,106 | |||||||||||
Income (loss) from continuing operations | 3,586 | 3,526 | (3,149 | ) | (787 | ) | |||||||||
Net loss | (9,013 | ) | (1,896 | ) | (7,044 | ) | (4,501 | ) | |||||||
14. Financial Information for the Company and Its Subsidiaries
The Company conducts substantially all of its business through its subsidiaries. Presented below is condensed consolidating financial information for the Company and its subsidiaries as required by regulations of the Securities and Exchange Commission (“SEC”) in connection with the Company’s Toggle Notes that have been registered with the SEC. The information segregates the parent company issuer, the combined wholly-owned subsidiary guarantors, the combined non-guarantors, and consolidating adjustments. The operating and investing activities of the separate legal entities are fully interdependent and integrated. Accordingly, the results of the separate legal entities are not representative of what the operating results would be on a stand-alone basis. All of the subsidiary guarantees are both full and unconditional and joint and several.
F-24
SYMBION, INC.
CONSOLIDATING BALANCE SHEET
December 31, 2010
Parent Issuer | Guarantor Subsidiaries | Combined Non-Guarantors | Eliminations | Total Consolidated | |||||||||||||||
ASSETS | |||||||||||||||||||
Current assets: | |||||||||||||||||||
Cash and cash equivalents | $ | 14,849 | $ | 27,700 | $ | 30,909 | $ | — | $ | 73,458 | |||||||||
Accounts receivable, net | — | 554 | 61,271 | — | 61,825 | ||||||||||||||
Inventories | — | 159 | 10,639 | — | 10,798 | ||||||||||||||
Prepaid expenses and other current assets | 1,201 | 78 | 7,355 | — | 8,634 | ||||||||||||||
Due from related parties | 2,285 | 43,798 | — | (46,083 | ) | — | |||||||||||||
Deferred tax asset | 2 | — | — | — | 2 | ||||||||||||||
Current assets of discontinued operations | — | — | 1,003 | — | 1,003 | ||||||||||||||
Total current assets | 18,337 | 72,289 | 111,177 | (46,083 | ) | 155,720 | |||||||||||||
Property and equipment, net | 1,005 | 2,329 | 137,298 | — | 140,632 | ||||||||||||||
Goodwill and intangible assets | 646,554 | — | — | — | 646,554 | ||||||||||||||
Investments in and advances to affiliates | 96,761 | 23,711 | 5,903 | (108,551 | ) | 17,824 | |||||||||||||
Other assets | 7,979 | 1 | 1,653 | — | 9,633 | ||||||||||||||
Long-term assets of discontinued operations | — | — | 34 | — | 34 | ||||||||||||||
Total assets | $ | 770,636 | $ | 98,330 | $ | 256,065 | $ | (154,634 | ) | $ | 970,397 | ||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||||
Current liabilities: | |||||||||||||||||||
Accounts payable | $ | 15 | $ | 103 | $ | 12,278 | $ | — | $ | 12,396 | |||||||||
Accrued payroll and benefits | 2,014 | 138 | 7,938 | — | 10,090 | ||||||||||||||
Due to related parties | — | — | 46,083 | (46,083 | ) | — | |||||||||||||
Other accrued expenses | 15,906 | 331 | 9,577 | — | 25,814 | ||||||||||||||
Current maturities of long-term debt | 21,783 | 42 | 7,370 | — | 29,195 | ||||||||||||||
Current liabilities of discontinued operations | — | — | 923 | — | 923 | ||||||||||||||
Total current liabilities | 39,718 | 614 | 84,169 | (46,083 | ) | 78,418 | |||||||||||||
Long-term debt, less current maturities | 487,994 | 84 | 19,339 | — | 507,417 | ||||||||||||||
Deferred income tax payable | 51,307 | — | 2 | — | 51,309 | ||||||||||||||
Other liabilities | 288 | 871 | 67,791 | — | 68,950 | ||||||||||||||
Long-term liabilities of discontinued operations | — | — | 22 | — | 22 | ||||||||||||||
Noncontrolling interest - redeemable | — | — | 36,030 | — | 36,030 | ||||||||||||||
Total Symbion, Inc. stockholders’ equity | 191,329 | 96,761 | 5,887 | (108,551 | ) | 185,426 | |||||||||||||
Noncontrolling interests - nonredeemable | — | — | 42,825 | — | 42,825 | ||||||||||||||
Total equity | 191,329 | 96,761 | 48,712 | (108,551 | ) | 228,251 | |||||||||||||
Total liabilities and stockholders’ equity | $ | 770,636 | $ | 98,330 | $ | 256,065 | $ | (154,634 | ) | $ | 970,397 | ||||||||
F-25
SYMBION, INC.
CONSOLIDATING BALANCE SHEET
December 31, 2009
Parent Issuer | Guarantor Subsidiaries | Combined Non-Guarantors | Eliminations | Total Consolidated | |||||||||||||||
ASSETS | |||||||||||||||||||
Current assets: | |||||||||||||||||||
Cash and cash equivalents | $ | 11,272 | $ | 14,992 | $ | 21,485 | $ | — | $ | 47,749 | |||||||||
Accounts receivable, net | — | 586 | 34,405 | — | 34,991 | ||||||||||||||
Inventories | — | — | 9,361 | — | 9,361 | ||||||||||||||
Prepaid expenses and other current assets | 4,234 | 416 | 7,642 | — | 12,292 | ||||||||||||||
Deferred tax asset | 432 | — | — | — | 432 | ||||||||||||||
Current assets of discontinued operations | — | — | 2,934 | — | 2,934 | ||||||||||||||
Total current assets | 15,938 | 15,994 | 75,827 | — | 107,759 | ||||||||||||||
Property and equipment, net | 1,331 | 433 | 86,092 | — | 87,856 | ||||||||||||||
Goodwill and intangible assets | 564,718 | — | — | — | 564,718 | ||||||||||||||
Investments in and advances to affiliates | 107,051 | 91,802 | 4,193 | (185,394 | ) | 17,652 | |||||||||||||
Other assets | 9,790 | 44 | 826 | — | 10,660 | ||||||||||||||
Long-term assets of discontinued operations | — | — | 2,081 | — | 2,081 | ||||||||||||||
Total assets | $ | 698,828 | $ | 108,273 | $ | 169,019 | $ | (185,394 | ) | $ | 790,726 | ||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||||
Current liabilities: | |||||||||||||||||||
Accounts payable | $ | 15 | $ | 136 | $ | 7,367 | $ | — | $ | 7,518 | |||||||||
Accrued payroll and benefits | 464 | 593 | 4,749 | — | 5,806 | ||||||||||||||
Other accrued expenses | 17,296 | 390 | 13,241 | — | 30,927 | ||||||||||||||
Current maturities of long-term debt | 10,865 | — | 9,253 | — | 20,118 | ||||||||||||||
Current liabilities of discontinued operations | — | — | 2,608 | — | 2,608 | ||||||||||||||
Total current liabilities | 28,640 | 1,119 | 37,218 | — | 66,977 | ||||||||||||||
Long-term debt, less current maturities | 428,655 | — | 16,103 | — | 444,758 | ||||||||||||||
Deferred income tax payable | 40,424 | — | 352 | — | 40,776 | ||||||||||||||
Other liabilities | 3,503 | 103 | 2,281 | — | 5,887 | ||||||||||||||
Long-term liabilities of discontinued operations | — | — | 3,868 | — | 3,868 | ||||||||||||||
Noncontrolling interest - redeemable | — | — | 31,650 | — | 31,650 | ||||||||||||||
Total Symbion, Inc. stockholders’ equity | 197,606 | 107,051 | 74,150 | (185,394 | ) | 193,413 | |||||||||||||
Noncontrolling interests - nonredeemable | — | — | 3,397 | — | 3,397 | ||||||||||||||
Total equity | 197,606 | 107,051 | 77,547 | (185,394 | ) | 196,810 | |||||||||||||
Total liabilities and stockholders’ equity | $ | 698,828 | $ | 108,273 | $ | 169,019 | $ | (185,394 | ) | $ | 790,726 | ||||||||
F-26
SYMBION, INC.
CONSOLIDATING STATEMENT OF OPERATIONS
For the year ended December 31, 2010
Parent Issuer | Guarantor Subsidiaries | Combined Non-Guarantors | Eliminations | Total Consolidated | |||||||||||||||
Revenues | $ | 35,101 | $ | 9,846 | $ | 376,719 | $ | (15,616 | ) | $ | 406,050 | ||||||||
Operating expenses: | |||||||||||||||||||
Salaries and benefits | — | 4,558 | 109,037 | — | 113,595 | ||||||||||||||
Supplies | — | 833 | 92,026 | — | 92,859 | ||||||||||||||
Professional and medical fees | — | 1,064 | 28,008 | — | 29,072 | ||||||||||||||
Rent and lease expense | — | 748 | 23,801 | — | 24,549 | ||||||||||||||
Other operating expenses | — | 434 | 29,636 | — | 30,070 | ||||||||||||||
Cost of revenues | — | 7,637 | 282,508 | — | 290,145 | ||||||||||||||
General and administrative expense | 22,464 | — | — | — | 22,464 | ||||||||||||||
Depreciation and amortization | 680 | 301 | 17,919 | 18,900 | |||||||||||||||
Provision for doubtful accounts | — | 176 | 6,462 | — | 6,638 | ||||||||||||||
Income on equity investments | — | (2,901 | ) | — | — | (2,901 | ) | ||||||||||||
Impairment and gains on disposal of long-lived assets | (911 | ) | — | — | — | (911 | ) | ||||||||||||
Litigation settlements, net | (35 | ) | — | — | (35 | ) | |||||||||||||
Management fees | — | — | 15,616 | (15,616 | ) | — | |||||||||||||
Business combination remeasurement gains | (3,169 | ) | — | — | — | (3,169 | ) | ||||||||||||
Equity in earnings of affiliates | (22,088 | ) | (17,454 | ) | — | 39,542 | — | ||||||||||||
Total operating expenses | (3,059 | ) | (12,241 | ) | 322,505 | 23,926 | 331,131 | ||||||||||||
Operating income (loss) | 38,160 | 22,087 | 54,214 | (39,542 | ) | 74,919 | |||||||||||||
Interest (expense) income, net | (39,213 | ) | 1 | (8,825 | ) | — | (48,037 | ) | |||||||||||
(Loss) income before taxes and discontinued operations | (1,053 | ) | 22,088 | 45,389 | (39,542 | ) | 26,882 | ||||||||||||
Provision for income taxes | 7,687 | — | 100 | — | 7,787 | ||||||||||||||
(Loss) income from continuing operations | (8,740 | ) | 22,088 | 45,289 | (39,542 | ) | 19,095 | ||||||||||||
Loss from discontinued operations, net of taxes | — | — | (964 | ) | — | (964 | ) | ||||||||||||
Net (loss) income | (8,740 | ) | 22,088 | 44,325 | (39,542 | ) | 18,131 | ||||||||||||
Net income attributable to noncontrolling interests | — | — | (26,871 | ) | — | (26,871 | ) | ||||||||||||
Net (loss) income attributable to Symbion, Inc. | $ | (8,740 | ) | $ | 22,088 | $ | 17,454 | $ | (39,542 | ) | $ | (8,740 | ) | ||||||
F-27
SYMBION, INC.
CONSOLIDATING STATEMENT OF OPERATIONS
For the year ended December 31, 2009
Parent Issuer | Guarantor Subsidiaries | Combined Non-Guarantors | Eliminations | Total Consolidated | |||||||||||||||
Revenues | $ | 35,064 | $ | 9,299 | $ | 307,957 | $ | (15,376 | ) | $ | 336,944 | ||||||||
Operating expenses: | |||||||||||||||||||
Salaries and benefits | — | 4,751 | 89,986 | — | 94,737 | ||||||||||||||
Supplies | — | 698 | 70,952 | — | 71,650 | ||||||||||||||
Professional and medical fees | — | 1,153 | 20,821 | — | 21,974 | ||||||||||||||
Rent and lease expense | — | 772 | 23,675 | — | 24,447 | ||||||||||||||
Other operating expenses | — | 507 | 26,088 | — | 26,595 | ||||||||||||||
Cost of revenues | — | 7,881 | 231,522 | — | 239,403 | ||||||||||||||
General and administrative expense | 21,448 | — | — | — | 21,448 | ||||||||||||||
Depreciation and amortization | 696 | 270 | 15,841 | — | 16,807 | ||||||||||||||
Provision for doubtful accounts | — | 198 | 2,683 | — | 2,881 | ||||||||||||||
Income on equity investments | — | (2,318 | ) | — | — | (2,318 | ) | ||||||||||||
Impairment and gains on disposal of long-lived assets | 835 | 2,422 | — | — | 3,257 | ||||||||||||||
Proceeds from insurance settlements, net | — | (430 | ) | — | — | (430 | ) | ||||||||||||
Management fees | — | — | 15,376 | (15,376 | ) | — | |||||||||||||
Equity in earnings of affiliates | (23,814 | ) | (22,544 | ) | — | 46,358 | — | ||||||||||||
Total operating expenses | (835 | ) | (14,521 | ) | 265,422 | 30,982 | 281,048 | ||||||||||||
Operating income (loss) | 35,899 | 23,820 | 42,535 | (46,358 | ) | 55,896 | |||||||||||||
Interest (expense) income, net | (51,134 | ) | (6 | ) | 6,182 | — | (44,958 | ) | |||||||||||
(Loss) income before taxes and discontinued operations | (15,235 | ) | 23,814 | 48,717 | (46,358 | ) | 10,938 | ||||||||||||
Provision for income taxes | 7,219 | — | 543 | — | 7,762 | ||||||||||||||
(Loss) income from continuing operations | (22,454 | ) | 23,814 | 48,174 | (46,358 | ) | 3,176 | ||||||||||||
Loss from discontinued operations, net of taxes | — | — | (5,899 | ) | — | (5,899 | ) | ||||||||||||
Net (loss) income | (22,454 | ) | 23,814 | 42,275 | (46,358 | ) | (2,723 | ) | |||||||||||
Net loss attributable to noncontrolling interests | — | — | (19,731 | ) | — | (19,731 | ) | ||||||||||||
Net (loss) income attributable to Symbion, Inc. | $ | (22,454 | ) | $ | 23,814 | $ | 22,544 | $ | (46,358 | ) | $ | (22,454 | ) | ||||||
F-28
SYMBION, INC.
CONSOLIDATING STATEMENT OF OPERATIONS
For the Year Ended December 31, 2008
Parent Issuer | Guarantor Subsidiaries | Combined Non-Guarantors | Eliminations | Total Consolidated | |||||||||||||||
Revenues | $ | 35,122 | $ | 10,685 | $ | 291,351 | $ | (15,674 | ) | $ | 321,484 | ||||||||
Operating expenses: | |||||||||||||||||||
Salaries and benefits | — | 17,229 | 71,247 | — | 88,476 | ||||||||||||||
Supplies | — | 923 | 63,340 | — | 64,263 | ||||||||||||||
Professional and medical fees | — | 5,416 | 12,141 | — | 17,557 | ||||||||||||||
Rent and lease expense | — | 2,032 | 18,895 | — | 20,927 | ||||||||||||||
Other operating expenses | — | 3,658 | 20,991 | — | 24,649 | ||||||||||||||
Cost of revenues | — | 29,258 | 186,614 | — | 215,872 | ||||||||||||||
General and administrative expense | 23,923 | — | — | — | 23,923 | ||||||||||||||
Depreciation and amortization | 280 | 492 | 14,073 | — | 14,845 | ||||||||||||||
Provision for doubtful accounts | — | 262 | 3,297 | — | 3,559 | ||||||||||||||
Income on equity investments | — | (1,504 | ) | — | — | (1,504 | ) | ||||||||||||
Impairment and gains on disposal of long-lived assets | — | — | 897 | — | 897 | ||||||||||||||
Litigation settlements, net | — | — | 893 | — | 893 | ||||||||||||||
Management fees | — | — | 15,674 | (15,674 | ) | — | |||||||||||||
Equity in earnings of affiliates | (22,312 | ) | (39,841 | ) | — | 62,153 | — | ||||||||||||
Total operating expenses | 1,891 | (11,333 | ) | 221,448 | 46,479 | 258,485 | |||||||||||||
Operating income (loss) | 33,231 | 22,018 | 69,903 | (62,153 | ) | 62,999 | |||||||||||||
Interest (expense) income, net | (41,977 | ) | 294 | (1,732 | ) | — | (43,415 | ) | |||||||||||
(Loss) income before taxes and discontinued operations | (8,746 | ) | 22,312 | 68,171 | (62,153 | ) | 19,584 | ||||||||||||
Provision for income taxes | 12,052 | — | 1,412 | — | 13,464 | ||||||||||||||
(Loss) income from continuing operations | (20,798 | ) | 22,312 | 66,759 | (62,153 | ) | 6,120 | ||||||||||||
Loss from discontinued operations, net of taxes | — | — | (3,097 | ) | — | (3,097 | ) | ||||||||||||
Net (loss) income | (20,798 | ) | 22,312 | 63,662 | (62,153 | ) | 3,023 | ||||||||||||
Net income attributable to noncontrolling interests | — | — | (23,821 | ) | — | (23,821 | ) | ||||||||||||
Net income (loss) attributable to Symbion, Inc. | $ | (20,798 | ) | $ | 22,312 | $ | 39,841 | $ | (62,153 | ) | $ | (20,798 | ) | ||||||
F-29
SYMBION, INC.
CONSOLIDATING STATEMENT OF CASH FLOWS
For the year ended December 31, 2010
Parent Issuer | Guarantor Subsidiaries | Combined Non- Guarantors | Eliminations | Total Consolidated | |||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||
Net (loss) income | $ | (8,740 | ) | $ | 22,088 | $ | 44,325 | $ | (39,542 | ) | $ | 18,131 | |||||||
Adjustments to reconcile net (loss) income to net cash from operating activities: | |||||||||||||||||||
Loss from discontinued operations | — | — | 964 | — | 964 | ||||||||||||||
Depreciation and amortization | 680 | 301 | 17,919 | — | 18,900 | ||||||||||||||
Amortization of deferred financing costs | 2,004 | — | — | — | 2,004 | ||||||||||||||
Non-cash payment-in-kind interest option | 26,079 | — | — | — | 26,079 | ||||||||||||||
Non-cash stock option compensation expense | 1,336 | — | — | — | 1,336 | ||||||||||||||
Non-cash recognition of other comprehensive loss into earnings | 2,732 | — | — | — | 2,732 | ||||||||||||||
Non-cash credit risk adjustment of financial instruments | 189 | — | — | — | 189 | ||||||||||||||
Non-cash gains | (4,080 | ) | — | — | — | (4,080 | ) | ||||||||||||
Deferred income taxes | 10,979 | — | — | — | 10,979 | ||||||||||||||
Equity in earnings of consolidated affiliates | (22,088 | ) | (17,454 | ) | — | 39,542 | — | ||||||||||||
Equity in earnings of unconsolidated affiliates, net of distributions received | — | 50 | — | — | 50 | ||||||||||||||
Provision for doubtful accounts | — | 176 | 6,462 | — | 6,638 | ||||||||||||||
Changes in operating assets and liabilities, net of effect of acquisitions and dispositions: | |||||||||||||||||||
Accounts receivable | — | — | (14,886 | ) | — | (14,886 | ) | ||||||||||||
Income taxes payable | 2,298 | — | — | — | 2,298 | ||||||||||||||
Other assets and liabilities | (54,224 | ) | 51,652 | 7 | — | (2,565 | ) | ||||||||||||
Net cash (used in) provided by operating activities — continuing operations | (42,835 | ) | 56,813 | 54,791 | — | 68,769 | |||||||||||||
Net cash used in operating activities —discontinued operations | — | — | (550 | ) | — | (550 | ) | ||||||||||||
Net cash (used in) provided by operating activities | (42,835 | ) | 56,813 | 54,241 | — | 68,219 | |||||||||||||
Cash flows from investing activities: | |||||||||||||||||||
Payments for acquisitions, net of cash acquired | — | (44,105 | ) | — | — | (44,105 | ) | ||||||||||||
Purchases of property and equipment, net | (196 | ) | — | (8,516 | ) | — | (8,712 | ) | |||||||||||
Payments from unit activity of unconsolidated facilities | (55 | ) | (55 | ) | |||||||||||||||
Change in other assets | — | — | (278 | ) | — | (278 | ) | ||||||||||||
Net cash used in investing activities —continuing operations | (251 | ) | (44,105 | ) | (8,794 | ) | — | (53,150 | ) | ||||||||||
Net cash used in investing activities —discontinued operations | — | — | (19 | ) | — | (19 | ) | ||||||||||||
Net cash used in investing activities | (251 | ) | (44,105 | ) | (8,813 | ) | — | (53,169 | ) | ||||||||||
Cash flows from financing activities: | |||||||||||||||||||
Principal payments on long-term debt | (11,204 | ) | — | (11,298 | ) | — | (22,502 | ) | |||||||||||
Proceeds from debt issuances | 56,423 | — | 552 | — | 56,975 | ||||||||||||||
Distributions to noncontrolling interests | — | — | (26,292 | ) | — | (26,292 | ) | ||||||||||||
Proceeds from unit activity of consolidated facilities | 4,708 | — | — | — | 4,708 | ||||||||||||||
Other financing activities | (3,264 | ) | — | (42 | ) | — | (3,306 | ) | |||||||||||
Net cash provided by (used in) financing activities —continuing operations | 46,663 | — | (37,080 | ) | — | 9,583 | |||||||||||||
Net cash provided by financing activities —discontinued operations | — | — | 1,076 | — | 1,076 | ||||||||||||||
Net cash provided by (used in) financing activities | 46,663 | — | (36,004 | ) | — | 10,659 | |||||||||||||
Net increase in cash and cash equivalents | 3,577 | 12,708 | 9,424 | — | 25,709 | ||||||||||||||
Cash and cash equivalents at beginning of period | 11,272 | 14,992 | 21,485 | — | 47,749 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 14,849 | $ | 27,700 | $ | 30,909 | $ | — | $ | 73,458 | |||||||||
F-30
SYMBION, INC.
CONSOLIDATING STATEMENT OF CASH FLOWS
For the year ended December 31, 2009
Parent Issuer | Guarantor Subsidiaries | Combined Non- Guarantors | Eliminations | Total Consolidated | |||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||
Net (loss) income | $ | (22,454 | ) | $ | 23,814 | $ | 42,275 | $ | (46,358 | ) | $ | (2,723 | ) | ||||||
Adjustments to reconcile net (loss) income to net cash from operating activities: | |||||||||||||||||||
Loss from discontinued operations | — | — | 5,899 | — | 5,899 | ||||||||||||||
Depreciation and amortization | 696 | 270 | 15,841 | — | 16,807 | ||||||||||||||
Amortization of deferred financing costs | 2,004 | — | — | — | 2,004 | ||||||||||||||
Non-cash payment-in-kind interest option | 23,263 | — | — | — | 23,263 | ||||||||||||||
Non-cash stock option compensation expense | 1,297 | — | — | — | 1,297 | ||||||||||||||
Non-cash recognition of other comprehensive loss into earnings | 2,853 | — | — | — | 2,853 | ||||||||||||||
Non-cash credit risk adjustment of financial instruments | 1,629 | — | — | — | 1,629 | ||||||||||||||
Non-cash losses | 1,265 | 1,562 | — | — | 2,827 | ||||||||||||||
Deferred income taxes | 8,682 | — | — | — | 8,682 | ||||||||||||||
Equity in earnings of consolidated affiliates | (23,814 | ) | (22,544 | ) | — | 46,358 | — | ||||||||||||
Equity in earnings of affiliates, net of distributions received | — | (207 | ) | — | — | (207 | ) | ||||||||||||
Provision for doubtful accounts | — | 198 | 2,683 | — | 2,881 | ||||||||||||||
Changes in operating assets and liabilities, net of effect of acquisitions and dispositions: | |||||||||||||||||||
Accounts receivable | — | — | (4,383 | ) | — | (4,383 | ) | ||||||||||||
Income taxes payable | 1,762 | — | — | — | 1,762 | ||||||||||||||
Other assets and liabilities | 19,678 | 2,098 | (24,083 | ) | — | (2,307 | ) | ||||||||||||
Net cash provided by operating activities — continuing operations | 16,861 | 5,191 | 38,232 | — | 60,284 | ||||||||||||||
Net cash provided by operating activities —discontinued operations | — | — | 62 | — | 62 | ||||||||||||||
Net cash provided by operating activities | 16,861 | 5,191 | 38,294 | — | 60,346 | ||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||
Payments for acquisitions, net of cash acquired | (126 | ) | — | — | — | (126 | ) | ||||||||||||
Purchases of property and equipment, net | (226 | ) | — | (9,378 | ) | — | (9,604 | ) | |||||||||||
Payments from unit activity of unconsolidated facilities | (724 | ) | — | — | — | (724 | ) | ||||||||||||
Change in other assets | — | — | (690 | ) | — | (690 | ) | ||||||||||||
Net cash used in investing activities —continuing operations | (1,076 | ) | — | (10,068 | ) | — | (11,144 | ) | |||||||||||
Net cash used in investing activities —discontinued operations | — | — | (301 | ) | — | (301 | ) | ||||||||||||
Net cash used in investing activities | (1,076 | ) | — | (10,369 | ) | — | (11,445 | ) | |||||||||||
Cash flows from financing activities: | |||||||||||||||||||
Principal payments on long-term debt | (4,046 | ) | — | (9,603 | ) | — | (13,649 | ) | |||||||||||
Proceeds from debt issuances | — | — | 678 | — | 678 | ||||||||||||||
Payment of debt issuance costs | (203 | ) | — | — | — | (203 | ) | ||||||||||||
Distributions to noncontrolling interests | — | — | (24,971 | ) | — | (24,971 | ) | ||||||||||||
Proceeds from unit activity of consolidated facilities | 307 | — | — | — | 307 | ||||||||||||||
Other financing activities | (4,940 | ) | — | — | — | (4,940 | ) | ||||||||||||
Net cash used in financing activities —continuing operations | (8,882 | ) | — | (33,896 | ) | — | (42,778 | ) | |||||||||||
Net cash used in financing activities —discontinued operations | — | — | (108 | ) | — | (108 | ) | ||||||||||||
Net cash used in financing activities | (8,882 | ) | — | (34,004 | ) | — | (42,886 | ) | |||||||||||
Net increase (decrease) in cash and cash equivalents | 6,903 | 5,191 | (6,079 | ) | — | 6,015 | |||||||||||||
Cash and cash equivalents at beginning of period | 4,369 | 9,801 | 27,564 | — | 41,734 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 11,272 | $ | 14,992 | $ | 21,485 | $ | — | $ | 47,749 | |||||||||
F-31
SYMBION, INC.
CONSOLIDATING STATEMENT OF CASH FLOWS
For the year ended December 31, 2008
Parent Issuer | Guarantor Subsidiaries | Combined Non- Guarantors | Eliminations | Total Consolidated | |||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||
Net (loss) income | $ | (20,798 | ) | $ | 22,312 | $ | 63,662 | $ | (62,153 | ) | $ | 3,023 | |||||||
Adjustments to reconcile net (loss) income to net cash from operating activities: | |||||||||||||||||||
Loss from discontinued operations | — | — | 3,097 | — | 3,097 | ||||||||||||||
Depreciation and amortization | 280 | 492 | 14,073 | — | 14,845 | ||||||||||||||
Amortization of deferred financing costs | 4,477 | — | — | — | 4,477 | ||||||||||||||
Non-cash payment-in-kind interest option | 17,616 | — | — | — | 17,616 | ||||||||||||||
Non-cash stock option compensation expense | 2,114 | — | — | — | 2,114 | ||||||||||||||
Non-cash gains and losses | — | — | 897 | — | 897 | ||||||||||||||
Deferred income taxes | 13,718 | — | — | — | 13,718 | ||||||||||||||
Equity in earnings of affiliates | (22,312 | ) | (39,841 | ) | — | 62,153 | — | ||||||||||||
Equity in earnings of unconsolidated affiliates, net of distributions received | — | 333 | — | — | 333 | ||||||||||||||
Provision for doubtful accounts | — | 262 | 3,297 | — | 3,559 | ||||||||||||||
Changes in operating assets and liabilities, net of effect of acquisitions and dispositions: | |||||||||||||||||||
Accounts receivable | — | — | (3,278 | ) | — | (3,278 | ) | ||||||||||||
Income tax payable | 1,895 | — | — | — | 1,895 | ||||||||||||||
Other assets and liabilities | 24,203 | 19,180 | (44,746 | ) | — | (1,363 | ) | ||||||||||||
Net cash provided by operating activities — continuing operations | 21,193 | 2,738 | 37,002 | — | 60,933 | ||||||||||||||
Net cash provided by operating activities — discontinued operations | — | — | 1,736 | — | 1,736 | ||||||||||||||
Net cash provided by operating activities | 21,193 | 2,738 | 38,738 | — | 62,669 | ||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||
Payments for acquisitions, net of cash acquired | — | — | (15,695 | ) | — | (15,695 | ) | ||||||||||||
Purchases of property and equipment, net | (580 | ) | — | (15,129 | ) | — | (15,709 | ) | |||||||||||
Change in other assets | (1,517 | ) | — | — | — | (1,517 | ) | ||||||||||||
Net cash used in investing activities —continuing operations | (2,097 | ) | — | (30,824 | ) | — | (32,921 | ) | |||||||||||
Net cash used in investing activities — discontinued operations | — | — | (286 | ) | — | (286 | ) | ||||||||||||
Net cash used in investing activities | (2,097 | ) | — | (31,110 | ) | — | (33,207 | ) | |||||||||||
Cash flows from financing activities: | |||||||||||||||||||
Principal payments on long-term debt | (13,513 | ) | — | (5,066 | ) | — | (18,579 | ) | |||||||||||
Repayment of bridge facility | (179,937 | ) | — | — | — | (179,937 | ) | ||||||||||||
Proceeds from debt issuances | 12,639 | — | 852 | — | 13,491 | ||||||||||||||
Proceeds from issuance of Toggle Notes | 179,937 | — | — | — | 179,937 | ||||||||||||||
Payment of debt issuance costs | (4,739 | ) | — | — | — | (4,739 | ) | ||||||||||||
Distributions to noncontrolling interests | — | — | (23,423 | ) | — | (23,423 | ) | ||||||||||||
Proceeds from unit activity of consolidated facilities | 219 | — | — | — | 219 | ||||||||||||||
Other financing obligations | (22,352 | ) | — | 23,665 | — | 1,313 | |||||||||||||
Net cash used in financing activities —continuing operations | (27,746 | ) | — | (3,972 | ) | — | (31,718 | ) | |||||||||||
Net cash used in financing activities — discontinued operations | — | — | (106 | ) | — | (106 | ) | ||||||||||||
Net cash used in financing activities | (27,746 | ) | — | (4,078 | ) | — | (31,824 | ) | |||||||||||
Net (decrease) increase in cash and cash equivalents | (8,650 | ) | 2,738 | 3,550 | — | (2,362 | ) | ||||||||||||
Cash and cash equivalents at beginning of period | 13,019 | 7,063 | 24,014 | — | 44,096 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 4,369 | $ | 9,801 | $ | 27,564 | $ | — | $ | 41,734 | |||||||||
F-32
15. Subsequent Events
The Company has evaluated subsequent events through the date that the Consolidated Financial Statements were issued, and concluded there are no material subsequent events.
F-33
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SYMBION, INC. | ||
March 25, 2011 | By: | /s/ Richard E. Francis, Jr. |
Richard E. Francis, Jr. | ||
Chairman of the Board and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in capacities and on the dates indicated.
Signature | Title | Date | ||
/s/ Richard E. Francis, Jr. | Chairman of the Board, Chief Executive Officer and Director | |||
Richard E. Francis, Jr. | (Principal Executive Officer) | March 25, 2011 | ||
/s/ Teresa F. Sparks | Senior Vice President of Financial and Chief Financial Officer | |||
Teresa F. Sparks | (Principal Financial and Accounting Officer) | March 25, 2011 | ||
/s/ Clifford G. Adlerz | ||||
Clifford G. Adlerz | President, Chief Operating Officer and Director | March 25, 2011 | ||
/s/ Thomas S. Murphy, Jr. | ||||
Thomas S. Murphy, Jr. | Director | March 25, 2011 | ||
/s/ Robert V. Delaney | ||||
Robert V. Delaney | Director | March 25, 2011 | ||
/s/ Quentin Chu | ||||
Quentin Chu | Director | March 25, 2011 | ||
/s/ Kurt E. Bolin | ||||
Kurt E. Bolin | Director | March 25, 2011 | ||
/s/ Craig R. Callen | ||||
Craig R. Callen | Director | March 25, 2011 |
Exhibit Index
No. | Description | ||
2 | Agreement and Plan of Merger, dated as of April 24, 2007, by and among Symbol Acquisition, L.L.C., Symbol Merger Sub, Inc. and Symbion, Inc. (a) | ||
3.1 | Amended Certificate of Incorporation of Symbion, Inc. (b) | ||
3.2 | Amended and Restated Bylaws of Symbion, Inc. (b) | ||
4.1 | Indenture, dated as of June 3, 2008, among Symbion, Inc., the Guarantors named therein and U.S. Bank National Association, as Trustee (b) | ||
4.2 | Form of Notes (included in Exhibit 4.1) | ||
4.3 | Registration Rights Agreement, dated as of June 3, 2007, among Symbion, Inc., the subsidiaries of Symbion, Inc. party thereto as guarantors, and Merrill, Lynch, Pierce, Fenner & Smith Incorporated, Banc of America Securities LLC and Greenwich Capital Markets, Inc. (b) | ||
4.4 | First Supplemental Indenture, dated as of September 18, 2008 among Symbion, Inc., the Guarantors named therein and U.S. Bank National Association, as Trustee (b) | ||
10.1 | Employment Agreement, dated August 23, 2007, between Symbion, Inc. and Richard E. Francis, Jr. (b) (g) | ||
10.2 | Employment Agreement, dated August 23, 2007, between Symbion, Inc. and Clifford G. Adlerz (b) (g) | ||
10.3 | Credit Agreement, dated as of August 23, 2007, among Symbol Holdings Corporation, Symbol Merger Sub, Inc., the Lenders party thereto from time to time, Merrill Lynch Capital Corporation as Administrative Agent and Collateral Agent, Bank of America, N.A. as Syndication Agent, The Royal Bank of Scotland PLC and Fifth Third Bank as Co-Documentation Agents, and Merrill Lynch & Co., Merrill, Lynch, Pierce, Fenner & Smith Incorporated and Banc of America Securities LLC as Joint Lead Arrangers and Joint Lead Bookrunners (c) | ||
10.4 | Lease Agreement, dated June 26, 2001, between Burton Hills IV Partners and Symbion, Inc. (d) | ||
10.5 | First Amendment to Lease Agreement, dated February 9, 2004, between Burton Hills IV Partners and Symbion, Inc. (e) | ||
10.6 | Symbion Holdings Corporation 2007 Equity Incentive Plan (b) (g) | ||
10.7 | Symbion, Inc. Executive Change in Control Severance Plan (b) (g) | ||
10.8 | Symbion Holdings Corporation Compensatory Equity Participation Plan (b) (g) | ||
10.9 | Shareholders Agreement, dated as of August 23, 2007, among Symbion Holdings Corporation and the stockholders of Symbion Holdings Corporation and other persons named therein (b) | ||
10.10 | Advisory Services and Monitoring Agreement, dated as of August 23, 2007, among Symbion, Inc., Symbion Holdings Corporation and Crestview Advisors, L.L.C. (b) | ||
10.11 | Form of Employee Contribution Agreement (b) | ||
10.12 | Symbion, Inc. Supplemental Executive Retirement Plan (f) (g) | ||
10.13 | Management Rights Purchase Agreement, dated as of July 27, 2005, by and among Parthenon Management Partners, LLC, Andrew A. Brooks, M.D., Randhir S. Tuli and SymbionARC Management Services, Inc. (c) | ||
10.14 | Interest Rate Swap Agreement, dated October 31, 2007, between Symbion, Inc and Merrill Lynch Capital Services, Inc. (c) | ||
10.15 | Interest Rate Swap Agreement, dated November 2, 2010, between Symbion, Inc. and Goldman Sachs Bank, USA | ||
21 | Subsidiaries of Registrant | ||
31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||
31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||
32.1 | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||
32.2 | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||
___________________________________________
(a) | Incorporated by reference to exhibits filed with the Registrant’s Current Report on Form 8-K filed April 24, 2007 (File No. 000-50574) |
(b) | Incorporated by reference to exhibits filed with the Registrant’s Registration Statement on Form S-4 (Registration No. 333-153678) |
(c) | Incorporated by reference to exhibits filed with the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2008, as amended (File No. 000-50574) |
(d) | Incorporated by reference to exhibits filed with the Registrant’s Registration Statement on Form S-1 (Registration No. 333-89554) |
(e) | Incorporated by reference to exhibits filed with the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2003 (File No. 000-50574) |
(f) | Incorporated by reference to exhibits filed with the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2005 (File No. 000-50574) |
(g) | Compensation plan or arrangement |